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ABSTRACT 
 
The ESCRT machinery has a well established role within the endocytic 
pathway. Studies conducted in Drosophila have identified ESCRT proteins as 
important regulators of epithelial cell polarity and growth. Consequently 
ESCRTs have been classified as potential tumour suppressors. Alterations in 
the expression of various ESCRT components have been observed in human 
cancers. However, the possible link between ESCRT proteins, mammalian 
epithelial cell polarity and tumourigenesis has not been investigated.  
 
This thesis demonstrates for the first time that the ESCRT-I protein, Tsg101, is 
required for maintenance of mammalian epithelial cell organisation and polarity. 
siRNA knockdown of Tsg101 in the human Caco-2 cell line results in the 
formation of a multilayered epithelium with compromised apicobasal polarity. In 
addition, Tsg101 depletion impairs differentiation of the epithelial sheet and 
formation of polarised 3D Caco-2 cysts.  
 
Depletion of Tsg101 also results in intracellular accumulation of the tight 
junction protein, claudin-1. This is shown to be constitutively endocytosed and 
recycled in Caco-2 epithelial monolayers, suggesting that ESCRT-I is required 
for claudin-1 recycling to tight junctions. Tsg101 knockdown also impairs 
epithelial barrier formation and enhances Caco-2 migratory ability. This 
suggests that tight junction integrity is impaired and may contribute to the loss 
of Caco-2 cell organisation and polarity observed upon Tsg101 depletion. 
 
Finally, Tsg101 depleted Caco-2 cells appear to overproliferate, forming 
multilayered regions of the epithelial sheet. However, multilayered cells are 
eventually eliminated via apoptosis. Preliminary results suggest that inhibition of 
this apoptotic response enhances the aberrant epithelial phenotype, suggesting 
that the ability to evade apoptosis may be an important factor in determining the 
tumourigenic potential of ESCRT-I depletion. 
 
Therefore, results presented in this thesis suggest that the role of ESCRT-I as a 
tumour suppressor is conserved from Drosophila to mammals.   
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1. INTRODUCTION 
 
1.1. Epithelial Cell Polarity 
 
Epithelial or epithelial-derived cells account for approximately 60% of 
mammalian cell types. The regulated association of these cells into epithelial 
sheets serves multiple functions, such as control of tissue architecture and 
barrier formation (Gibson and Perrimon, 2003; Bryant and Mostov, 2008). 
Epithelial cells are polarised along their apicobasal axis, which is achieved and 
maintained by asymmetric distribution of membrane proteins, lipids, the 
cytoskeleton and various other macromolecules within the cell. This results in 
the formation of apical and basolateral membrane domains with specific protein 
and lipid compositions (Figure 1.1) (Bryant and Mostov, 2008). Functionally 
distinct, apical surfaces are important for processes such as absorption and 
secretion; lateral membranes form cell-cell contacts with adjacent cells and are 
important for adhesion and diffusion barriers; and the basal surface contacts the 
underlying basement membrane and extracellular matrix (ECM). There are 
three key processes which are important for epithelial cell polarisation. These 
are formation of cell-cell junctions; asymmetrical distribution of polarity 
complexes; and interaction of cells with the ECM. These combined cues allow 
individual epithelial cells to establish polarity and coordinate to form a polarised 
tissue (Bryant and Mostov, 2008). 
 
1.1.1. Epithelial Cell-Cell Junctions 
 
Development and function of polarised epithelial tissues depends in part, on the 
formation of specialised cell-cell junctions. These form between the lateral 
membranes of adjacent cells and are composed of various transmembrane and 
membrane-associated proteins. The epithelial junctional complex is composed 
of tight junctions, adherens junctions and desmosomes (Figure 1.2). In addition, 
epithelial cells can also form gap junctions. These intercellular junctions play 
important roles in epithelial polarisation, cell-cell adhesion, barrier formation and 
signal transduction (Knust and Bossinger, 2002; Miyoshi and Takai, 2005; 
Balda and Matter, 2008).  
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  Side View    Top View 
 
 
 
 
 
 
 
Figure 1.1 Morphology of polarised epithelial cells. Most epithelial cells are polarised along 
their apicobasal axis resulting in distinct apical (red) and basolateral (green) membrane 
domains. Specialised cell-cell junctions form along lateral membranes of adjacent cells (side 
view), surrounding the circumference of each cell (top view). These junctions are important to 
maintain apicobasal polarity, cell-cell adhesion and to control diffusion across the epithelial 
sheet.  
 
 
Tight Junctions 
Tight junctions (TJs) form at the most apical part of the epithelial lateral 
membrane and appear as a series of very close membrane contacts between 
adjacent cells by transmission electron microscopy (Farquhar and Palade, 
1963). By freeze-fracture electron microscopy, TJs appear as a continuous 
network of intramembrane strands that encircle the cells (Staehelin, 1973). TJs 
define the boundary between the apical and basolateral membrane domains of 
epithelial cells. Here they serve a fence function to restrict intramembrane 
diffusion of lipids in the outer leaflet of the plasma membrane (Shin et al., 2006; 
Matter and Balda, 2007). This is thought to be important to help maintain 
apicobasal cell polarity although one study has demonstrated that in epithelial 
cells which mostly lack expression of the cytoplasmic TJ proteins, ZO-1, -2 and 
-3, apicobasal cell polarity is unperturbed despite a complete lack of TJ 
formation (Umeda et al., 2006).  
 
TJs also form a barrier to regulate paracellular diffusion across the epithelial 
sheet, which is crucial for the function of epithelial tissues (Matter and Balda, 
2007). This epithelial barrier is semipermeable, allowing selective diffusion of 
ions and small hydrophilic molecules depending on their charge and size. 
Paracellular permeability is regulated by various distinct molecular mechanisms. 
15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Composition of the epithelial junctional complex. Polarised epithelial cells form 
tight junctions (TJs), adherens junctions (AJs) and desmosomes, which collectively form the 
epithelial junctional complex. TJs are the most apical cell-cell junctions and mark the boundary 
between the apical (red) and basolateral (green) membrane domains. TJs are composed of 
three families of transmembrane proteins: claudins, TJ-associated MARVEL protein family 
(TAMP) occludin, marvelD3 and tricellulin, and JAMs. TJs interact with the actin cytoskeleton 
via various cytoplasmic adaptor proteins, such as the ZO-1. AJs are localised below TJs and 
are composed of transmembrane proteins, E-cadherin and nectin, which interact with 
cytoplasmic adaptor proteins, β-catenin and afadin, respectively. β-catenin binds to α-catenin 
which interacts with actin. p120-catenin also associates with the cadherin/catenin complex. 
Afadin binds to actin and can also interact with α-catenin. Lastly desmosomes are composed of 
transmembrane proteins, desmogleins and desmocollins, which bind to cytoplasmic proteins, 
plakoglobin and plakophilin. These interact with desmoplakin which associates with 
intermediate filaments. Epithelial cells also form cell-ECM contacts along the basal membrane 
(adapted from Miyoshi and Takai, 2005) 
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and can differ among epithelia (reviewed in Gonzalez-Mariscal et al., 2008). It is 
also becoming increasingly apparent that TJs play an important role in 
establishment of epithelial cell polarity, proliferation, differentiation and gene 
expression through multiple signalling mechanisms (reviewed in Kohler and 
Zahraoui, 2005; Shin et al., 2006; Matter and Balda, 2007). 
 
TJs are composed of three main families of transmembrane proteins. Claudins 
along with the tight junction associated MARVEL (MAL and related proteins for 
vesicle trafficking and membrane link) protein (TAMP) family, occludin, tricellulin 
and marvelD3, are all tetraspan transmembrane proteins whereas the junctional 
adhesion molecules (JAMs) are single-span transmembrane proteins (Shin et 
al., 2006; Chiba et al., 2008; Balda and Matter, 2008; Mariano et al., 2011).  
 
The claudins, a family of at least 27 proteins, are thought to be the main 
structural components of the TJ barrier (Mineta et al., 2011). These are 
expressed in a tissue-specific manner, with most cells expressing at least two 
claudin family members (Balda and Matter, 2008; Chiba et al., 2008). Various 
studies have indicated that claudins are important for the barrier function of TJs 
in epithelial tissues. Furthermore, TJ claudin composition determines the 
paracellular permeability of an epithelial tissue (reviewed in Van Itallie and 
Anderson, 2006; Krause et al., 2008). Some claudins are thought to tighten the 
paracellular barrier, for example a sealing function has been demonstrated for 
claudin-1 as knockout mice display defective epidermal barrier function and die 
soon after birth due to transepidermal water loss (Furuse et al., 2002). Similarly, 
in claudin-5 deficient mice leakage of small tracers across the brain 
endothelium is observed (Nitta et al., 2003) and claudin-14 knockout is thought 
to result in deafness due to perturbed barrier function of the inner ear epithelium 
(Ben-Yosef et al., 2003).  
 
In contrast, other claudins have been shown to increase permeability across the 
epithelium by forming charge-selective paracellular ion pores (Van Itallie and 
Anderson, 2006; Krause et al., 2008). For example, claudin-2 overexpression in 
MDCK cells results in the formation of paracellular cation pores increasing 
cation permeability across the epithelial sheet (Amasheh et al., 2002). 
Correlating with this, claudin-2 expression in vivo is found in leaky epithelia, 
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such as proximal renal tubules, where it is required for the cation paracellular 
permeability properties of the epithelium (Muto et al., 2010).  
  
The TAMP family of TJ transmembrane proteins includes occludin, the first 
transmembrane TJ protein to be identified (Furuse et al., 1993). However, the 
function of occludin remains to be fully determined. A role for occludin in the 
barrier and fence functions of TJs has been demonstrated, for example 
expression of mutant occludin in MDCK cells increases paracellular flux of small 
tracers and disrupts polarised distribution of the lipid sphingomyelin to the apical 
membrane (Balda et al., 1996). In contrast, occludin knockout mice appear to 
retain normal TJ morphology and barrier formation (Saitou et al., 2000). 
However, these knockout mice displayed growth retardation and histological 
abnormalities in various tissues, suggesting that the role of occludin is more 
complex than TJ barrier formation alone. Indeed occludin has been linked to 
regulation of various signalling pathways (reviewed in Chiba et al., 2008). 
Studies have demonstrated that occludin is important for regulation of the actin 
cytoskeleton in MDCK cells via RhoA signalling (Yu et al., 2005) and inhibition 
of apoptosis via mitogen-activated protein kinase (MAPK) signalling pathways 
(Murata et al., 2005). Therefore, further studies will no doubt continue to 
elucidate mechanisms underlying occludin function in epithelial tissues.   
 
More recently identified components of TJs, tricellulin and marvelD3, also 
belong to the TAMP family (Ikenouchi et al., 2005; Steed et al., 2009; Raleigh et 
al., 2010; Mariano et al., 2011). However, similarly to occludin, tricellulin and 
marvelD3 are unable to form tight junction strands in the absence of claudins 
(Ikenouchi et al., 2008; Raleigh et al., 2010). Tricellulin is enriched at contacts 
between three epithelial cells and is thought to play a role in TJ formation as 
RNAi knockdown impairs epithelial barrier formation (Ikenouchi et al., 2005). 
However, the only phenotype of mutations in the tricellulin gene in humans 
appears to be deafness (Riazuddin et al., 2006) and therefore, the precise 
function of tricellulin is still to be elucidated. MarvelD3 has also been shown to 
colocalise with occludin at TJs (Steed et al., 2009; Raleigh et al., 2010)  
Although marvelD3 is not required for TJ formation (Steed et al., 2009), studies 
suggest that this protein is important for permeability properties of epithelial 
monolayers. However, results from these studies seem to be somewhat 
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contrasting with one study demonstrating an increase in transepithelial 
resistance (TER) upon siRNA knockdown of marvelD3 in Caco-2 cells (Steed et 
al., 2009) whereas a delay in TER development was observed by another study 
(Raleigh et al., 2010). Therefore, the role of marvelD3 in TJ function remains to 
be clarified.  
 
Interactions between marvelD3 and both occludin and tricellulin have been 
observed whereas occludin and tricellulin do not appear to associate directly 
(Raleigh et al., 2010). It has been suggested that tricellulin and marvelD3 may 
be able to compensate for occludin loss as siRNA knockdown of occludin in 
MDCK cells induces redistribution of tricellulin from tricellular to bicellular TJs 
(Ikenouchi et al., 2008). In addition, increased tricellulin and marvelD3 
expression and localisation to TJs have been observed in vivo after tumour 
necrosis factor (TNF) treatment (Raleigh et al., 2010). TNF treatment of mice 
has previously been shown to disrupt the intestinal epithelial barrier and induce 
occludin internalisation (Clayburgh et al., 2005). Therefore, the observed 
increase in expression of tricellulin and marvelD3 may reflect an effort to 
stabilise the TJ and compensate for occludin loss, although this is not sufficient 
to restore barrier function (Raleigh et al., 2010). The possibility of overlapping 
functions of these three TJ proteins may provide an explanation as to why 
barrier function is not affected in occludin knockout mice (Saitou et al., 2000). 
 
The third transmembrane protein family found at TJs are JAMs. These are 
members of the immunoglobulin superfamily and are expressed in other cell 
types as well as epithelial cells, such as leukocytes and endothelial cells (Shin 
et al., 2006). This means that JAMs can regulate cell-cell adhesion between 
distinct as well as the same types of cells (Chiba et al., 2008). Four JAMs have 
been identified: JAM-A, -B, -C and -D and these proteins are thought to be 
involved in TJ formation and barrier function, although further work is required 
to understand the role of JAMs in more detail (Shin et al., 2006, Balda and 
Matter, 2008; Chiba et al., 2008). In addition to JAMs, other types of single-span 
transmembrane proteins associate with the TJ. These include Crumbs 3 
(CRB3), which is important for epithelial polarisation, and blood vessel 
epicardial substance (Bves), thought to contribute to the establishment and/or 
maintainence of TJs (Balda and Matter, 2008; Russ et al., 2011). 
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TJs composition also involves various cytoplasmic adaptor proteins which 
interact with the intracellular domains of the transmembrane TJ proteins. These 
cytoplasmic adaptor proteins have key roles in organisation of the 
transmembrane proteins, attachment to the actin cytoskeleton and initiation of 
cell signalling (reviewed in Shin et al., 2006). The most studied TJ adaptor 
protein is zonula occludens (ZO)-1, the first TJ protein to be identified 
(Stevenson et al., 1986). This is one of three ZO isoforms which belong to the 
membrane-associated guanylate kinase (MAGUK) family of proteins (Shin et 
al., 2006). ZO-1 contains several protein-protein interaction domains, allowing it 
to bind to claudins, ZO-2 or ZO-3, occludin, actin and α-catenin as well as 
several signalling proteins (Balda and Matter, 2008). ZO proteins play an 
important role in the assembly and function of TJs, for example simultaneous 
depletion of ZO-1, -2 and -3 in cultured epithelial cells inhibits claudin 
polymerisation during TJ formation (Umeda et al., 2006). 
 
Another important cytoplasmic protein which localises to TJs is cingulin (Citi et 
al., 1989). Cingulin interacts with other TJ proteins, ZO-1, ZO-2, ZO-3 and JAM-
A as well as actin and myosin, suggesting that cingulin is important for linking 
the TJ to the actin cytoskeletan (Cordenonsi et al., 1999; Bazzoni et al., 2000; 
D'Atri and Citi, 2001; D'Atri et al., 2002). Mutation of cingulin in mouse embryoid 
bodies does not disrupt TJ formation (Guillemot et al., 2004). This has also 
been demonstrated in MDCK cells, where depletion of cingulin has no effect on 
TJ organisation or barrier function (Guillemot and Citi, 2006). However, cingulin 
disruption results in increased protein and mRNA expression levels of various 
TJ proteins, including occludin, claudin-2 and ZO-3, suggesting that cingulin 
plays a role in transcriptional regulation of TJ proteins (Guillemot et al., 2004; 
Guillemot and Citi, 2006).  
 
Cingulin has also been shown to regulate RhoA signalling, which is important 
for epithelial proliferation (Aijaz et al., 2005; Guillemot and Citi, 2006). 
Interaction between cingulin and the RhoA guanine nucleotide exchange factor 
(GEF) protein, GEF-H1/Lfc, at TJs inactivates GEF-H1/Lfc and therefore, 
inhibits RhoA signalling (Aijaz et al., 2005). Consistent with this, depletion of 
cingulin results in increased RhoA activity causing increased cell proliferation 
and density (Guillemot and Citi, 2006). In addition, RhoA signalling is also 
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important for TJ assembly and a recent study has identified the RhoA GEF, 
p114RhoGEF, as an important regulator of RhoA activation specifically at cell-
cell junctions (Terry et al., 2011). Interestingly, this study also shows that 
recruitment of p114RhoGEF to TJs requires cingulin, therefore demonstrating 
additional roles for this protein in regulation of RhoA signalling and TJ 
formation.  
 
Epithelial cell proliferation is also regulated by the cytoplasmic TJ protein, ZO-1-
associated nucleic acid binding protein (ZONAB), a Y-box transcription factor 
which is regulated ZO-1 (Balda and Matter, 2000). Overexpression of ZONAB 
increases epithelial cell proliferation in vitro and in vivo (Balda et al., 2003; 
Georgiadis et al., 2010). Proliferation is promoted by nuclear accumulation of 
ZONAB, resulting in expression of target genes such as ErbB-2 (Balda and 
Matter, 2000). In addition, ZONAB has been shown to regulate nuclear 
localisation of cell division kinase (CDK) 4 which is important for G1/S transition 
(Balda et al., 2003).  
 
Adherens Junctions 
Localised just below the tight junctions are the adherens junctions (AJs), which 
form a continuous adhesion belt across the epithelial sheet (reviewed in 
Niessen and Gottardi, 2008). The key function of AJs is to mediate strong cell-
cell adhesion, however, these junctions also have additional important roles and 
are crucial for establishment of epithelial cell polarity (Nejsum and Nelson, 
2007).  
 
AJs are comprised of two basic adhesive units: the cadherin/catenin and 
nectin/afadin complexes (Niessen and Gottardi, 2008; Coradini et al., 2011). 
Classic cadherins are type I, single-pass transmembrane glycoproteins which 
mediate calcium-dependent intercellular adhesion via homophilic binding of 
their extracellular domains. The cytoplasmic domain of cadherins interact with 
cytoplasmic adaptor proteins, catenins (Ozawa et al., 1990). This interaction is 
important for mediating key structural and signalling activities required for 
adhesion (Miyoshi and Takai, 2005; Niessen and Gottardi, 2008). The primary 
cadherin expressed in epithelial cells is E-cadherin. This binds to β-catenin, 
which in turn binds α-catenin, mediating association with the actin cytoskeleton 
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(Kobielak and Fuchs, 2004). Cadherins also associate with p120 catenin, which 
seems to play an important role in regulation of cadherin levels and formation of 
strong, more “compacted” adhesions (Ireton et al., 2002). 
 
Cooperating with the cadherin/catenin complex, the nectin/afadin complex also 
mediates intercellular adhesion and actin association. Nectins (1-4) are 
members of the immunoglobulin superfamily of calcium-independent adhesion 
molecules (Miyoshi and Takai, 2005; Niessen and Gottardi, 2008). Nectins are 
single-pass transmembrane proteins which can engage in homophilic and 
heterophilic adhesion with nectins or nectin-like receptors on adjacent cells 
(Miyoshi and Takai, 2005; Niessen and Gottardi, 2008). Nectins interact with 
afadin which can bind to the actin cytoskeleton (Takahashi et al., 1999). Afadin 
can also bind to α-catenin, therefore providing a link between the two adhesive 
units of AJs (Tachibana et al., 2000). 
 
Desmosomes 
Desmosomes are the third component of the epithelial junctional complex, 
together with TJs and AJs (Balda and Matter, 2008). Desmosomes are found 
below the AJs and function to anchor intermediate filaments (IFs) to sites of 
strong adhesion, therefore playing a key role in maintenance of epithelial tissue 
integrity. In addition, desmosomes appear to function in other cellular 
processes, such as epithelial proliferation and differentiation and are important 
for epithelial tissue architecture and morphogenesis (reviewed in Yin and 
Green, 2004; Delva et al., 2009).  
 
Desmosomes consist of single-pass transmembrane glycoproteins of the 
desmosomal cadherin family, desmogleins (Dsg 1-4) and desmocollins (Dsc 1-
3), which mediate calcium-dependent adhesion between adjacent cells via their 
extracellular domains. The cytoplasmic domains of Dsgs and Dscs bind to the 
armadillo family proteins, plakoglobin and plakophilins (Witcher et al., 1996; 
Chen et al., 2002). These proteins associate with desmoplakin, the most 
abundant component of the desmosome, which anchors the junction to IFs 
(Kouklis et al., 1994; Yin and Green, 2004; Delva et al., 2009). However, this 
linear model may be insufficient to describe the complexity of the desmosomal 
architecture (Yin and Green. 2004). Additional protein-protein interactions have 
23 
 
been observed, for example plakophilin can also bind to plakoglobin and IF 
proteins, and Dsgs and Dscs can associate with desmoplakin independently of 
plakoglobin (Smith and Fuchs, 1998; Bonne et al., 2003). These multiple points 
of contact may result in greater tensile strength of the desmosome (Yin and 
Green, 2004). 
 
Gap Junctions 
Epithelial cells can also form a fourth type of intercellular junction called gap 
junctions. These junctions mediate intercellular signalling and may also 
contribute to cellular adhesion (reviewed in Nakagawa et al., 2010). Gap 
junctions are comprised of tens to thousands of intercellular gap junction 
channels. These allow passage of ions and small molecules up to 1 kDa in size 
and are gated by multiple mechanisms. Gap junction channels are formed by 
pairing of two hemichannels on adjacent cells. Each hemichannel is composed 
of six connexin (Cx) subunits surrounding a central pore and has distinct 
permeability and selectivity properties. 
 
1.1.2. Epithelial Cell-ECM Contacts 
 
In addition to cell-cell contacts, epithelial cells must also form contacts with the 
ECM to allow complete polarisation of epithelial tissues (Eaton and Simons, 
1995; Matlin et al., 2003). The main components of cellular adhesions to the 
ECM are the cell surface integrin receptors. Integrins are heterodimeric type I 
transmembrane glycoproteins comprised of α and β chains which, upon binding 
to ECM ligands such as fibronectin, laminin or collagen, regulate many aspects 
of cell behaviour (Matlin et al., 2003; Barczyk et al., 2010). In epithelial cells 
most integrins are β1-containing heterodimers which, together with various 
other proteins, are important for the formation of focal adhesions, cell-ECM 
contacts connected to the actin cytoskeleton (Stutzmann et al., 2000; Matlin et 
al., 2003). Epithelial cells also express the epithelial specific α6β4 integrin. This 
is found in hemidesmosomes, cell-ECM adhesion sites that associate with 
intermediate filaments and are important for maintenance of epithelial tissue 
integrity (Nievers et al., 1999; Stutzmann et al., 2000; Matlin et al., 2003). 
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Integrin-mediated cell-ECM contacts are important for polarisation of epithelial 
tissues (Eaton and Simons, 1995; Matlin et al., 2003). This was initially 
suggested by studies which demonstrated that α6β1 integrin was required for 
epithelial polarisation and differentiation in the kidney (Klein et al., 1988; 
Sorokin et al., 1990). Subsequent studies have also shown that orientation of 
the apicobasal axis in MDCK cells is dependent on β1 integrin (Ojakian and 
Schwimmer, 1994) and polarisation of mammary epithelial cells in vitro requires 
α6β4 integrin (Weaver et al., 2002). Therefore, this demonstrates that 
orientation of epithelial polarity depends on cell-ECM contacts. It has also been 
suggested that maintenance of a polarised epithelium may require continued 
interaction with the ECM to act as a polarising cue along with cell-cell contacts 
(Bryant and Mostov, 2008). 
 
1.1.3. Epithelial Polarity Complexes 
 
Establishment and maintenance of epithelial cell polarity is regulated via three 
conserved core polarity complexes (Figure 1.3) (Gibson and Perrimon, 2003; 
Suzuki and Ohno, 2006; Assemat et al., 2008; Bryant and Mostov, 2008). 
These are the Partitioning-Defective (PAR) complex, the Crumbs (CRB) 
complex and the Scribble (SCRIB) complex. Originally identified in 
Caenorhabditis elegans and Drosophila melanogaster, these complexes have 
since been identified in vertebrates and are essential for epithelial cell polarity 
(Assemat et al., 2008). 
 
The PAR Complex 
The PAR complex consists of two PDZ-domain-containing scaffold proteins, 
PAR-6 and PAR-3, and an atypical protein kinase C, aPKC. The complex is 
recruited to the apical membrane where it promotes establishment of 
apicobasal polarity and development of tight junctions (Suzuki et al., 2001; 
Suzuki and Ohno, 2006; Assemat et al., 2008; Horikoshi et al., 2009). PAR-6 
interacts with aPKC and acts as an adaptor molecule, allowing aPKC to interact 
with its downstream effectors, such as PAR-3 (Suzuki et al., 2001; Assemat et 
al., 2008). PAR-3 is thought to localise to sites of forming cell-cell junctions and 
recruit the aPKC-PAR6 complex. The function of PAR-3 seems to be dependent 
on its phosphorylation state. This is partially regulated by aPKC, whose kinase 
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activity is required for the formation of the mature junctional complex (Suzuki et 
al., 2002; Suzuki and Ohno, 2006; Assemat et al., 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Polarity complexes important for establishment and maintenance of epithelial 
cell polarity. Epithelial cell apicobasal polarity is regulated by three core polarity complexes: 
the PAR complex (Par3/Par6/aPKC; yellow), CRB complex (CRB/PALS1/PATJ; red), and 
SCRIB complex (SCRIB/LGL/DLG; green). The PAR and CRB complexes localise in the apical 
region of the cell and promotes formation of the apical membrane (red) and maturation of cell-
cell junctions. The SCRIB complex is localised to and maintains the basolateral membrane 
domain (green). Mutual antagonism between the apical and basolateral polarity complexes 
ensures maintainance of apicobasal polarity (adapted from Suzuki and Ohno, 2006; Coradini et 
al., 2011).  
 
 
The CRB Complex 
The CRB complex also localises to the apical membrane and is composed of a 
transmembrane protein, CRB-3, and two cytoplasmic scaffolding proteins, 
PALS1 (Proteins Associated with Lin Seven 1) and PATJ (PALS1-Associated 
Tight Junction protein) (Assemat et al., 2008). CRB-3 and PALS1 directly 
interact and are important for tight junction formation and epithelial polarity (Roh 
et al., 2003). In addition, CRB-3 appears to be involved in differentiation of the 
apical membrane (Assemat et al., 2008). PALS1 also binds to PATJ and is 
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essential for PATJ expression (Straight et al., 2004). PATJ is important for tight 
junction formation and polarisation and is thought to stabilise the CRB complex 
(Shin et al., 2005; Assemat et al., 2008). 
 
The SCRIB Complex 
Finally, the SCRIB complex consisting of SCRIB, DLG (Discs Large) and LGL 
(Lethal Giant Larvae) is basolaterally localised and functions to establish 
apicobasal polarity by restricting apical membrane identity (Bilder and Perrimon, 
2000; Kallay et al., 2006). SCRIB is a large cytoplasmic multidomain protein 
which is thought to bind to LGL (Kallay et al., 2006). DLG is able to bind to a 
variety of additional proteins thought to be important for stability of DLG and its 
distribution to cellular junctions (Assemat et al., 2008).  
 
Functional Interactions between Polarity Complexes 
Activities of the three polarity complexes are coordinated in order to establish a 
polarised epithelium. In addition, further proteins are also implicated within the 
process of epithelial cell polarisation and interaction with various junctional 
proteins appears to be important for recruitment and activity of the polarity 
complexes (reviewed in Suzuki and Ohno, 2006; Assemat et al., 2008). Briefly, 
during establishment of epithelial cell polarity one of the initial events is the 
recruitment of PAR-3 to the early junctional complex, thought to be mediated by 
association with JAMs (Itoh et al., 2001; Rehder et al., 2006). PAR-3 then 
recruits aPKC-PAR-6. Concurrently, activation of aPKC via phosphorylation 
must occur. This is thought to be initiated by Cdc42 which is activated upon E-
cadherin mediated cell-cell adhesion (Kim, 2000). Active aPKC then 
phosphorylates PAR-3, resulting in formation of the active PAR complex at the 
apical junctions. Once phosphorylated, PAR-3 dissociates from aPKC leaving it 
free to phosphorylate further target proteins and resulting in accumulation of 
phosphorylated PAR-3 at tight junctions. The CRB complex is then recruited to 
the apical membrane and evidence suggests that interactions between the PAR 
and CRB complexes stabilises their localisation to the apical membrane and 
promotes maturation of cell-cell junctions (Lemmers et al., 2004; Assemat et al., 
2008; Krahn et al., 2010).  
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The SCRIB complex is recruited to the basolateral membrane slightly later and 
mutual antagonism between this complex and the apical PAR and CRB 
complexes ensures maintenance of apical and basolateral membrane domain 
identity (Suzuki and Ohno, 2006). LGL competes with PAR-3 for binding to 
aPKCPAR-6, sequestering aPKCPAR-6 away from PAR-3. Upon aPKC 
activation, aPKC phosphorylates LGL which then dissociates from aPKCPAR-
6 and can interact with SCRIB and DLG at the lateral membrane. Therefore, 
aPKC is essential for restricting the SCRIB complex to the basolateral 
membrane and LGL maintains apical localisation of the active PAR complex 
(Bilder et al., 2003; Chalmers et al., 2005; Yamanaka et al., 2006; Assemat et 
al., 2008). 
 
Therefore, establishment and maintenance of epithelial cell polarity is a 
complex, highly regulated process and ongoing work will continue to elucidate 
the dynamics of the cell polarity machinery. 
 
1.2. Epithelial Cell Polarity and Cancer 
 
Tumour formation and progression is a complex, multi-step process in which 
tumour cells acquire various physiological alterations including self-sufficiency 
in growth signalling, insensitivity to growth-inhibitory signals, evasion of 
apoptosis, and tissue invasion and metastasis (reviewed in Hanahan and 
Weinberg, 2011). These hallmarks of cancer collectively result in the growth of 
malignant tumours. Most human cancers originate from epithelial cells and one 
key step in the process of tumour formation and metastasis is loss of epithelial 
cell polarity, often termed epithelial-to-mesenchymal transition (EMT) (Yang and 
Weinberg, 2008). During EMT, epithelial cells lose cell-cell adhesion and 
progressively redistribute or downregulate apical and basolateral epithelial-
specific proteins, acquiring a more mesenchymal phenotype. Consequently 
cells lose their polarised morphology and are able to migrate from the epithelial 
sheet, invade the underlying ECM and metastasise to distant sites in the body 
where they will proliferate and form new tumour cell colonies (Yang and 
Weinberg, 2008; Coradini et al., 2011). Formation of these metastases 
accounts for the majority of cancer deaths (Hanahan and Weinberg, 2011; 
Kopfstein and Christofori, 2006).  
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Therefore, it is clear that regulation of epithelial cell polarity is crucial to maintain 
structure and function of epithelial tissues and prevent diseases such as cancer. 
Indeed, numerous studies have identified a role for many of the proteins 
involved in maintenance of epithelial cell-cell junctions and apicobasal polarity 
during tumourigenesis (reviewed in Coradini et al., 2011). Proteins from all three 
core polarity complexes have been implicated in cancer. Experiments in 
Drosophila have classified scrib, lgl and dlg as neoplastic tumour suppressor 
genes, mutations in which disrupt epithelial polarity and result in neoplastic 
overgrowth of epithelial tissues (Bilder, 2004). The importance of the SCRIB 
complex in tumour suppression has also been demonstrated in mammals. For 
example, depletion of SCRIB disrupts cell polarity and promotes transformation 
of mammary epithelial cells in vitro and in vivo (Zhan et al., 2008). Decrease in 
SCRIB expression has also been associated with invasive cervical cancers 
(Nakagawa et al., 2004). Reduced expression of LGL has been reported in 
gastric adenocarcinoma (Lisovsky et al., 2009), colorectal cancer (Schimanski 
et al., 2005) and malignant melanoma (Kuphal et al., 2006). Components of 
other polarity complexes are also important within the process of 
tumourigenesis, for example loss of CRB3 has been associated with 
tumourigenicity of mouse kidney epithelial cells (Karp et al., 2008). In addition, 
aPKC has been classed as a potential oncogene in ovarian and non-small cell 
lung cancers where overexpression is associated with poor survival (Eder et al., 
2005; Regala et al., 2005). 
 
In addition to the polarity complexes, components of cell-cell and cell-ECM 
contacts are also often associated with cancer. E-cadherin downregulation is 
frequently observed in various human cancers and has been shown to correlate 
with increased metastatic behaviour (Perl et al., 1998; Coradini et al., 2011). 
Alterations in tight junction structure and function are also often associated with 
enhanced invasiveness of human carcinomas (Miyoshi and Takai, 2005; 
Oliveira and Morgado-Diaz, 2007). For example, occludin levels have been 
found to be reduced in breast and prostate cancer (Busch et al., 2002; Martin et 
al., 2010) and changes in expression of claudins are frequently observed in 
human tumours (Morin, 2005). Claudin-1 has been found to be reduced in 
breast (Kramer et al., 2000; Tokes et al., 2005); lung (Chao et al., 2008); and 
colon (Resnick et al., 2005) cancers, and upregulation of claudins has also 
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been associated with carcinogenesis (Oliveira et al., 2005). Cell-ECM 
interactions are also important for the development of carcinomas and changes 
in expression of integrin receptors is often observed in neoplastic cells (Bosman 
et al., 1993). 
 
The incidence of defective epithelial cell polarity during tumour formation and 
progression highlights the need to fully understand the mechanisms governing 
polarisation within normal, healthy epithelial tissues. As already discussed, 
various mechanisms involving polarity complexes and formation of cellular 
contacts are required to establish epithelial polarity. However, in order to carry 
out their function these proteins must be delivered and maintained at the correct 
location. Polarised epithelial cells feature a complex, highly regulated protein 
trafficking network and it is becoming clear that this is important for the 
establishment and maintenance of a functional epithelium.  
 
1.3. Protein Trafficking and Epithelial Cell Polarity 
 
1.3.1. Endocytosis 
 
In general, endocytosis is the process by which cells transport extracellular 
material or membrane-bound cargo from the plasma membrane to specific 
intracellular compartments. This process is required for many important cellular 
functions, including regulation of cell-surface receptors, uptake of extracellular 
nutrients and maintenance of cell polarity (Mukherjee et al., 1997). Several 
mechanisms of endocytosis exist but generally, the endocytic pathway begins 
with internalisation of transmembrane proteins into endocytic vesicles which 
invaginate and pinch off from the plasma membrane. These are delivered to the 
early endosome and from here, material can either be recycled back to the cell 
surface via recycling endosomes, or can be degraded via trafficking to the 
lysosome (Mukherjee et al., 1997; Stuffers et al., 2009a). In order to sort cargo 
destined for degradation from that which must be recycled, the formation of 
multivesicular bodies (MVB) occurs (Mukherjee et al., 1997; Babst, 2005). 
MVBs are formed by invagination and budding of vesicles from the early 
endosomal membrane into the lumen. During this process, proteins to be 
degraded are sorted into these intralumenal vesicles (ILVs), whereas those to 
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be recycled are retained on the endosomal limiting membrane and sorted 
towards the recycling pathway. Eventually the MVB will fuse with the lysosome 
and its contents will be degraded (Figure 1.4) (Mukherjee et al., 1997; Babst, 
2005; Stuffers et al., 2009a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 The endocytic pathway. Generally the endocytic pathway begins with endocytosis 
of proteins into endocytic vesicles which invaginate and pinch off from the plasma membrane. 
Upon delivery to the early endosome, proteins can either be recycled back to the cell surface 
via recycling endosomes, or can be targeted for degradation. Proteins to be degraded are 
internalised from the endosomal membrane into intraluminal vesicles, forming the multivesicular 
body (MVB). The MVB will then fuse with the lysosome and its contents will be degraded 
(adapted from Babst, 2005). 
 
 
Endocytosis in polarised cells is a complex, highly dynamic process and various 
signalling and sorting mechanisms are important to regulate transport to and 
from the distinct apical and basolateral membrane domains in order to maintain 
apicobasal polarity (Hoekstra et al., 2004; Mellman and Nelson, 2008; Weisz 
and Rodriguez-Boulan, 2009). In comparison to unpolarised cells, polarised 
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epithelial cells contain additional populations of endosomal compartments and 
protein trafficking can occur along multiple endocytic routes (Figure 1.5) 
(Hoekstra et al., 2004; Golachowska et al., 2010).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Endocytic compartments and trafficking routes in polarised epithelial cells. 
Cargo internalised from the apical (red) or basolateral (green) membrane is delivered to apical 
early endosomes (AEE) or basolateral early endosomes (BEE), respectively. Cargo can then be 
recycled back to the plasma membrane domain of origin, directed to the degradative pathway 
(blue arrows) via trafficking to late endosomes (LE) and lysosomes (LYS), or transported to the 
common recycling endosome (CRE). From the CRE, cargo can be transported to the 
basolateral (green arrow) or apical (red arrows) membrane, or can be directed to lysosomes for 
degradation. Apically destined cargo can travel directly from the CRE or via apical recycling 
endosomes (ARE). Recycling endosomes are also important for the biosynthetic trafficking 
pathway. Newly synthesised proteins can be delivered from the TGN to their specific membrane 
domain directly, via the CRE or BEE (broken arrows) (adapted from Hoekstra et al., 2004; 
Golachowska et al., 2010). 
 
 
32 
 
1.3.2. Endocytic Trafficking in Polarised Cells 
 
In polarised epithelial cells, cargo endocytosed either from the apical or 
basolateral membrane is delivered to apical early endosomes (ARE) or 
basolateral early endosomes (BEE), respectively. From here, cargo can either 
be recycled back to the plasma membrane domain of origin, directed to the 
degradative late endosomal (LE)/lysosomal pathway (LYS), or transported to 
the common recycling endosome (CRE) (Hoekstra et al., 2004; Golachowska et 
al., 2010). The CRE, which appears to be a ubiquitous feature of epithelial cells, 
is characterised as a mildly acidic, tubulovesicular network which clusters in the 
apical region and extends to the cell periphery (Knight et al., 1995; Futter et al., 
1998; Wang et al., 2000; Hoekstra et al., 2004). Above the CRE is a population 
of cup-shaped vesicles termed the apical recycling endosomes (ARE). These 
localise just below the apical membrane and contain apically destined cargo but 
not basolaterally recycling cargo (Gibson et al., 1998; Brown et al., 2000). It is 
not clear whether ARE are separate compartments or sub-domains of the CRE 
and there is evidence to support both scenarios (reviewed in Hoekstra et al., 
2004; Golachowska et al., 2010).  
 
The CRE is, therefore, an important organelle within the polarised endocytic 
pathway. As endocytosed apical and basolateral cargo merge in this 
compartment it is suggested that the CRE acts as a sorting centre crucial for 
establishment and maintenance of membrane polarity (Hoekstra et al., 2004; 
Golachowska et al., 2010). Data suggests that sorting is carried out after 
endocytosed apical and basolateral cargo reaches the CRE rather than cargo 
being transported to distinct regions of entry (Golachowska et al., 2010). This is 
thought to be achieved through lateral membrane segregation of endocytosed 
apical and basolateral plasma membrane proteins in the CRE, a process which 
has been visualised directly in polarised MDCK cells (Thompson et al., 2007). 
From the CRE cargo can recycle back to the basolateral or apical surface. 
Transport to the apical surface can occur directly or via the ARE. In addition, 
cargo can also be directed from the CRE to lysosomes.  
 
Sorting and subsequent trafficking from the CRE is regulated by various 
mechanisms, the complexities of which are still to be unravelled. Examples of 
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proteins which appear to be important in this process include clathrin adaptor 
proteins and Rab proteins. In addition, it appears that cargo can be transported 
via multiple routes and these can change as cells polarise (Hoekstra et al., 
2004; Weisz and Rodriguez-Boulan, 2009; Golachowska et al., 2010). 
 
It should be noted that the CRE also plays an important role in the biosynthetic 
trafficking pathway (reviewed in Folsch et al., 2009). Newly synthesised proteins 
can be sorted in the trans-Golgi network (TGN) and delivered directly to the 
apical or basolateral plasma membrane. Alternatively, cargo can be transported 
from the TGN to the specific membrane domain via recycling endosomes, for 
which multiple routes exist (Cresawn et al., 2007; Cramm-Behrens, 2008; Farr 
et al., 2009). It seems that basolaterally destined cargo can travel via the CRE 
or may avoid this compartment and traffic through BEE instead. Apically 
destined cargo can travel from the TGN to the plasma membrane via the CRE, 
ARE or AEE and studies have suggested that multiple pathways exist 
depending on the cargo involved (Folsch et al., 2009). In addition, cargo can 
reach the apical surface by transcytosis from the basolateral membrane, a 
process which also involves trafficking through the CRE (Apodaca et al., 1994; 
Hoekstra et al., 2004). 
 
1.3.3. Endocytosis: Important Regulator of Polarity? 
 
Tightly regulated protein trafficking is key for the maintenance of plasma 
membrane polarity and it is becoming clear that it is also important for 
establishment of epithelial cell polarity (Hoekstra et al., 2004; Folsch et al., 
2009; Golachowska et al., 2010). For example, knockdown of proteins 
implicated in apical transport, such as Rab-11 and annexin-13, disrupted 
establishment of polarity in 3D cell culture cysts (Torkko et al., 2008; Gao and 
Kaestner, 2010).  
 
Studies to elucidate mechanisms underlying establishment and maintenance of 
epithelial cell polarity have mainly focused on protein trafficking along the 
biosynthetic pathway, including transcytosis (Folsch et al., 2009). However, it is 
becoming clear that endocytosis plays an essential role in establishment and 
maintenance of a polarised epithelium (Shivas et al., 2010). For example, 
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endocytosis has been implicated in biogenesis of the apical membrane in 
MDCK cells. Schluter and colleagues have demonstrated that during the first 
MDCK cell division, Crumbs is internalised and concentrates in Rab11-positive 
ARE which are delivered to the site of cytokinesis and thus form the first apical 
membrane (Schluter et al., 2009). This suggests that endocytosis is important 
for targeted delivery of proteins required for establishment of epithelial cell 
polarity. In support of this, during C.elegans embryonic development correct 
polarisation of PAR proteins requires dynamin and Rab-11, important for 
clathrin-mediated endocytosis and endocytic recycling, respectively (Zhang et 
al., 2008; Nakayama et al., 2009).  
 
Dynamics of Cell-Cell Junctions 
A key role of endocytosis within maintenance of epithelial polarity could be 
through the regulation of cell-cell junctions. Once formed, cell-cell junctions are 
dynamic structures that are continuously being remodelled, suggesting that the 
endocytic machinery is important for the regulation of cell-cell junction structure 
and function (Ivanov et al., 2005; Shen et al., 2008; Yu and Turner, 2008; Steed 
et al., 2010). Previous studies have demonstrated that occludin and E-cadherin 
are continuously endocytosed and recycled back to the plasma membrane in 
mammalian epithelial cells (Le et al., 1999; Morimoto et al., 2005). Constitutive 
endocytosis of claudin-1 has also been observed (Matsuda et al., 2004) and 
inhibition of recycling in MDCK cells altered the localisation of claudin-1 and 
specifically delayed recruitment of claudin-1 to tight junctions (Marzesco et al., 
2002). Internalisation of different junctional components appears to be highly 
specific and may be mediated by ubiquitylation by specific E3 ubiquitin ligases 
(Fujita et al., 2002; Traweger et al., 2002; Yu and Turner, 2008; Takahashi et 
al., 2009).  
 
Disruption of cell-cell junctions can often perturb epithelial cell polarity and 
therefore, endocytic trafficking of cell-cell junction proteins may be important for 
regulation of epithelial cell polarity (Brennan et al., 2010; Coradini et al., 2011; 
Turksen and Troy, 2011). For example, the balance of E-cadherin trafficking 
plays an important role in regulation of epithelial cell adhesion (Bryant and 
Stow, 2004) and loss of E-cadherin from adherens junctions is associated with 
loss of polarity and EMT (Perl et al., 1998; Yang and Weinberg, 2008). It is 
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possible that trafficking of other junctional proteins is also important for the 
maintenance of epithelial cell polarity. 
 
Evidence from Drosophila 
Various studies have provided evidence for links between endocytosis, 
regulation of epithelial junctions (Ivanov et al., 2005) and cell polarity (Shivas et 
al., 2010). Therefore, it is likely that protein trafficking plays a crucial role in 
maintaining a polarised epithelium although a direct role for endocytosis in this 
process is yet to be determined. Studies in Drosophila, however, have provided 
strong evidence for the importance of endocytosis in regulation of epithelial cell 
polarity. In these studies, mosaic genetic screens were conducted in order to 
uncover further novel regulators of epithelial cell polarity. Interestingly the 
majority of these newly isolated genes have been identified as regulators of the 
endocytic pathway (reviewed in Hariharan and Bilder, 2006, Vaccari and Bilder, 
2009; Herz and Bergmann, 2009; Lobert and Stenmark, 2011). Mutation of 
these genes disrupts epithelial cell polarity and induces overproliferation 
resulting in formation of neoplastic tumours. These genes have accordingly 
been classified as endocytic tumour suppressor genes (TSGs) (Vaccari and 
Bilder, 2009). 
 
The proteins encoded by these endocytic TSGs can be split into two groups: 
those that regulate cargo entry into the early endosome, and those that regulate 
cargo sorting within MVBs (Vaccari and Bilder, 2009). The first group include 
the Drosophila homologues of syntaxin 7/12 (Avalanche), required for vesicle 
fusion to form early endosomes, and the GTPase Rab5, required to regulate 
traffic to the early endosome. In addition, the syntaxin binding protein Vps45, 
and the Rab5 effector Rabenosyn-5 (Rbsn) have also been identified as tumour 
suppressors (Lu and Bilder, 2005; Morrison et al., 2008). The second group of 
endocytic TSGs encode components of the Endosomal Sorting Complex 
Required for Transport (ESCRT) machinery. This family of proteins act at a later 
stage of the endocytic pathway and are required for cargo sorting and MVB 
formation (Hariharan and Bilder, 2006). The ESCRT proteins are the focus of 
this thesis and will be discussed in detail below.   
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1.4. ESCRT Proteins 
 
The ESCRT machinery is comprised of four multi-subunit complexes termed 
ESCRT-0, -I, -II and -III, as well as several accessory components (Table 1.1). 
Originally identified in yeast as the class E vacuolar protein sorting (Vps) 
proteins, the ESCRT machinery has since been shown to be highly conserved 
in eukaryotic cells (Raymond et al., 1992; Babst, 2005; Hurley, 2008). ESCRT 
proteins have a well established role in the sorting of ubiquitylated proteins for 
degradation via the formation of MVBs and trafficking to the lysosome (Hurley 
and Emr, 2006; Hurley, 2008; Raiborg and Stenmark, 2009; Roxrud et al., 
2010). 
 
1.4.1. The ESCRT Complexes: Structure 
 
The composition of the ESCRT machinery has been studied over several years 
and detailed structural biology of the ESCRT proteins is described in recent 
reviews (Hurley and Emr, 2006; Williams and Urbe, 2007). Here I will briefly 
summarise the components of each ESCRT complex and provide details of the 
key interactions.  
 
ESCRT-0 
ESCRT-0 consists of Hrs (hepatocyte growth factor (HGF)-regulated Tyrosine-
kinase substrate) and STAM (signal transducing adaptor molecule) and is 
required for initial selection of ubiquitylated cargo at the endosomal membrane 
(Williams and Urbe, 2007). ESCRT-0 binds monoubiquitin via ubiquitin-
interacting motifs (UIMs) found on both Hrs and STAM. Ubiquitylation provides 
the signal for sorting into the MVB pathway (Clague and Urbe, 2006) and 
therefore, ESCRT-0 binding to ubiquitin is the initial step in the sorting process 
(Urbe et al., 2003). ESCRT-0 is recruited to the early endosomal membrane via 
the FYVE (Fab1, YOTB, Vac1 and early endosome antigen-1 (EEA1)) zinc 
finger domain of Hrs which binds to the endosomal lipid, phosphatidylinositol-3-
phosphate (PI(3)P) (Katzmann et al., 2003; Hurley and Emr, 2006). ESCRT-0 
proteins also bind to the coat protein clathrin and are thought to sequester 
ubiquitylated cargo into clathrin-coated microdomains which will eventually form 
ILVs (Sachse et al., 2002; Raiborg et al., 2006; Williams and Urbe, 2007; 
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Raiborg and Stenmark, 2009). Finally, ESCRT-0 is important for recruitment of 
downstream ESCRTs via direct interaction of Hrs with ESCRT-I (Bache et al., 
2003a; Katzmann et al., 2003).  
 
Complex Yeast Protein Mammalian Protein 
ESCRT-0 Vps27 HRS 
 Hse1 STAM1, 2 
ESCRT-I Vps23 Tsg101 
 Vps28 Vps28 
 Vps37 Vps37A, B, C, D 
 Mvb12 Mvb12A, B 
ESCRT-II Vps22 Vps22 (EAP30) 
 Vps25 Vps25 (EAP20) 
 Vps36 Vps36 (EAP45) 
ESCRT-III Vps20 CHMP6 
 Vps32 (Snf7) CHMP4A,B,C 
 Vps24 CHMP3 
 Vps2 CHMP2A,B 
 Vps46 (Did2) CHMP1A,B 
 Vps60 CHMP5 
      CHMP 7 
Vps4 Vps4 Vps4A,B 
 Vta1 LIP5 
Accessory  Bro1 Alix 
DUB Doa4 UBPY 
      AMSH 
 
Table 1.1 Endosomal Sorting Complex Required For Transport (ESCRT) protein subunits 
and ESCRT-related proteins. The ESCRT complexes are comprised of several proteins 
subunits. For each yeast class E Vps protein, one or more mammalian homologues have been 
identified. 
 
ESCRT-I 
ESCRT-I consists of four subunits: Tsg101 (tumour susceptibility gene 101), 
Vps28, Vps37 and Mvb12 (multivesicular body sorting factor of 12 kDa) 
(Raiborg and Stenmark, 2009). This ESCRT complex also binds to ubiquitin via 
the Tsg101 and Mvb12 proteins (Hurley and Emr, 2006; Roxrud et al., 2010). 
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ESCRT-I binds to ESCRT-0 via Tsg101 (Bache et al., 2003a; Katzmann et al., 
2003) and, in yeast, ESCRT-I binds to ESCRT-II via its Vps28 subunit although 
no direct link has been observed in mammalian cells (Teo et al., 2006; Williams 
and Urbe, 2007).  
 
ESCRT-II 
The ESCRT-II complex contains one Vps22 subunit, one Vps36 subunit and 
two Vps25 subunits (Hierro et al., 2004). The Vps36 subunit has a GLUE 
(GRAM-like ubiquitin-binding in EAP45) domain at its N-terminus which can 
bind to PI(3)P, ubiquitin and the ESCRT-I subunit Vps28 (Williams and Urbe, 
2007; Raiborg and Stenmark, 2009). ESCRT-II also recruits, and possibly 
activates, ESCRT-III via its Vps25 subunit (Im et al., 2009; Raiborg and 
Stenmark, 2009). Therefore, ESCRT-II is thought to provide a link between 
ubiquitylated cargo, the endosomal membrane, and ESCRT-I and -III (Hurley 
and Emr, 2006).  
 
ESCRT-III 
ESCRT-III consists of several small, highly charged subunits, termed CHMPs 
(charged multivesicular body proteins) in mammalian cells. Seven CHMPs have 
been identified (CHMP1-7) and each of these, with the exception of CHMP7, 
correspond to one of the six different ESCRT-III subunits present in yeast 
(Table 1.1) (Lata et al., 2009). In contrast to ESCRT-0, -I and -II, which exist as 
soluble complexes in the cytosol, ESCRT-III proteins are thought to assemble 
into a multimeric complex on endosomal membranes (Lata et al., 2009; Raiborg 
and Stenmark, 2009).  
 
All of the ESCRT-III proteins have a basic N-terminal and acidic C-terminal 
region (Williams and Urbe, 2007). Studies into the structure of CHMP3 have 
revealed that the C-terminal region is autoinhibitory and interacts with the N-
terminal core to form a closed, inactive conformation (Lata et al., 2008a). 
Activation of the ESCRT-III subunits is thought to be triggered by a 
conformational change which displaces the C-terminal region from the N-
terminal core, relieving the autoinhibition and allowing membrane targeting and 
assembly of the ESCRT-III complex (Lata et al., 2008; Lata et al., 2009; Raiborg 
and Stemark, 2009). This may occur in a directional manner in that one 
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ESCRT-III subunit activates the next and so on. Studies in yeast have 
demonstrated that the core ESCRT-III complex, consisting of Vps20, Vps32, 
Vps24 and Vps2 (CHMP6, CHMP4, CHMP3 and CHMP2, respectively), 
assembles sequentially on the endosomal membrane (Teis et al., 2008). Vps20 
is N-terminally myristoylated and can interact with the endosomal membrane. In 
addition, Vps20 also binds to the ESCRT-II subunit Vps25 which is thought to 
activate Vps20 and initiate assembly of the ESCRT-III complex (Yorikawa et al., 
2005; Im et al., 2009; Raiborg and Stenmark, 2009). Vps20 also interacts with 
Vps32 and triggers the assembly of Vps32 into oligomers which appear to be 
capped by Vps24. Vps2 then associates with Vps24 and recruits the AAA-
ATPase Vps4, which is important for disassembly of the ESCRT-III complex 
(Teis et al., 2008; Raiborg and Stenmark, 2009). CHMP1 and CHMP5 are 
thought to regulate the recruitment and activity of the AAA-ATPase Vps4, 
although the exact mechanism of this is unknown (Raiborg and Stenmark, 
2009). 
 
1.4.2. The ESCRT Complexes: Function 
 
ESCRTs have been classically characterised for their role in endosomal sorting 
and degradation of ubiquitylated proteins via MVB formation. It is also becoming 
increasingly clear that ESCRT proteins have additional functional roles within 
the endocytic pathway as well as other biological processes (Roxrud et al., 
2010).   
 
Targeting Proteins for Degradation via Formation of MVBs 
In the conventional model for ESCRT assembly it is thought that, during MVB 
formation, the ESCRT complexes are recruited sequentially to the early 
endosomal membrane (Figure 1.6) (Hurley, 2008). ESCRT-0 is proposed to be 
responsible for the initial recognition of ubiquitylated cargo. However, the 
presence of ubiquitin-binding domains in ESCRT-I and -II has led to a model 
whereby ubiquitylated cargo is handed over sequentially from one ESCRT 
complex to the other (Hurley, 2008; Raiborg and Stenmark, 2009). In support of 
this model, studies have demonstrated that the ubiquitin-binding domains of all 
three ESCRT complexes interact with the same hydrophobic region of ubiquitin 
at Ile44 (Hurley and Emr, 2006; Raiborg and Stenmark, 2009). However, the 
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binding sites for ubiquitylated cargo and the ubiquitin-interacting domain of 
ESCRT-II are at opposite ends of the 25 nm long ESCRT-I complex, therefore 
arguing against cargo exchange from ESCRT-I to ESCRT-II (Kostelansky et al., 
2007; Hurley, 2008; Raiborg and Stenmark, 2009). An alternative model 
proposes that simultaneous binding of ESCRT-0, -I and -II to multiple 
ubiquitylated proteins allows clustering of cargo for subsequent packaging into 
ILVs (Hurley and Emr, 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Cargo sorting and MVB formation is dependent on the ESCRT protein 
complexes. During MVB formation the ESCRT complexes are thought to be recruited 
sequentially to the endosomal membrane where they recognise ubiquitylated membrane 
proteins (cargo) and function to package these into intraluminal vesicles (ILV) which bud off into 
the lumen of the MVB. Both ESCRT-0 components, Hrs and STAM, bind to ubiquitin. Hrs also 
binds to the endosomal lipid, PI(3)P, and recruits ESCRT-I via interaction with Tsg101. ESCRT-I 
binds ubiquitin via Tsg101 and Mvb12, and Vps28 is thought to interact with the ESCRT-II 
subunit, Vps36. Vps36 also binds to ubiquitin and PI(3)P. In contrast to the other ESCRTs, 
which exist as soluble complexes in the cytosol, assembly of ESCRT-III is thought to occur on 
the endosomal membrane. CHMP6 binds to the ESCRT-II protein, Vps25, which initiates 
recruitment of CHMP4, CHMP3 and CHMP2. The ATPase Vps4 complex is then recruited 
which disassembles the ESCRT-III complex, allowing membrane scission to occur forming the 
ILV. Prior to ILV budding, ESCRT-III also recruits a deubiquitylating enzyme (DUB) which 
removes the ubiquitin from the cargo (adapted from Tanaka et al., 2008). 
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The mechanism responsible for endosomal membrane deformation and 
scission, which is required to form ILVs, is not fully understood. However, the 
prime candidate to elicit this process is ESCRT-III. Evidence to support this is 
provided by a study which demonstrates that overexpressed CHMP4 (Vps32) 
polymerises into spiral filaments which induce protrusion of buds and tubules 
from the plasma membrane in mammalian cells (Hanson et al., 2008). Budding 
of ILVs into the MVB also requires the AAA-ATPase Vps4. Vps4 is recruited by 
ESCRT-III where it appears to induce disassembly of the ESCRT-III complex in 
an ATP-dependent manner (Hurley et al., 2008; Raiborg and Stenmark, 2009: 
Saksena et al., 2009). Experiments which have reconstituted ESCRT-III 
assembly in vitro have shown that C-terminally truncated CHMP2A 
coassembles with CHMP3 into hollow helical tubules with a diameter of ~40nm. 
Membrane interaction sites were found on the inside of these tubules where 
binding of Vps4 also occurred, mediating disassembly of the tube upon ATP 
hydrolysis (Lata et al., 2008b). These studies suggest that assembly of the 
ESCRT-III complex deforms the endosomal membrane to form ILVs. Vps4 then 
enters these forming ILVs and depolymerises the ESCRT-III complex from the 
inside. The concerted action of these two complexes leads to membrane 
constriction and scission (Lata et al., 2009; Raiborg and Stenmark, 2009; 
Saksena et al., 2009; Wollert et al., 2009). It is currently not clear whether Vps4 
is directly required to contribute energy for the membrane scission event as well 
as disassembling the ESCRT-III complex (Lata et al., 2009). 
 
The final process important for the formation of MVBs is deubiquitylation of 
cargo. This is carried out by deubiquitylating enzymes (DUBs) which are 
recruited by the ESCRT-III complex and accessory protein Alix (Hurley, 2008; 
Lata et al., 2009; Raiborg and Stenmark, 2009). The key DUBs associated with 
the MVB pathway are Doa4 in yeast, and AMSH and UBPY in mammals 
(Hurley, 2008). Interestingly, in mammalian cells these DUBs are also recruited 
by the ESCRT-0 subunit STAM (McCullough et al., 2006; Row et al., 2007) and 
therefore appear to function at both early and late stages of MVB formation. 
This could allow deubiquitylation of cargo that is not destined for degradation, 
adding further complexity to the MVB sorting process (Raiborg and Stenmark, 
2009; Berlin et al., 2010).    
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Therefore, ESCRT proteins are required for efficient sorting of proteins along 
the degradative endosomal pathway. Disruption of the ESCRT machinery 
generally results in the inhibition of MVB formation and accumulation of 
endosomal cargo in aberrant endosomes, therefore perturbing endosomal 
trafficking and degradation (Raymond et al., 1992; Bishop et al., 2002; Bache et 
al., 2003b; Lu et al., 2003; Doyotte et al., 2005; Bache et al., 2006; Razi and 
Futter, 2006; Malerod et al., 2007; Williams and Urbe, 2007; Raiborg et al., 
2008, Stuffers et al., 2009b).  
 
Additional Role for ESCRTs in Endosomal Recycling 
Although ESCRT proteins have been classically characterised for their 
involvement in degradation of membrane proteins (Hurley and Emr, 2006; 
Raiborg and Stenmark, 2009), it is also reported that ESCRT function is 
important for recycling. Some studies have demonstrated that depletion of Hrs 
or Tsg101 increases recycling of epidermal growth factor (EGF) receptor 
(EGFR) upon stimulation with EGF ligand. However, knockdown of Vps22 and 
Vps24 has no effect on EGFR and EGF recycling (Razi and Futter, 2006; 
Raiborg et al., 2008). In contrast, other studies have suggested that knockdown 
of Tsg101 causes a decrease in recycling resulting in reduced levels of EGFR 
and transferrin receptor (TfR) at the cell surface (Doyotte et al., 2005). In 
addition, ESCRT-I and -III are required for recycling of EGFR upon stimulation 
with amphiregulin (AR) whereas ESCRT-0 and -II are dispensable for this 
process (Baldys and Raymond, 2009). Vps4 has also been shown to be 
required for recycling of TfR and low-density lipoprotein receptor (LDLR) back to 
the cell surface (Yoshimori et al., 2000; Fujita et al., 2003). Further evidence for 
the importance of ESCRTs in the endosomal recycling pathway is provided by 
the observation that the ESCRT-0 subunit, STAM can bind the DUB, UBPY 
(McCullough et al., 2006; Row et al., 2007). Deubiquitylation of EGFR by UBPY 
protects EGFR from degradation via an Hrs-dependent pathway demonstrating 
that UBPY and ESCRT-0 play in key role in determining the fate of endocytosed 
EGFR (Berlin et al., 2010). Therefore, it is becoming apparent that the ESCRT 
machinery is important for regulating sorting of cargo between degradative and 
recycling pathways and ESCRT function may be required for efficient trafficking 
along both these endosomal routes.   
 
43 
 
ESCRTs and Regulation of Signalling  
ESCRT proteins also play a crucial role in regulation of cell signalling (Rodahl et 
al., 2009a; Wegner et al., 2011). Sequestration of activated membrane 
receptors into ILVs during MVB formation and subsequent lysosomal 
degradation terminates ligand-induced signalling (Sorkin and Von Zastrow, 
2009). Therefore, this provides one mechanism whereby ESCRTs can 
negatively regulate receptor signalling (Wegner et al., 2011). This is highlighted 
through various studies which demonstrate that ESCRTs are required for 
degradation of activated receptor tyrosine kinases (RTK) (Wegner et al., 2011). 
For example, disruption of the ESCRT machinery causes reduced degradation 
of EGF-stimulated EGFR (Bishop et al., 2002; Lu et al., 2003; Bache et al., 
2006; Malerod et al., 2007; Raiborg et al., 2008). ESCRTs can also negatively 
regulate other signalling pathways such as Notch, Toll-like receptor (TLR) and 
G-protein coupled receptor (GPCR) signalling (Rodahl et al., 2009a; Wegner et 
al., 2011).  Therefore, perturbed ESCRT function can enhance activity of 
various signalling pathways.  
 
In addition to reduced degradation of activated receptors, there are also other 
possible mechanisms which could account for the increase in receptor 
signalling in ESCRT depleted cells. Firstly, receptors may remain active whilst 
on the limiting membrane of endosomes and therefore, disrupted sequestration 
into ILVs may prolong the time that the receptor is signal competent (Sorkin and 
Von Zastrow, 2009; Wegner et al., 2011). This is supported by studies which 
show that depletion of ESCRT-0 and -I, but not ESCRT-II and -III, results in 
sustained EGFR activity indicating a requirement for early acting ESCRT 
proteins in the attenuation of EGFR signalling (Bache et al., 2006; Malerod et 
al., 2007). In addition, some signalling complexes preferentially assemble on 
endosomal membranes and therefore, disruption of endosomal trafficking upon 
ESCRT disruption will enhance their activity (Sorkin and Von Zastrow, 2009). 
This is observed for the Notch signalling pathway in Drosophila whereby 
ESCRT mutation results in increased endosomal signalling due to accumulation 
of Notch within early endosomes (Thompson et al., 2005; Vaccari and Bilder, 
2005; Herz et al., 2006; Herz et al., 2009; Gilbert et al., 2009; Vaccari et al., 
2009).  
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Alternatively, blocking endosomal degradation by ESCRT depletion may 
enhance recycling of endocytosed receptors back to the plasma membrane 
resulting in sustained signalling (Wegner et al., 2011). This is supported by the 
observation that Hrs or Tsg101 depletion decreases degradation but increases 
recycling of epidermal growth factor (EGF) receptor (EGFR) upon stimulation 
with EGF ligand (Razi and Futter, 2006; Raiborg et al., 2008). However, other 
studies have demonstrated the opposite effect in that ESCRT disruption 
decreases recycling of other receptors, such as the transferrin receptor 
(Yoshimori et al., 2000; Fujita et al., 2003; Doyotte et al., 2005). Therefore, 
there may be a number of mechanisms by which ESCRTs regulate cellular 
signalling pathways and the importance of these could differ depending on 
various factors such as receptor type, ligand concentration and cell type 
(Wegner et al., 2011).  
 
It is also important to note that the ESCRT pathway may play a positive role in 
the regulation of other signalling pathways (Wegner et al., 2011). For example, 
ESCRT-dependent sequestration of the inhibitory glycogen synthase kinase 3 
(GSK3) within MVBs is required for activation of canonical Wnt signalling 
(Taelman et al., 2010). Therefore, whilst perturbed ESCRT function can 
enhance receptor signalling, it could also inhibit signalling through other 
pathways at the same time.  
 
ESCRTs and Autophagy 
Autophagy is a degradation pathway for cytoplasmic components, such as 
protein aggregates, cellular macromolecules, damaged organelles and invading 
pathogens (Fader and Colombo, 2009; Rusten and Stenmark, 2009). 
Autophagy is tightly regulated by cellular signalling mechanisms, in particular 
those activated by nutrient starvation and cellular stress (Mizushima et al., 
2008). The protein kinase Tor (target of rapamycin) is central to this regulation 
by inhibiting the autophagic process under nutrient rich conditions (Rusten and 
Stenmark, 2009). During the autophagic process a portion of cytoplasm is 
engulfed by a cup-shaped double membrane structure called the phagophore 
which will seal the sequestered cytoplasmic contents, forming an 
autophagosome. These autophagosomes then fuse with lysosomes to form an 
autolysosome and the contents are degraded. Autophagosomes can also fuse 
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with endosomes to form amphisomes prior to fusion with lysosomes (Fader and 
Colombo, 2009; Rusten and Stenmark, 2009).   
 
At least 30 evolutionary conserved Atg (autophagy related) proteins have been 
identified which make up two ubiquitin-like conjugation systems required for 
autophagosome formation (Fader and Colombo, 2009; Rusten and Stenmark, 
2009). Interestingly various studies have revealed a role for the ESCRT 
machinery within the process of autophagy and disruption of ESCRT function 
results in autophagosome accumulation (Nara et al., 2002; Filimonenko et al., 
2007; Rusten et al., 2007; Tamai et al., 2007). It is currently not clear why 
ESCRTs are important for autophagy. It has been suggested that a functional 
MVB is necessary to allow autophagic degradation and therefore, disruption of 
MVB formation due to perturbed ESCRT function may consequently inhibit 
autophagy (Fader and Colombo, 2009). Alternatively, ESCRTs may be required 
for autophagosome fusion with endosomes and lysosomes (Rusten and 
Stenmark, 2009). ESCRT disruption would inhibit this fusion resulting in an 
increase in the number of autophagosomes and a decrease in amphisomes and 
autolysosomes, an effect which has been reported previously (Rusten et al., 
2007; Tamai et al., 2007). There may also be other mechanisms to explain the 
importance of the ESCRT machinery within the process of autophagy and 
further work will continue to elucidate the possibility of interplay between 
autophagy and MVB biogenesis.  
 
Non Endosomal Functions of ESCRTs 
ESCRT proteins are also involved in other cellular processes in addition to their 
roles within endocytic trafficking (Roxrud et al., 2010). These include cytokinesis 
and viral budding, both processes involving membrane fission. Cytokinesis is 
the final step of cell division whereby the dividing cell is physically cleaved into 
two daughter cells (Barr and Gruneberg, 2007). Various studies have implicated 
the ESCRT machinery in this process (Raiborg and Stenmark, 2009; Roxrud et 
al., 2010). ESCRT-III is recruited to the midbody by ESCRT-I and/or Alix and, 
as in MVB formation, Vps4 appears to be required for ESCRT-III disassembly 
and subsequent membrane scission (Carlton and Martin-Serrano, 2007; Morita 
et al., 2007; Dukes et al., 2008). The role, if any, of ESCRT-II in this process 
remains to be elucidated.  
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Budding of enveloped viruses from the plasma membrane of infected cells also 
requires ESCRT function. During this process viruses hijack the ESCRT 
machinery by binding to the ESCRT-I subunit Tsg101 and/or Alix. ESCRT-III 
and Vps4 are then recruited to mediate membrane fission and the viral buds are 
released from the plasma membrane (Garrus et al., 2001; Martin-Serrano et al., 
2003; Fujii et al., 2007; Roxrud et al., 2010). The role of ESCRT-II in viral 
budding however is unclear. It appears that ESCRT-II is not essential for 
budding of HIV-1 (Langelier et al., 2006) whereas release of avian sarcoma 
virus requires the ESCRT-II subunit Vps25 (Pincetic et al., 2008). Therefore, it 
seems that different viruses can utilise different ESCRT-mediated budding 
pathways (Roxrud et al., 2010). In addition, ESCRT-independent viral budding 
has also been demonstrated (Chen and Lamb, 2008).   
 
1.5. ESCRTs as Tumour Suppressors 
 
1.5.1. Lessons from Drosophila 
 
Loss of Epithelial Cell Polarity and Organisation   
Genetic screens in Drosophila have discovered a role for the ESCRT machinery 
within regulation of epithelial cell polarity and tumourigenesis (Vaccari and 
Bilder, 2009; Herz and Bergmann, 2009; Lobert and Stenmark, 2011). Two of 
the first ESCRT proteins to be identified as potential neoplastic tumour 
suppressors in Drosophila were Tsg101, a component of ESCRT-I, and Vps25, 
a component of ESCRT-II (Moberg et al., 2005; Thompson et al., 2005; Vaccari 
and Bilder, 2005; Herz et al., 2006). Since these initial studies, other 
components of the ESCRT machinery have been identified as important 
regulators of epithelial cell polarity, although the precise roles for each ESCRT 
protein may differ (Table 1.2) (Rodahl et al., 2009b; Herz et al., 2009; Vaccari et 
al., 2009).  
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Table 1.2 Comparison of phenotypes resulting from mutation of ESCRTs in epithelial tissues of Drosophila. The main phenotypes resulting from ESCRT 
mutation are listed. Positive (+) and negative (-) results and corresponding references are indicated for each ESCRT component studied. For some ESCRT 
components the effect of mutation on certain phenotypes has not been reported in the literature, indicated by ‘n/a’. All results listed are from studies conducted in 
imaginal discs, the developing epithelial tissues of the Drosophila embryo. Phenotypes listed were observed in the ESCRT mutant cells, with the exception of 
‘Hyperplastic growth’ which represents non-cell autonomous overproliferation. 
Complex ESCRT-0 ESCRT-I ESCRT-II ESCRT-III ATPase 
References 
Component Hrs Tsg101 Vps28 Vps25 Vps22 Vps36 Vps20 Vps32 Vps2 Vps4 
E
ff
e
c
t 
o
f 
M
u
ta
ti
o
n
 
Enlarged 
Endosomes 
+ 
1 
n/a n/a + 
4,8 
+ 
8 
+ 
8 
n/a n/a n/a + 
9 (1) Jekely & 
Rorth, 2003 
(2) Moberg et 
al., 2005 
(3) Thompson et 
al., 2005 
(4) Vaccari & 
Bilder, 2005 
(5) Herz et al., 
2006 
(6) Vaccari et 
al., 2008 
(7) Gilbert et al., 
2009 
(8) Herz et al., 
2009 
(9) Rodahl et al., 
2009b 
(10) Vaccari et 
al, 2009 
Accumulation of 
Ubiquitin 
+ 
1 
+ 
2 
+ 
10 
+ 
3,5,8,10 
+ 
8,10 
+ 
8 
+ 
10 
+ 
10 
+ 
10 
+ 
9 
Accumulation of 
EGFR 
+ 
1 
n/a + 
10 
+ 
10 
+ 
10 
n/a + 
10 
+ 
10 
+ 
10 
n/a 
Sustained EGFR 
signalling 
n/a n/a + 
10 
+ 
10 
+ 
10 
n/a + 
10 
+ 
10 
+ 
10 
n/a 
Accumulation of 
Notch 
+ 
1,6 
+ 
2,6 
+ 
10 
+ 
4,5,6,8,10 
+ 
8,10 
+ 
8 
+ 
6,10 
+ 
10 
+ 
10 
+ 
9 
Increased Notch 
activity 
- 
6 
+ 
2,6 
+ 
10 
+ 
4,5,6,8,10 
+ 
8,10 
- 
8 
+ 
6,10 
+ 
10 
+ 
10 
n/a 
Disrupted epithelial 
organisation 
- 
1 
+ 
2,7 
+ 
10 
+ 
3,8,10 
+ 
8,10 
+ 
8 
+ 
10 
+ 
10 
+ 
10 
+ 
9 
Disrupted 
apicobasal polarity 
- 
1 
+ 
2,7 
n/a + 
4 
n/a n/a n/a n/a n/a + 
9 
Reduced 
differentiation 
n/a n/a n/a + 
3,4,5 
n/a n/a n/a n/a n/a n/a 
Increased 
apoptosis 
n/a n/a n/a + 
4,5,8 
+ 
8 
+ 
8 
n/a n/a n/a + 
9 
Neoplastic growth - 
1,6 
+ 
2,7 
n/a + 
4,8 
+ 
8 
+ 
8 
n/a n/a n/a + 
9 
Hyperplastic 
growth 
- 
1,6 
+ 
2,6 
+ 
10 
+ 
3,4,5,8,10 
+ 
8,10 
- 
8 
+ 
10 
+ 
10 
+ 
10 
+ 
9 
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The majority of analysis of ESCRT function has been carried out in Drosophila 
imaginal discs, polarised epithelial tissues found in the larva which will develop 
to form the eye, leg and wing of the adult fly (Muller, 2000). Mutation of 
ESCRTs disrupts the endocytic pathway resulting in aberrant endosomes and 
accumulation of ubiquitylated proteins (Moberg et al., 2005; Thompson et al., 
2005; Vaccari and Bilder, 2005; Vaccari et al., 2008). Interestingly, ESCRT 
mutation also results in a loss of epithelial cell polarity indicating that ESCRTs 
are important to maintain the polarised architecture of epithelial tissues (Figure 
1.7) (Moberg et al., 2005; Thompson et al., 2005; Vaccari and Bilder, 2005; 
Herz et al., 2006; Rodahl et al., 2009b; Herz et al., 2009; Vaccari et al., 2009). 
In these mutant cells, aPKC is localised throughout the entire plasma 
membrane instead of being restricted to the apical membrane domain (Vaccari 
and Bilder, 2005). The mechanism responsible for this loss of apicobasal 
polarity is unclear, however, studies have demonstrated that the polarity protein 
Crumbs may be important. In Tsg101 mutant cells, Crumbs is mislocalised from 
the apical membrane to aberrant endosomes (Moberg et al., 2005; Gilbert et al., 
2009). Overexpression of Crumbs has been shown to disrupt apicobasal 
polarity and drive neoplastic transformation (Lu and Bilder, 2005) and therefore, 
it is suggested that the intracellular accumulation of Crumbs may contribute to 
the polarity defects observed in ESCRT mutant cells (Vaccari and Bilder, 2009). 
 
Mutation of ESCRTs in Drosophila also results in overproliferation, although the 
mechanisms responsible for this appear to differ depending on the context of 
the mutant tissue. The majority of studies have analysed the mechanism 
underlying this overproliferation in mosaic imaginal discs whereby ESCRT 
mutant cells are surrounded by wild type cells. In these tissues the ESCRT 
mutant cells do not overproliferate. Instead ESCRT mutation results in the 
overproliferation of surrounding wild type cells, despite these cells displaying a 
normal epithelial morphology (Figure 1.7B). Consequently, the resulting adult 
tissue is enlarged but is mainly comprised of wild type cells (Moberg et al., 
2005; Thompson et al., 2005; Vaccari and Bilder, 2005; Herz et al., 2006; Herz 
et al., 2009; Rodahl et al., 2009b; Vaccari et al., 2009).  
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Figure 1.7 ESCRT proteins act as tumour suppressors in Drosophila. (A) Drosophila 
imaginal discs composed almost entirely of ESCRT mutant cells lose polarity and form large 
masses lacking normal epithelial morphology. Mutants die as enlarged larvae. (B) In Drosophila 
mosaic imaginal discs, whereby mutant cells are surrounded by wild type cells, ESCRT mutant 
cells lose epithelial polarity and organisation. Despite retaining polarity, surrounding wild type 
cells overproliferate due to increased Notch activation in mutant cells resulting in ectopic 
production of the secreted growth factor Unpaired (Upd). Eventually mutant cells are eliminated 
via apoptosis and therefore, the resulting enlarged adult tissue is composed mainly of wild type 
cells. However, if apoptosis is inhibited mutant cells overproliferate and form tumour-like 
growths capable of metastasis (Moberg et al., 2005; Thompson et al., 2005; Vaccari and Bilder, 
2005; Herz et al., 2006). 
 
 
This non-cell autonomous proliferation is attributed to endosomal accumulation 
of Notch in ESCRT mutant cells resulting in increased Notch signalling 
(Thompson et al., 2005; Vaccari and Bilder, 2005; Herz et al., 2006; Herz et al., 
2009; Vaccari et al., 2009). Interestingly Notch can be activated in a ligand-
independent manner although the mechanism of this is presently unclear 
(Thompson et al., 2005; Vaccari et al., 2008; Vaccari and Bilder, 2009). Steady 
state levels of Notch are maintained by continuous turnover of unliganded 
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Notch via endocytic trafficking (Sakata et al., 2004). In ESCRT mutant cells it 
appears that Notch trafficking is blocked and consequently the unliganded 
receptor accumulates within enlarged endosomes. Notch is activated upon 
cleavage by γ-secretase, the activity of which is optimal at endosomal pH 
(Pasternak et al., 2003). Therefore, it is possible that Notch activation is due to 
γ-secretase-mediated cleavage of unliganded Notch which has accumulated 
within ESCRT mutant cells (Thompson et al., 2005; Vaccari et al., 2008; Vaccari 
and Bilder, 2009). The consequence of increased Notch activity in ESCRT 
mutant cells is ectopic production of the secreted growth factor, Unpaired (Upd). 
This then induces proliferation of surrounding wild type cells via paracrine 
activation of the Jak-STAT signalling pathway (Thompson et al., 2005; Vaccari 
and Bilder, 2005; Herz et al., 2006; Herz et al., 2009; Gilbert et al., 2009; 
Vaccari et al., 2009). 
 
In contrast, in imaginal discs composed almost entirely of ESCRT mutant cells, 
mutant cells overproliferate to form large masses lacking normal epithelial 
morphology which are characteristic of neoplastic tumours (Figure 1.7A). The 
resulting mutant larvae are enlarged and will eventually die. This neoplastic 
growth is thought to be due to an extended period of proliferation rather than an 
increased growth rate and therefore suggests that ESCRT mutant cells are 
unable to respond to signals which usually sense and restrict organ size 
(Moberg et al., 2005; Vaccari and Bilder, 2005; Herz et al., 2009; Vaccari et al., 
2009). The mechanism responsible for this overproliferation is currently 
unknown although it has been suggested that increased mitogenic signalling 
may play a role (Vaccari and Bilder, 2009). For example, EGFR accumulates in 
ESCRT mutant cells and consequently signalling is sustained (Jekely and 
Rorth, 2003; Lloyd et al., 2006; Vaccari et al., 2009). EGFR signalling is 
important for regulation of proliferation and increased signalling can induce 
overproliferation and is often linked to tumourigenesis (Kim and Choi, 2010). 
Therefore, sustained EGFR activation may contribute to the overgrowth 
associated with ESCRT disruption in Drosophila.  
 
Another mechanism which may account for the overproliferation of ESCRT 
mutant cells is increased Notch activity. As in mosaic ESCRT mutant discs, 
endosomal accumulation and increased activation of Notch is observed when 
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the disc is almost entirely mutant for ESCRTs (Vaccari et al., 2008). Whether 
this increase in Notch activity can induce cell-autonomous overproliferation 
remains to be established. Therefore, ESCRT mutation appears to affect 
multiple mitogenic signalling pathways and further research will be important to 
determine the contribution of these pathways and potentially others to the 
phenotype induced by ESCRT disruption.  
 
The Importance of Apoptosis 
In mosaic ESCRT mutant imaginal discs studies found that ESCRT mutant cells 
are eventually eliminated via apoptosis (Thompson et al., 2005; Herz et al., 
2006; Rodahl et al., 2009b). Therefore, the mutant cells only seem to contribute 
to a small proportion of the resulting overgrown tissue. Strikingly, if apoptosis is 
blocked ESCRT mutant cells undergo extensive overproliferation and form 
neoplastic tumours capable of metastasis (Thompson et al., 2005; Herz et al., 
2006; Rodahl et al., 2009b). This suggests that when ESCRT mutant cells are 
surrounded by wild type cells, activation of apoptotic pathways overrides any 
potential increase in mitogenic signalling, therefore, hindering the proliferative 
capacity of ESCRT mutant cells.  
 
Studies have demonstrated that apoptosis of ESCRT mutant cells is induced by 
at least two pathways, one mediated by c-Jun N-terminal kinase (JNK) 
signalling and another mediated by Hid/Diap1/Dronc/Ark (Herz et al., 2006; 
Rodahl et al., 2009b; Vaccari and Bilder, 2009). Hippo signalling has been 
suggested to function as an upstream regulator of these two apoptotic pathways 
as inactivation of Hippo signalling in ESCRT mutant cells completely blocks cell 
death (Herz et al., 2006). Interestingly, Hippo signalling is important for a wide 
range of cellular processes including cell proliferation and polarity (Genevet and 
Tapon, 2011; Halder and Johnson, 2011). JNK, a member of the mitogen-
activated protein (MAP) kinase family, is also thought to have roles in cell 
survival and proliferation in addition to inducing apoptosis (Weston and Davis, 
2002; Bode and Dong, 2007). Therefore, these signalling pathways represent 
potential mechanisms to link the apoptotic, proliferative and polarity defects 
observed upon disruption of the ESCRT machinery in Drosophila (Vaccari and 
Bilder, 2009).   
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It is interesting that when the entire imaginal disc is mutant for ESCRTs, mutant 
cells are not apoptotic. The mechanism which results in this contrasting 
behaviour of ESCRT mutant cells is unknown, however, it is possible that at the 
boundaries of wild type and mutant cells signalling discontinuities occur which 
may influence cell behaviour. For example, activation of JNK-mediated 
apoptosis has been observed when morphogenic gradients between adjacent 
cells are disrupted in developing Drosophila imaginal discs (Adachi-Yamada 
and O’Connor, 2002). It is also important to note that Vps25 mutation has been 
shown to increase levels of Diap1, an inhibitor of apoptosis, in wild type cells 
surrounding ESCRT mutant clones (Herz et al., 2006). Therefore, loss of 
ESCRT function may confer apoptotic resistance and enhance the survival of 
surrounding wild type tissue whilst at the same time, apoptotic pathways are 
activated in the mutant cells.  
 
Therefore, these studies have demonstrated that disruption of the ESCRT 
machinery can lead to loss of cell polarity and self-sufficiency in growth 
signalling, two important hallmarks of cancer (Hanahan and Weinberg, 2011). 
Data suggests that ESCRT function is required for trafficking of important 
regulators of epithelial cell polarity and proliferation in Drosophila and as a 
result, ESCRT proteins have been classified as potential tumour suppressors 
(Vaccari and Bilder, 2009). 
 
1.5.2. ESCRTs and Cancer in Vertebrates 
 
Although recent studies have elucidated important roles for the ESCRT proteins 
within regulation of cell polarity and tumourigenesis in Drosophila, the situation 
in mammalian cells is still unclear. However, there is emerging evidence that 
genes identified as tumour suppressors in Drosophila have similar roles in 
mammals (Stuffers et al., 2009a).   
 
Tumour Susceptibility Gene 101: True or False? 
The ESCRT-I protein, Tsg101 was originally identified in mice, whereby 
knockout of the gene resulted in cellular transformation of mouse fibroblasts 
and formation of metastatic tumours in nude mice (Li and Cohen, 1996). 
However, subsequent mice knockout studies have failed to support a tumour 
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suppressor function of Tsg101. Null mutation of the Tsg101 gene in mice results 
in early embryonic lethality whereas heterozygous mutation does not affect 
development (Ruland et al., 2001; Wagner et al., 2003). In conditional knockout 
mice, whereby Tsg101 was deleted in mammary epithelial cells, reduced 
proliferation and increased cell death was observed resulting in impaired 
mammary development during lactation (Wagner et al., 2003). Despite these 
effects, tumour formation was not observed in either heterozygous complete or 
tissue-specific Tsg101 knockout mice monitored over two years (Wagner et al., 
2003). Therefore, these results suggest that Tsg101 is not acting as a tumour 
suppressor in mice, although it is possible that the full tumourigenic potential of 
Tsg101 is masked by the high level of cell death, similar to the situation 
observed in Drosophila mosaic ESCRT mutant tissues (Thompson et al., 2005; 
Herz et al., 2006).  
 
Subsequent to its identification in mice, the human homologue of Tsg101 was 
identified and mapped to chromosome 11, subbands p15.1-15.2, a region that 
often shows loss of heterozygosity in a variety of human cancers (Li et al., 
1997). Aberrant Tsg101 transcripts have been observed in various tumours 
including breast (Lee and Feinberg, 1997), cervical (O’Boyle et al., 1999) and 
small cell lung cancer (Oh et al., 1998), although no genomic deletions or 
mutations have been observed. In addition, reduced expression of Tsg101 
protein has been observed in ovarian and endometrial tumours (Bennett et al., 
2001). Conversely, overexpression of Tsg101 has been associated with breast 
(Oh et al., 2007), thyroid (Liu et al., 2002) and ovarian cancers (Young et al., 
2007). Furthermore, one study found that reduction of Tsg101 inhibited tumour 
cell growth in prostate and breast cancer cell lines (Zhu et al., 2004), suggesting 
that Tsg101 could also exhibit oncogenic properties. Therefore, the role of 
Tsg101 in human cancers is somewhat controversial and a clear role for this 
ESCRT protein within the process of tumourigenesis in vertebrates is still to be 
confirmed. 
 
Expression of Other ESCRT Proteins in Human Tumours 
There is evidence to suggest that other components of the ESCRT machinery 
act as tumour suppressors within human cancer models. Reduced expression 
of the ESCRT-I component, Vps37A is found in hepatocellular and ovarian 
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carcinomas. Knockdown of this protein increased cell growth and invasive 
abilities of both heptatocellular and ovarian cancer cell lines in vitro (Xu et al., 
2003; Bache et al., 2004; Wittinger et al., 2011). In addition, Vps37A knockdown 
in an ovarian cancer cell line resulted in increased tumour growth in a mouse 
xenograft model (Wittinger et al., 2011). Furthermore, a study by Li and 
colleagues demonstrated that silencing of the ESCRT-III component, CHMP1A, 
resulted in cellular transformation and tumour formation in vivo, as well as 
increased growth of human pancreatic tumour cells in vitro  (Li et al., 2008). In 
contrast with these studies, overexpression of Hrs, an ESCRT-0 component, 
has been observed in stomach, colon, liver, cervix and melanoma tumour 
samples. In addition, Hrs was required to maintain tumourigenic properties of 
HeLa cells, suggesting that Hrs is an oncogenic factor which may play a role in 
determining the malignancy of cancer cells (Toyoshima et al., 2007). 
 
In summary the role of ESCRTs in human cancer remains unclear. Although 
various studies have associated reduced ESCRT function with tumourigenesis, 
increased expression of ESCRT proteins also seems to enhance 
tumourigenicity. It has been suggested that overexpression of ESCRTs may 
have a dominant negative effect (Vaccari and Bilder, 2009), however, this is yet 
to be confirmed.  
 
Potential Roles of ESCRTs in Tumourigenesis 
In Drosophila, studies suggest that ESCRTs act as tumour suppressors by 
regulating epithelial cell polarity and growth signalling. It is tempting to 
speculate that this could also be true in mammalian tissues. Indeed, signalling 
pathways affected by ESCRT mutation in Drosophila have been linked to 
tumour formation in humans. Firstly, EGFR has been shown to play an 
important role in tumourigenesis with expression observed in the majority of 
human carcinomas (Normanno et al., 2006; De Luca et al., 2008). Furthermore, 
mutations in EGFR occur frequently in lung and colorectal cancers and 
inhibitors of EGFR, such as gefitinib, are used therapeutically for the treatment 
of non-small cell lung cancer (Paez et al., 2004; Grandal and Madshus, 2008; 
Kim and Choi, 2010). The Notch signalling pathway has also been implicated in 
a variety of human cancers (Roy et al., 2007). The best studied example of 
oncogenic Notch signalling is in T-acute lymphoblastic leukemia/lymphoma (T-
55 
 
ALL), but Notch upregulation has also been associated with colon and breast 
cancers (Reedijk et al., 2005; Grabher et al., 2006; Meng et al., 2009).  
 
In addition to its role in apoptosis, JNK signalling has also been implicated in 
promoting cell survival and proliferation (Davis, 2000; Bode and Dong, 2007). 
Evidence suggests that JNK plays an important role in tumourigenesis, for 
example, JNK activity has been reported to be elevated in glioblastomas (Tsuiki 
et al., 2003; Bode and Dong, 2007). Interestingly, Hrs and Tsg101 have been 
shown to be required for lysosomal localisation and degradation of the 
transcription factor Jun (Ikeda and Kerppola, 2008). Jun is a major substrate for 
JNK and has also been implicated in carcinogenesis (Bode and Dong, 2007), 
for example the v-jun oncogene has a longer half-life that is thought to 
contribute to cell transformation (Treier et al., 1994). Finally, the possibility of 
aberrant Hippo signalling in Drosophila ESCRT mutants may be relevant to 
human carcinogenesis as deregulation of various components of the Hippo 
pathway is expected to cause defects in cell growth, often resulting in tumour 
formation (reviewed in Zeng and Hong, 2008; Chan et al., 2011).  
 
The other major phenotype routinely observed upon ESCRT disruption in 
Drosophila was a loss of epithelial cell polarity. As discussed previously, 
endocytosis is thought to be important for regulation of epithelial polarity in 
mammalian tissues, however, the role of ESCRTs in this process has not been 
studied.  Therefore, it is possible that ESCRT proteins function as tumour 
suppressors in vertebrates and similar mechanisms of tumourigenesis identified 
in Drosophila may also be important within mammalian tumour formation and 
progression.  
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1.6. Thesis Aims  
 
The overall aim of this thesis is to determine whether ESCRT proteins function 
as tumour suppressors in mammalian epithelial tissues. Specifically, the 
importance of ESCRT proteins in the regulation of mammalian epithelial cell 
polarity and growth will be investigated. The mechanisms underlying any 
regulatory functions will also be explored. This study will provide important 
insight into the role of endocytic trafficking within the maintenance of 
mammalian epithelial tissues and may implicate impaired endocytosis as a 
contributing factor to the process of tumour formation, maintenance and 
progression.  
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CHAPTER TWO 
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2. MATERIALS AND METHODS 
 
2.1. Materials 
 
2.1.1. Reagents 
Unless otherwise specified, all chemicals and general laboratory reagents were 
of molecular biology grade and were purchased from Sigma-Aldrich or 
ThermoFisher Scientific. 
 
Cell Culture Buffers: 
Caco-2 Growth Media 
Dulbecco’s Modified Eagle Medium (DMEM) (4.5g/L glucose, without L-
glutamine; BE12-614F) supplemented with 20% (v/v) fetal bovine serum (FBS) 
(heat inactivated; DE14-801FH), 2mM L-glutamine (BE17-605E), 1X non-
essential amino acid solution (NEAA) (BE13-114E), 100U/ml penicillin, 
100µg/ml streptomycin (DE17-602F) (all Lonza) and 10mM Hepes, pH 7.4 (in 
dH2O, sterile filtered; Sigma). 
 
Caco-2 Antibiotic-Free Media 
As Caco-2 growth media but lacking penicillin/streptomycin. 
 
Caco-2 Serum-Free Media  
As Caco-2 growth media but lacking FBS and penicillin/streptomycin. 
 
Dulbecco’s Phosphate Buffered Saline (DPBS) 
1X DPBS without calcium and magnesium purchased from Lonza (17-512F). 
 
Cell Biology Buffers: 
Phosphate Buffered Saline (PBS) 
12.5 mM Na2HPO4.12H2O, 154 mM NaCl, pH 7.2. 
 
Cell Lysis Buffer 
50mM Tris-HCl pH 8, 150mM NaCl, 1% NP40, 0.5% sodium deoxycholate and 
10M protease inhibitor cocktail for mammalian cell extracts (Sigma, P8340). 
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4% Paraformaldehyde (PFA) 
4% PFA (w/v) was dissolved in PBS by heating at 65°C, with stirring. When 
dissolved and cooled, it was adjusted to pH 7.4 and stored at -20°C until 
required. 
 
Immunoprecipitation (IP) Buffer 
50mM Tris-HCl pH 7.4, 200mM NaCl, 0.5% (w/v) sodium deoxycholic acid, 1% 
(v/v) Triton X-100, 0.1% (w/v) SDS, 1mM EDTA. 
 
10X Wash Buffer (Caco-2 Cysts) 
1.3M NaCl, 70mM dibasic heptahydrate sodium phosphate, 30mM monobasic 
monohydrate sodium phosphate, 77mM sodium azide, 1% (w/v) BSA, 2% (v/v) 
Triton-X 100, 0.4% (v/v) Tween-20, pH 7.4. 
 
Mowiol Mounting Medium 
2.4g Mowiol 4-88 (Calbiochem, 475904) was mixed with 6g glycerol and 6ml 
dH2O and incubated for 2 h at RT, stirring. 12ml 0.2M Tris, pH 8.5 was added 
and the solution was heated to 53°C until Mowiol 4-88 had dissolved. Solution 
was centrifuged at 5000g for 20 min to remove any undissolved solid and stored 
in 1ml aliquots at -20°C until required. 
 
Western Blotting Buffers: 
Resolving Gel Buffer 
1.5M Tris-HCl pH 8.8, 0.4% (w/v) SDS. 
 
Stacking gel buffer 
0.5 M Tris-HCl pH 6.8, 0.4% (w/v) SDS. 
 
3X Sample Buffer  
187.5mM Tris-HCl pH 6.8, 6% (w/v) SDS, 30% (w/v) glycerol, 0.03% (w/v) 
bromophenol blue. Prior to use, Dithiothreitol (DTT) was added to a final 
concentration of 100mM. 
 
SDS Electrophoresis Buffer 
25mM Tris-HCl pH 8.3, 0.2M glycine, 0.1% (w/v) SDS. 
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Transfer Buffer 
48mM Tris-HCl pH 8.8, 39mM glycine, 0.0375% (w/v) SDS, 20% (v/v) methanol.  
 
Ponceau S Stain 
0.1% (w/v) Ponceau S, 3% (w/v) trichloroacetic acid. 
 
Tris-Buffered Saline containing Tween-20 (TBST) 
10mM Tris-HCl pH 7.4, 154mM NaCl, 0.1% (v/v) Tween-20. 
 
Blocking Buffer 
5% (w/v) Marvel milk powder in TBST. 
 
Enhanced Chemiluminescence (ECL) Reagent 
Solution A: 100mM glycine (pH 10), 0.4mM luminol, 8mM 4-iodophenol. 
Solution B: 0.12% (w/v) hydrogen peroxide in water. 
 
Biotinylation Assay Buffers: 
Phosphate Buffered Saline with Calcium and Magnesium (PBS/CM) 
PBS supplemented with 0.9mM calcium chloride and 0.33mM magnesium 
chloride purchased from Lonza (BE17-513Q). 
 
Tris-Buffered Saline with Calcium (TBS/C) 
50mM Tris-HCl pH 8.6, 100mM NaCl, 2.5mM CaCl2. 
 
Wash Buffer 
50mM Tris-HCl pH 8.0, 150mM NaCl, 0.5% (v/v) Triton X-100, 0.1% (w/v) SDS, 
5mM EDTA. 
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2.1.2. Antibodies 
A list of antibodies used, supplier and dilutions for different applications is 
detailed in Table 2.1. 
 
 Antibody Species Source Application/Dilution 
P
R
IM
A
R
Y
 
α-Tsg101 
mouse, 
monoconal 
Abcam 
ab83 
WB - 1:1000  
(in 5% milk) 
α-Vps25 
(serum #6973) 
rabbit, 
polyclonal 
Gift 
(Dr Kate Bowers) 
WB - 1:1000  
(in 5% milk) 
α-β tubulin 
(clone TUB 2.1) 
mouse, 
monoclonal 
Sigma 
T4026 
WB - 1:5000 
α-claudin-1* 
rabbit, 
polyclonal 
Zymed 
59-9000 
WB - 1:2000 
IF - 1:25 
α-claudin-1 
mouse, 
monoclonal 
Zymed 
37-4900 
WB - 1:1000 
α-claudin-4* 
mouse, 
monoclonal 
Zymed 
32-9400 
WB - 1:1000 
IF - 1:25 
α-occludin* 
mouse, 
monoclonal 
Zymed 
33-1500 
WB - 1:1000 
IF - 1:25 
α-ZO-1 
mouse, 
monoclonal 
Zymed 
33-9100 
IF - 1:25 
α-ZO-1 
rabbit, 
polyclonal 
Zymed 
61-7300 
IF - 1:25 
α-E-cadherin 
mouse, 
monoclonal 
Zymed 
33-4000 
WB - 1:1000 
IF - 1:25 
α-desmoglein-2 
mouse, 
monoclonal 
Abcam 
ab14415 
IF - 1:25 
α-JAM-A 
mouse, 
monoclonal 
Zymed 
36-1700 
IF - 1:50 
α-PKC-ζ (C-20) 
rabbit, 
polyclonal 
Santa Cruz 
sc-216 
IF - 1:200 
α-DppIV 
(CD26) 
mouse, 
monoclonal 
Abcam 
ab3154 
IF - 1:50 
α-ubiquitin (mono- & 
polyubiquitinated 
conjugates, clone 
FK2) 
mouse, 
monoclonal 
Enzo Life Sciences 
BML-PW8810 
WB - 1:1000 
IF - 1:500 
α-EEA1 
mouse, 
monoclonal 
BD Biosciences 
610457 
IF - 1:500 
α-EEA1 
rabbit, 
polyclonal 
Abcam 
ab2900 
IF - 1:500 
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 Antibody Species Source Application/Dilution 
P
R
IM
A
R
Y
 
α-CD63 
mouse, 
monoclonal 
Santa Cruz 
sc5275 
IF - 1:1000 
α-M6PR 
mouse, 
monoclonal 
Abcam 
ab2733 
IF - 1:200 
α-TfR 
mouse, 
monoclonal 
Zymed 
13-6800 
IF - 1:50 
α-Lamp 1 
mouse, 
monoclonal 
Gift 
(Dr Scott Lawrence) 
IF - 1:8000 
α-active caspase 3 
rabbit, 
polyclonal 
Abcam 
ab13847 
IF - 1:100 
α-phospho-histone 
H3 
mouse, 
monoclonal 
Abcam 
ab14955 
IF - 1:500 
α-p44/42 MAPK 
(Erk1/2) 
rabbit, 
monoclonal 
Cell Signalling 
4695 
WB - 1:1000 
α-phospho-p44/42 
MAPK (p-Erk1/2) 
mouse, 
monoclonal 
Cell Signalling 
9106S 
WB - 1:2000 
IF - 1:200 
α-SAPK/JNK 
rabbit, 
polyclonal 
Cell Signalling 
9252 
WB - 1:1000 
α-phospho-
SAPK/JNK 
mouse, 
monoclonal 
Cell Signalling 
9255S 
WB - 1:2000 
α-BrdU 
(part of labelling kit) 
mouse, 
monoclonal 
Roche 
11 296 736 001 
IF - 1:10 
S
E
C
O
N
D
A
R
Y
 
α-mouse IgG (H+L) 
Alexa Fluor 488 
goat, 
polyclonal 
Molecular Probes 
A11001 
IF - 1:100 
α-mouse IgG (H+L) 
Alexa Fluor 546 
goat, 
polyclonal 
Molecular Probes 
A11003 
IF - 1:100 
α-rabbit IgG (H+L) 
Alexa Fluor 488 
goat, 
polyclonal 
Molecular Probes 
A11008 
IF - 1:100 
α-rabbit IgG(H+L) 
Alexa Fluor 546 
goat, 
polyclonal 
Molecular Probes 
A11010 
IF - 1:100 
α-rabbit IgG (H+L)-
HRP 
goat, 
polyclonal 
Pierce 
31460 
WB - 1:5000 
α-mouse IgG (Fc 
specific)-HRP 
goat, 
polyclonal 
Sigma 
A2554 
WB - 1:5000 
 
Table 2.1 List of antibodies used. Supplier and catalogue number of antibodies are detailed, 
dilutions are of original supplied stocks. For the conditions of antibody utilisation, refer to main 
text. For IF, antibodies which required fixation in methanol are indicated by ‘*’, 4% PFA fixation 
was used for all other antibodies (see section 2.2.8 for details). Abbreviations: WB = Western 
Blotting, IF = Immunofluorescence.  
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2.1.3. RNA Interference 
Tsg101 and Vps25 proteins were depleted using the small interfering RNA 
(siRNA) oligonucleotides detailed in Table 2.2 and 2.3. All siRNA was 
purchased from Dharmacon.  
 
Target Protein Catalogue Number Target sequence (5’3’) 
Tsg101 L-003549-00 
I1: CCGUUUAGAUCAAGAAGUA 
I2: CUCCAUACCCAUCCGGAUA 
I3: CCACAACAAGUUCUCAGUA 
I4: CCAAAUACUUCCUACAUGC 
Vps25 L-004699-01 
I1: GAUCAUCACUGUCAGCGAU 
I2: ACGUCAAGCUACAGCGAAA 
I3: CAGUCCAGCAUGACGGUGA 
I4: ACCUCGAGUGGUUGGAUAA 
Non Targeting Control D-001810-10 N/A 
 
Table 2.2 ON-TARGETplus SMARTpool siRNA used for transient knockdown of Tsg101 
and Vps25. Tsg101 and Vps25 were depleted via transfection with ON-TARGETplus 
SMARTpool siRNA, composed of four separate siRNA target sequences. ON-TARGETplus 
Non-Targeting Pool was used as a control.  
 
 
 
Name Catalogue Number Target sequence (5’3’) 
Tsg101 J-003549-06 (I1) CCGUUUAGAUCAAGAAGUA 
Tsg101 A1 J-003549-07 (I2) CUCCAUACCCAUCCGGAUA 
Tsg101 A2 
J-003549-07 
J-003549-08 
(I2) CUCCAUACCCAUCCGGAUA 
(I3) CCACAACAAGUUCUCAGUA 
 
Table 2.3 ON-TARGETplus siRNA sequences used for Tsg101 knockdown. Tsg101 
knockdown was carried out using a single siRNA oligonucleotide sequence for the majority of 
experiments. Verification of knockdown phenotype was carried out using an alternate single 
Tsg101 siRNA oligonucleotide (A1) and a mixture of two Tsg101 siRNA oligonucleotides (A2). 
All Tsg101 siRNA sequences were part of the original SMARTpool, denoted I1 - I4 in Table 2.2. 
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2.2. Methods 
 
2.2.1. Cell Culture 
Caco-2 (human colorectal adenocarcinoma; HPA, 86010202) cells were 
cultured in Caco-2 complete growth media at 37°C in 5% CO2. Cells were 
maintained in T75 flasks and passaged every 3-4 days, after reaching 
approximately 80% confluence. Cells were used between passages 40 to 60. 
Cells were routinely tested for mycoplasma contamination using MycoAlert® 
Mycoplasma Detection Kit (Lonza, LT07-218). All tissue cultured treated 
plasticware was purchased from Greiner Bio-One unless otherwise stated. 
 
To plate cells for experimental conditions, cells were washed in DPBS and 
incubated with 1X trypsin (in DPBS; Lonza, BE02-007E) for approximately 10 
min at 37°C, 5% CO2, until detached. Trypsin was neutralised with Caco-2 
antibiotic-free media and cell suspension was centrifuged at 200g for 3 min. 
Cells were resuspended in antibiotic-free media and counted using a 
haemocytometer (Fisher Scientific). Cells were diluted to the desired 
concentration in antibiotic-free media, plated to either 35mm dishes or 13mm 
glass coverslips (Fisher Scientific, MNJ-500-010G) in 24-well plates and 
incubated at 37°C, 5% CO2.  
 
2.2.2. Phase Contrast Microscopy 
Caco-2 cell morphology was monitored using a Nikon Eclipse TS100-F Inverted 
Microscope (10X or 20X objective). Images were obtained using a Nikon 
CoolPix 5000 digital camera and were processed using Adobe Photoshop.  
 
2.2.3. Transfection with small interfering RNA (siRNA) 
Caco-2 cells were plated at 7.5 x 104 cells/ml (unless otherwise indicated) onto 
either 35mm dishes (2ml per well), or 13mm glass coverslips (for 
immunofluorescence, 1ml per coverslip) and incubated in antibiotic-free media 
at 37°C, 5% CO2 for approximately 4 h to adhere. 2µM siRNA (in DPBS) and 
DharmaFECT 1 (Dharmacon, T-2001) were diluted in serum-free media (SFM) 
as detailed below (Table 2.4) and incubated for 5 min at RT. The two solutions 
were mixed and incubated for 20 min at RT. The required volume of antibiotic-
free media was added and the transfection mixture was added to cells. Cells 
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were incubated at 37°C, 5% CO2 for the desired time period, changing media to 
complete growth media after 3 d. 
 
 
Tube 1 (µl) Tube 2 (µl) Antibiotic-
free media 
(µl) 
Final 
volume 
(µl) 
20µM 
siRNA 
DPBS SFM 
Dharma 
FECT-1 
SFM 
35mm dish 10 90 100 4 (5) 196 (195) 1600 2000 
Coverslip 2.5 22.5 25 1 (1.25) 49 (48.75) 400 500 
 
Table 2.4 Volumes of reagents required for transfection with siRNA oligonucleotides. 
Solutions were prepared as detailed in methods using the volumes indicated. Transfection with 
Vps25 siRNA required an increased volume of DharmaFECT-1, as indicated in brackets.  
 
2.2.4. Cell Lysis and Protein Quantification 
Cells were washed once in ice-cold PBS and scraped into an appropriate 
volume of ice-cold cell lysis buffer containing mammalian protease inhibitors. 
Cell lysates were pulse sonicated on ice, five times for 3 s and incubated for 30 
min at 4°C, with rotation. Lysates were centrifuged at 15000g for 15 min at 4°C 
to remove nuclear debris and stored at -20°C until required for further analysis.  
 
Protein quantification of cell lysates was carried out with the colorimetric BCA 
(bicinchoninic acid) Protein Assay Kit (Pierce, 23227) using a bovine serum 
albumin (BSA) standard curve (0, 1, 2, 4, 6, 8, 10µg BSA). BCA solution 
(reagent A + 1:50 dilution reagent B) was freshly prepared and 200l was 
added to each well of a 96-well flat bottom plate (Iwaki) containing standard or 
test samples (2l). All samples were carried out in triplicate. The plate was 
incubated for 30 min at 37°C and absorbance was measured at 565nm using a 
Spectra Rainbow Thermo microplate spectrophotometer (Tecan). Results were 
analysed using Microsoft Excel and unknown protein concentrations were 
calculated.  
 
2.2.5. SDS-PAGE and Immunoblotting 
Proteins were separated according to size using sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). Equal amounts of lysate (10-
25µg protein) was added to 1X sample buffer (final concentration) containing 
100mM DTT and incubated for 5 min at 95°C. Polyacrylamide gels of 1mm 
thickness were prepared using acrylamide/bis-acrylamide (30% (w/v) 
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acrylamide: 0.8% (w/v) bis-acrylamide) (ProtoGel; National Diagnostics, EC-
890) and gel buffers previously described. Polymerisation of the gels was 
induced by the addition of 10% (w/v) ammonium persulphate (APS; Sigma) and 
N,N,N,N’-tetramethylethylenediamine (TEMED; Sigma). The gels were 
composed of a 12% resolving gel (pH 8.8) and a lower percentage stacking gel 
(pH 6.8). The composition of the resolving and stacking gels is given in Table 
2.5. Gels were assembled into the mini PAGE chamber (ATTO Corporation, 
model AE-6450) and samples (25µl) were loaded alongside 8µl Broad Range 
Prestained Protein Marker (New England Biolabs, P77085). Gels were run at 40 
mA/gel for approximately 50 min.  
 
Solution Resolving Gel (12%) Stacking Gel 
Protogel 3 ml 850 µl 
Resolving gel buffer 2.5 ml - 
Stacking gel buffer - 1.25 ml 
dH20 2 ml 1.875 ml 
10% APS 50 µl 20 µl 
TEMED 4 µl 5 µl 
 
Table 2.5. Composition of SDS-PAGE gels. Volumes are for one 90 x 80 x 1mm gel. 
 
Separated proteins were then transferred to Biotrace™ Pure Nitrocellulose 
Blotting Membrane (Pall Life Sciences, 66485). Filter papers (Extra thick, 
7.5x10cm; Bio-Rad, 1703965) and the nitrocellulose membrane were pre-
soaked in transfer buffer and assembled onto the HorizBlot semi-dry transfer 
apparatus (ATTO Corporation, model AE-6675L) in the following order: filter 
paper, nitrocellulose membrane, gel, filter paper. Air bubbles were carefully 
removed and transfer of proteins was carried out at 54 mA/gel for 110 min. 
Following the transfer, nitrocellulose membranes were briefly incubated with 
Ponceau S stain to confirm the presence of transferred proteins. 
 
Detection of specific proteins transferred to nitrocellulose membrane was 
performed via immunoblotting. Membranes were rinsed with TBST to remove 
Ponceau S stain and incubated in blocking buffer for 1 h at RT. Membranes 
were then incubated with primary antibodies diluted in 1% (w/v) BSA (in TBST) 
(unless otherwise stated) for either 2 h at RT or overnight at 4°C. The 
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appropriate species-specific horseradish-peroxide (HRP)-conjugated secondary 
antibody was diluted in blocking buffer and added to membranes for 1 h at RT. 
Following all antibody incubations, membranes were washed 6 times in TBST, 5 
min per wash. To visualise proteins, membranes were incubated for 5 min at RT 
with either equal volumes of Solution A and B of the ECL Reagent (homemade), 
or Luminata™ Forte HRP Substrate (Millipore, WBLUF0500). Proteins were 
visualised and quantified using an Optichem detector with associated software 
(Ultra Violet Products).  
 
2.2.6. Immunoprecipitation 
Caco-2 cells were plated onto 35mm dishes, transfected with siRNA as detailed 
previously (section 2.2.3) and incubated for 7 d at 37°C, 5% CO2. Cells were 
lysed in 100µl cell lysis buffer as previously described (section 2.2.4) and 10µl 
of total lysate was taken from each sample for use as a loading control. The 
remaining lysate was used for immunoprecipitation of claudin-1. Protein A-
coupled Sepharose Beads (Amersham Biosciences, 17-0780-01) were 
prepared as follows. 0.1g sepharose beads were suspended in 20ml dH2O and 
allowed to swell for 30 min. Beads were centrifuged at 1000g for 5 min at RT. 
Beads were washed three times by resuspension and centrifugation using IP 
Buffer. A slurry was prepared containing 75% beads and 25% IP Buffer. Prior to 
immunoprecipitation, a pre-clearing step was performed to reduce non-specific 
binding. 80µl cell lysate was added to 80µl IP Buffer, 1µg rabbit IgG (Sigma, 
I5006) and 50µl 75% slurry and the sample was incubated for 2 h at 4°C, with 
rotation. Concurrently, a coupling reaction was prepared to allow binding of the 
antibody to the sepharose beads. 1µg rabbit anti-claudin-1 was added to 500µl 
IP Buffer and 50µl 75% slurry and the sample was incubated for 2 h at 4°C, with 
rotation. Both samples were then centrifuged at 1000g for 3 min. The 
supernatant from the pre-clearing sample was added to the sepharose beads 
from the coupling reaction and the sample was incubated overnight at 4°C, with 
rotation in order to isolate claudin-1 protein from the cell lysate. Beads were 
washed 5 times by centrifuging at 1000g for 3 min and resuspending in 1ml cold 
IP Buffer. Finally, beads were resuspended in 1X sample buffer (final 
concentration) containing 100mM DTT and incubated for 15 min at 95°C to 
release isolated proteins from the beads. Samples were centrifuged at 1000g 
for 3 min and supernatant was collected. Samples were then analysed using 
68 
 
SDS-PAGE and immunoblotting (see section 2.2.5). Antibodies used were 
mouse anti-claudin-1, to verify that the immunoprecipitation was successful, and 
mouse anti-ubiquitin, to analyse the amount of ubiquitinated claudin-1 present. 
Total cell lysates were included alongside immunoprecipitation samples to 
serve as loading controls. 
 
To ensure the immunoprecipitation was specific for claudin-1, the following 
controls were also included: a no antibody control and an IgG control, in which 
the rabbit anti-claudin-1 was replaced with dH2O or 1µg rabbit IgG, respectively. 
 
2.2.7. Biotinylation Trafficking Assays 
The biotinylation assay to study endocytosis and recycling of tight junction 
proteins was modified from a method described previously (Nishimura and 
Sasaki, 2008). See Figure 2.1 for a schematic of the process. 
 
Endocytosis Assay 
Prior to carrying out the biotinylation assay, Caco-2 cells were plated at 7.5 x 
104 cells/ml onto 35 mm dishes and cultured for 7 d at 37°C, 5% CO2. Cells 
were transferred to ice and washed with PBS supplemented with calcium and 
magnesium (PBS/CM).  Cells were then incubated with 1ml of the cleavable 
non-membrane permeable sulfo-NHS-SS-biotin (Pierce; in PBS/CM) at a 
concentration of 0.5mg/ml for 30 min on ice to label all cell surface proteins.  
Free biotin was quenched with 50mM NH4Cl (Sigma) (in PBS/CM) for 3 x 5 min 
washes on ice. For the endocytosis assay, 2ml pre-warmed complete growth 
medium was added and cells returned to 37°C, 5% CO2 for indicated times.  
Cells were then transferred to ice to stop endocytosis, and surface (non-
endocytosed) biotin was stripped by reduction with 100mM 2-
mercaptoethanesulfonate (MESNA; Sigma) (in tris-buffered saline 
supplemented with calcium; TBS/C) for 3 x 10 min washes on ice.  Internalised 
biotinylated cargo was protected from biotin stripping with MESNA by an intact 
plasma membrane.  Free –SH groups were then quenched by incubating cells 
with 5 mg/ml iodoacetamide (Sigma) (in PBS/CM) for 3 x 5 min washes on ice. 
Following the endocytosis assay, cells were either lysed to determine amount of 
protein endocytosed (‘endocytosis’ sample) or used for the subsequent 
recycling assay.  
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Alongside the ‘endocytosis’ sample, a number of controls were also carried out. 
Firstly, a ‘no biotin’ condition was included to which no sulfo-NHS-SS-biotin was 
added. This ensured the neutravidin pull down was specific for biotinylated 
proteins. To ensure the stripping procedure was efficient, a ‘surface strip’ 
condition was included whereby biotin was stripped from the cell surface 
immediately after incubation. Lastly, the total amount of biotinylated protein at 
the cell surface (‘surface label’) was determined by lysing cells after incubation 
with biotin.  
 
Recycling Assay 
For the recycling assay, 2ml pre-warmed complete growth medium was added 
and cells were returned to 37°C, 5% CO2 for 20 min. This allows for potential 
recycling of internalised biotinylated proteins back to the cell surface. Cells were 
then transferred to ice, and surface biotin was stripped by reduction with 
100mM MESNA (in TBS/C) for 3 x 10 min washes on ice.  Free –SH groups 
were quenched by incubating cells with 5 mg/ml iodoacetamide (in PBS/CM) for 
3 x 5 min washes on ice. Therefore, the remaining biotinylated protein is that 
which has endocytosed and not recycled back to the cell surface (‘recycling’ 
sample). To control for potential loss of biotinylated cargo via degradation rather 
than recycling, a ‘degradation control’ was included which lacked the second 
MESNA treatment.  Thus any loss in biotinylated cargo at this step, relative to 
the ‘endocytosis’ step, would indicate a loss in signal due to degradation of 
cargo instead of recycling. The amount of recycled cargo is indicated by the 
difference in signal between the ‘degradation control’ and ‘recycling’ samples.  
 
Cell Lysis and Isolation of Biotinylated Proteins  
Cells were lysed in 100µl cell lysis buffer and protein concentration determined 
as previously described (see section 2.2.4). An equal amount of total lysate 
(10µg protein) was taken from each sample for use as a loading control. 
Remaining samples were diluted to equal protein concentrations (in 100µl cell 
lysis buffer) and biotinylated proteins were collected by incubation with 50µl 
Neutravidin beads (Pierce), rotating overnight at 4oC.  Beads were washed by 
centrifuging at 1000g for 2 min, 5 times with 1ml wash buffer and 3 times with 
1ml PBS/CM.  Sample buffer containing 100mM DTT was then added to beads 
and samples were incubated for 15 min at 95°C to release biotinylated proteins 
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from the beads. Samples were centrifuged at 1000g for 3 min and supernatant 
was collected. The amount of biotinylated proteins present in each sample was 
analysed using SDS-PAGE and immunoblotting for the protein of interest (see 
section 2.2.5). Total cell lysates were included alongside Neutravidin pull-downs 
to serve as a loading control. For quantification of the biotinylated proteins, the 
amount of protein was normalized to the respective total protein bands 
determined from total cell lysate samples.   
 
 
 
 
Figure 2.1 Biotinylation Endocytosis and Recycling Assay. Schematic to illustrate the steps 
involved. Cells were lysed at each step and levels of biotinylated protein was compared.   
 
 
2.2.8. Cycloheximide Treatment 
Caco-2 cells were plated at 7.5 x 104 cells/ml onto 35 mm dishes and cultured 
for 7 d at 37°C, 5% CO2. Cells were incubated with 2µg/ml cycloheximide 
(Sigma, C4859) diluted in antibiotic-free media for 20 min, 1 h, 6 h, 16 h or 24 h 
at 37°C, 5% CO2. DMSO controls were carried out alongside. At each timepoint 
cells were lysed and processed for SDS-PAGE and immunoblotting to analyse 
levels of occludin, claudin-1 and connexion-43, which was used as a positive 
control (sections 2.2.4, 2.2.5). 
 
2.2.9. Immunofluorescence  
Cells were cultured on 13mm glass coverslips for the desired time. Prior to 
processing for immunofluorescence, media was removed and cells were 
washed twice in PBS. Depending on the antibodies used (see Table 2.1 for list 
of antibodies and conditions required), cells were fixed according to the 
following protocols. Following fixation, cells were either immediately processed 
for antibody staining or stored in PBS at 4°C until required. 
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Fixation in 4% PFA 
Cells were fixed in 4% (w/v) paraformaldehyde (PFA) for 20 min at RT. Cells 
were washed twice in PBS and then permeabilised in ice-cold 100% Methanol 
for 5 min at -20°C, followed by two further PBS washes. 
 
Fixation in Methanol 
Cells were fixed and permeabilised in ice-cold 100% Methanol for 10 min at -
20°C followed by two PBS washes.  
 
Antibody Staining 
Following fixation, cells were incubated in 10% FBS (v/v in PBS) for 30 min at 
RT to block non-specific binding sites. Cells were then washed twice in 2% FBS 
(v/v in PBS) and once in PBS, 3 min per wash. Primary antibodies diluted in 2% 
FBS were added and cells were either incubated for 2 h at RT or overnight at 
4°C. Cells were incubated with species specific fluorophore-conjugated 
secondary antibodies for 1 h at RT, in the dark. After all antibody incubations 
cells were washed 3 x 5 min in 2% FBS and 3 x 5 min in PBS. Nuclei were 
stained using 1µg/ml DAPI (4’,6-diamidino-2-phenylindole) (Sigma, D9564) for 
10 min at RT, in the dark. Following a quick wash in PBS, cells were mounted 
onto glass slides using Mowiol Mounting Medium and allowed to dry at RT 
overnight, protected from light. Stained cells were examined on a Zeiss 
LSM510META laser-scanning confocal microscope (Plan-ApoChromat 63x/1.4 
Oil DIC objective). Images were taken and processed using the LSM Image 
Browser Software (Zeiss) and Adobe Photoshop.  
 
2.2.10. EGF Stimulation 
Cells were serum starved overnight prior to EGF treatment. For 
immunofluorescence studies, cells were incubated in 500ng/ml EGF 
(Calbiochem, 324831) or EGF-Alexa Fluor® 555 diluted in SFM for 4 h at 37°C, 
5% CO2. Cells were washed in PBS and then processed as detailed previously 
(section 2.2.9). For pulse-chase experiments, cells were incubated in 500ng/ml 
EGF in SFM for 10 min on ice. Media was replaced with SFM and cells were 
incubated in SFM for 15 min, 1 h or 4 h at 37°C, 5% CO2. Cells were then lysed 
and processed for SDS-PAGE and immunoblotting to analyse levels of p-Erk1/2 
and total Erk1/2 (sections 2.2.4, 2.2.5).  
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2.2.11. Cysts 
Caco-2 cells were plated at 1 x 105 cells/ml into 35mm dishes, transfected with 
siRNA as detailed previously (section 2.2.3), incubated at 37°C, 5% CO2 for 3 d. 
Cells were washed in DPBS, trypsinised and centrifuged at 200g for 3 min. 
Cells were resuspended in 300µl complete growth media and counted using a 
haemocytometer, including 0.2% (v/v) Trypan Blue (Sigma, T8154) to exclude 
dead cells. Cells were diluted to 3.5 x 105 cells/ml in complete growth media. A 
cell:matrix mix was prepared on ice containing 5.8 x 104 cells/ml, 0.02 M 
HEPES, pH 7.4, 1 mg/ml Collagen I (Inamed Biomaterials, 5409) and 40% 
Growth Factor Reduced BD Matrigel™ Matrix (BD Biosciences, 356230) (see 
Table 2.6). All solutions were kept on ice and tubes and pipette tips were pre-
cooled to prevent the matrigel from solidifying. The cell:matrix mix was plated 
into an 8 chamber slide (BD Biosciences, 354108), 100µl per chamber, 
incubated at 37°C, 5% CO2 for 1 h to solidify and overlaid with 300µl complete 
growth media. Cysts were allowed to develop for 7 d at 37°C, 5% CO2, 
changing media every 3-4 d.   
 
Component Volume (µl) Final Concentration 
3.5 x 10
5 
cells/ml Caco-2 cell suspension 41.4 5.8 x 10
4 
cells/ml 
Caco-2 complete growth media 20.3 N/A 
1M HEPES, pH 7.4 5 0.02 M 
Collagen I, 3 mg/ml 83.3 1 mg/ml 
Growth Factor Reduced BD Matrigel™ Matrix 100 40 % 
 
Table 2.6. Composition of cell:matrix mix for culture of Caco-2 cell cysts. Volumes given 
are sufficient for 2 wells of an 8 chamber slide, plating 100µl per well.   
 
After 7 d culture, cysts were washed 3 x 5 min in PBS and treated with 5U/ml 
Collagenase VII (in PBS) (Sigma, C0773) for 15 min at RT. Cysts were washed 
in PBS then fixed in 4% (w/v) PFA for 30 min at RT. Cysts were washed 3 x 10 
min with 1X wash buffer (in dH2O) and incubated with blocking buffer (10% (v/v) 
FBS in 1X wash buffer) for 1 h at RT. Cysts were then incubated with primary 
antibodies diluted in blocking buffer overnight at 4°C, followed by incubation 
with species specific fluorophore-conjugated secondary antibodies diluted in 
blocking buffer for 1 h at RT, in the dark. Following all antibody incubations 
cysts were washed 3 x 20 min in 1X wash buffer. Cysts were rinsed 2 x 5 min in 
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PBS and post-fixed in 4% (w/v) PFA for 30 min at RT. Following a further 3 x 5 
min washes with PBS, nuclei were stained with 1μg/ml DAPI for 30 min at RT. 
After a final rinse in PBS, cysts were mounted in Mowiol Mounting Medium and 
examined on a Zeiss LSM510 META laser-scanning confocal microscope (Plan-
ApoChromat 63x/1.4 Oil DIC objective). Images were taken and processed 
using the LSM Image Browser Software (Zeiss) and Adobe Photoshop.  
 
2.2.12. Transepithelial Resistance (TER) Measurements 
Caco-2 cells were plated at 1 x 105 cells/ml into 35mm dishes, transfected with 
siRNA as detailed previously (section 2.2.3) and incubated at 37°C, 5% CO2 for 
3 d. To plate onto filters, cells were washed in DPBS, trypsinised and 
centrifuged at 200g for 3 min. Cells were resuspended in 300µl complete growth 
media and counted using a haemocytometer, including 0.2% (v/v) Trypan Blue 
to exclude dead cells. Cells were diluted to 1.25 x 106 cells/ml in complete 
growth media. Cells were plated in triplicate on Transwell® (Corning; 3470) 
permeable polyester filters (0.4µm pore size, 0.33cm2 surface area), 200µl per 
filter (2.5 x 105 cells/filter final density). Filter inserts were placed in a 24-well 
plate and 1ml complete growth media was added to each basal compartment. 
Cells were incubated at 37°C, 5% CO2. TER was measured every 24 h for 4 d 
using a EVOM TER machine with an Endohm-6TM chamber (World Precision 
Instruments), changing media after every reading. 
 
Calcium Switch 
To induce disassembly followed by reassembly of cell-cell junctions, a calcium 
switch method was carried out. Following culture of Caco-2 cells on filters for 4 
d, cells were washed in DPBS and incubated in calcium-free media (EMEM with 
Earle’s BSS, with NEAA and L-glutamine, without calcium; Lonza, 06-174G) for 
90 min at 37°C, 5% CO2 to induce internalisation of cell-cell junction proteins. 
Following measurement of TER, media was replaced with complete growth 
media and cells were incubated at 37°C, 5% CO2 to allow cell-cell junctions to 
reform. Recovery of TER was measured every hour for 5 h.  
 
2.2.13. MTT Assay 
Caco-2 cells were plated at 7.5 x 104 cells/ml into 35mm dishes, transfected 
with siRNA as detailed previously (section 2.2.3) and incubated at 37°C, 5% 
CO2 for the desired time period. To carry out the MTT assay, cells were washed 
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briefly in DPBS and incubated with 2ml 2.5mg/ml MTT (3-(4,5-Dimethyl-2-
thiazolyl)-2,5-diphenyltetrazolium bromide) (Alfa Aesar, L11939) in phenol red-
free media (DMEM with 4.5 g/L glucose, without L-glutamine or phenol red; 
Lonza, BE12-917F) for 1 h at 37°C, 5% CO2. A control was included containing 
no cells. MTT solution was removed and cells were incubated with 1ml of 
isopropanol for 20 min at RT in the dark. The isopropanol solution was 
transferred to a 96-well flat bottomed clear plate, 100µl per well and absorbance 
was measured at 570nm using a Spectra Rainbow Thermo microplate 
spectrophotometer (Tecan). Results were analysed using Microsoft Excel, 
calculating mean absorbance for each condition and subtracting background 
absorbance obtained from no cell control. 
 
2.2.14. Quantification of Cell Number 
Caco-2 cells were stained with appropriate antibodies and nuclei stained with 
DAPI as detailed previously (section 2.2.8). Stained cells were examined on a 
Zeiss LSM510META laser-scanning confocal microscope (Plan-ApoChromat 
63x/1.4 Oil DIC objective). Z-stack images were taken at random and cell 
number was quantified using Image J software. Six images were taken per 
condition and, for Tsg101 knockdown cells, regions were distinguished as either 
monolayerd or multilayered.  
 
2.2.15. BrdU Incorporation 
Caco-2 cells were plated onto 13mm glass coverslips, transfected with siRNA 
as detailed previously (section 2.2.3) and incubated at 37°C, 5% CO2 for 6 d. 
BrdU (5-Bromo-2’-deoxy-uridine) labelling reagent (BrdU Labelling and 
Detection Kit; Roche, 11 296 736 001) was added at 1:1000 dilution directly to 
media in each well and cells were incubated for 24 h at 37°C, 5% CO2. Cells 
were washed twice in PBS and fixed in cold 100% Ethanol for 20 min at -20°C. 
After 2 x 5 min washes in PBS, cells were incubated in 10% (v/v) FBS (in PBS) 
for 30 min at RT, followed by three further PBS washes. Anti-BrdU (included in 
the labelling kit) was diluted 1:10 in Incubation Buffer and added to cells for 30 
min at 37°C. Cells were then incubated with anti-mouse Alexa Fluor® 488 
secondary antibody (in PBS) for 1 h at RT, in the dark. Following both antibody 
incubations, cells were washed 6 x 5 min in PBS. Nuclei were stained using 
1µg/ml DAPI for 10 min at RT, in the dark. Following a quick wash in PBS, cells 
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were mounted onto glass slides using Mowiol Mounting Medium and allowed to 
dry at RT overnight, protected from light. Stained cells were examined on a 
Zeiss LSM510META laser-scanning confocal microscope (Plan-ApoChromat 
63x/1.4 Oil DIC objective). Z-stack images were taken at random and BrdU 
incorporation was quantified using Image J software. Six images were taken per 
condition and, for Tsg101 knockdown cells, regions were distinguished as either 
monolayerd or multilayered.  
 
2.2.16. Caspase Inhibition 
Caco-2 cells were plated onto 13mm glass coverslips, transfected with siRNA 
as detailed previously (section 2.2.3) and incubated at 37°C, 5% CO2 for a total 
of 7 or 10 d. The General Caspase Inhibitor (Q-VD-OPh; R&D Systems, 
OPH001) was added to cells on day 4 and day 7 (for 10 d knockdowns) at 
25µM in Caco-2 growth media and cells were incubated at 37°C, 5% CO2 for 
the remainder of the incubation period. DMSO controls were carried out 
alongside. After 7 d and 10 d knockdown, cells were fixed in 4% (w/v) PFA and 
processed for immunofluorescence (see section 2.2.8) to stain for active 
Caspase-3. Stained cells were examined on a Zeiss LSM510META laser-
scanning confocal microscope (Plan-ApoChromat 63x/1.4 Oil DIC objective). 
Six z-stack images per condition were taken at random and caspase-positive 
and -negative cell numbers were quantified using Image J software. 
 
2.2.17. Migration Assay 
Caco-2 cells were plated at 1 x 105 cells/ml into 35mm dishes, transfected with 
siRNA as detailed previously (section 2.2.3) and incubated at 37°C, 5% CO2 for 
3 d. To perform the migration assay, Caco-2 cells were replated into both wells 
of Culture-Inserts (Ibidi, 80209) placed into 35mm dishes. Cells were washed in 
DPBS, trypsinised and centrifuged at 200g for 3 min. Cells were resuspended in 
200µl complete growth media and counted using a haemocytometer, including 
0.2% (v/v) Trypan Blue to exclude dead cells. Cells were diluted to 6.5 x 105 
cells/ml in complete growth media and 70µl cell suspension was added to each 
well of the Culture-Insert. Cells were incubated for 3 d at 37°C, 5% CO2. To 
initiate migration, Culture-Inserts were removed using sterile forceps, leaving a 
500µm cell-free gap. Cells were washed carefully in DPBS and incubated in 
SFM for 24 h at 37°C, 5% CO2. Migration was monitored at 0, 12 and 24 h 
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using phase contrast microscopy and images were obtained (section 2.2.2). 
Quantification of the cell-free area was conducted using Image J Software. 
 
2.2.18. Statistical Analysis 
Mean and standard error were calculated using Microsoft Excel and results 
were plotted graphically using GraphPad (Prism). Each experiment was 
repeated in triplicate unless otherwise stated. Statistical analysis was carried 
out using either a one-way ANOVA with a Dunnett’s post test or a two-way 
ANOVA with a Bonferroni post test for comparison of data sets over time. 
Significance level was graded as * p < 0.05, ** p < 0.01, *** p < 0.001.  
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CHAPTER THREE 
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3.  ESCRT proteins are required for mammalian 
epithelial cell organisation and polarity 
 
3.1. Introduction 
 
3.1.1. ESCRTs and Mammalian Epithelial Cell Polarity 
 
Previous work conducted in Drosophila has revealed a close link between 
ESCRT proteins, epithelial cell polarity and tumour formation (reviewed in 
Vaccari and Bilder, 2009; Herz and Bergmann, 2009; Lobert and Stenmark, 
2011). Mutation of ESCRT proteins in Drosophila results in loss of epithelial cell 
polarity and overproliferation. Upon inhibition of apoptosis, this effect is 
exacerbated and tumour-like growths capable of metastasis are formed. As a 
result ESCRT proteins have been classified as potential tumour suppressors 
(Moberg et al., 2005; Thompson et al., 2005; Vaccari and Bilder, 2005; Herz et 
al., 2006; Herz et al., 2009; Rodahl et al., 2009b; Vaccari et al., 2009).  
 
In mammalian cells, the potential relationship between ESCRTs and epithelial 
cell polarity has not been investigated. Both reduced expression (Xu et al., 
2003; Li et al., 2008) and overexpression (Liu et al., 2002; Oh et al., 2007; 
Toyoshima et al., 2007; Young et al., 2007) of ESCRT proteins have been 
associated with various human cancers, however, evidence for a direct role of 
ESCRTs in mammalian tumourigenesis is inconclusive. The ESCRT-I protein, 
Tsg101 was originally identified in mice, whereby knockout of the gene resulted 
in cellular transformation of mouse fibroblasts and acquired ability to form 
metastatic tumours when injected into nude mice (Li and Cohen, 1996). 
However, subsequent mice knockout studies have failed to support a tumour 
suppressor function of Tsg101. Null mutation of the Tsg101 gene in mice results 
in early embryonic lethality (Ruland et al., 2001; Wagner et al., 2003). Tsg101-
deficient embryos are reduced in size, displaying a decrease in cellular 
proliferation but no increase in apoptosis, and fail to develop past day 6.5 of 
embryogenesis. This was attributed to an accumulation of p53 via a 
posttranscriptional mechanism, causing cell cycle arrest and embryonic death 
(Ruland et al., 2001). Conditional knockout mice, whereby Tsg101 was deleted 
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in mammary epithelial cells, showed impaired mammary development during 
lactation due to an increase in apoptosis of Tsg101-deficient cells. In addition, 
Tsg101 knockout resulted in reduced proliferation and increased cell death of 
mammary epithelial cells in vitro. Despite these effects, tumour formation was 
not observed in either heterozygous complete or tissue-specific Tsg101 
knockout mice monitored over two years (Wagner et al., 2003). Therefore, 
these results suggest that Tsg101 is not a tumour suppressor gene for initiation 
of sporadic forms of breast cancer, contradicting previous studies (Li and 
Cohen, 1996; Li et al., 1997). This discrepancy may be explained by the high 
level of cell death observed in these Tsg101 deficient mice as it is possible that 
this masks the full tumourigenic potential of Tsg101. Indeed, in Drosophila 
ESCRT mutants, tumourous masses are only formed when apoptosis is 
inhibited (Thompson et al., 2005; Herz et al., 2006). Therefore, an alternative 
model may be required to fully investigate the importance of ESCRT function in 
maintenance of epithelial cell polarity and tumour suppression.  
 
3.1.2. Caco-2 Cells as a Model System for Studying Mammalian Epithelial 
Cell Polarity 
 
The human Caco-2 colon adenocarcinoma cell line provides a good in vitro 
model to study the potential relationship between ESCRT proteins and 
mammalian epithelial cell polarity. Caco-2 cells are a well characterised 
epithelial cell line. In culture they form cell-cell junctions with neighbouring cells 
and polarise to establish distinct apical and basolateral membrane domains 
(Grasset et al., 1984; Sambuy et al., 2005; Volpe, 2008). Caco-2 cells are a 
heterogeneous population and, upon reaching confluency, spontaneously 
differentiate to resemble mature enterocytes (Chantret et al., 1988; Engle et al., 
1998). During differentiation cell-cell junctions mature, lateral height increases 
and a brush border of microvilli forms with expression of small intestine 
hydrolase enzymes, including sucrose-isomerase and dipetidylpeptidase IV 
(DppIV), at the apical membrane (Chantret et al., 1988; Sambuy et al., 2005; 
Volpe, 2008). 
 
In addition, when cultured in a matrigel suspension, Caco-2 cells form 3D 
polarised cysts whereby a single layer of cells surrounds a central lumen. These 
80 
 
cells polarise so that their apical membranes are orientated to the luminal side 
and the basal membranes are in contact with the matrigel. These 3D cultures 
are an additional method of  investigating cell polarity in vitro and are often 
considered more physiologically relevant than conventional 2D cell culture 
methods (Martin-Belmonte and Mostov, 2008). 
 
3.1.3. Depletion of ESCRTs via siRNA knockdown 
 
RNA interference (RNAi) is a powerful tool for functional analysis of mammalian 
genes. It offers a simple, cost-effective approach for sequence-specific gene 
silencing at the posttranscriptional level (Sandy et al., 2005). Two RNAi 
approaches can be used for knockdown of mammalian genes, the first of which 
utilises synthetic small interfering RNAs (siRNAs). These are ~21-nucleotide-
long double-stranded RNA (dsRNA) molecules composed of a 19-bp core 
sequence specific for the mRNA of interest along with two unpaired nucleotides 
at each 3’ end (Sandy et al., 2005; Shan, 2010). Once introduced into the cell 
via transfection, one strand of the siRNA duplex is integrated into RNA-induced 
silencing complex (RISC), with Ago2 as its core component, whereas the other 
‘passenger’ strand is degraded (Shan, 2010). Inside the RISC, the siRNA guide 
strand associates with its complementary mRNA sequence and induces mRNA 
degradation. Consequently, translation of the targeted mRNA is inhibited and 
levels of the encoded protein are reduced (Sandy et al., 2005; Shan, 2010). An 
alternative RNAi approach is to use short hairpin RNAs (shRNAs) expressed 
from plasmids or viral-based vectors. These are useful when longer lasting 
gene silencing is required or when cells are particularly hard to transfect (Sandy 
et al., 2005). However, over time cells may adapt to the knockdown and 
therefore this may result in a different phenotype compared with a transient 
siRNA knockdown. 
 
Efficient siRNA knockdown of ESCRT proteins has been demonstrated 
previously in mammalian cell culture (Bishop et al., 2002; Lu et al., 2003; 
Doyotte et al., 2005; Bache et al., 2006; Raiborg et al., 2008) and, therefore, 
offers an attractive method to study the function of ESCRT proteins in vitro. In 
addition, due to their relatively simple design and synthesis, siRNAs are often 
commercially available in a ready-to-transfect format. Another important 
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consideration when performing siRNA knockdown experiments is the 
incorporation of appropriate controls. Firstly, a negative control should be 
employed, typically an RNA duplex with a sequence that has no perfect match 
within the genome (Shan, 2010). Secondly, any phenotypic effect elicited by 
knockdown of a particular gene should be confirmed using alternative siRNA 
duplexes against the same gene in order to exclude off-target effects (Sandy et 
al., 2005). 
 
3.1.4. Domain Structure of Tsg101 and Vps25 Proteins 
 
As studies in Drosophila identified a role for Tsg101 (ESCRT-I) and Vps25 
(ESCRT-II) within the maintenance of epithelial cell polarity, it is of interest to 
determine the effect of disrupting the mammalian homologues of these proteins. 
Tsg101 is approximately 44 KDa with a catalytically inactive N-terminal ubiquitin 
E2 variant (UEV) domain which binds directly to ubiquitin and mediates 
interaction of the ESCRT-I complex with ubiquitylated cargo (Figure 3.1A). This 
UEV domain also mediates binding of ESCRT-I to the Hrs subunit of ESCRT-0 
(Hurley and Emr, 2006; Williams and Urbe, 2007). In addition, Tsg101 contains 
a proline-rich domain (PRD), a coiled-coil (CC) domain and a C-terminal 
steadiness box (SB) domain, which is thought to be important for autoregulation 
of protein expression (Pornillos et al., 2002; Hurley and Emr, 2006; Williams 
and Urbe, 2007; McDonald and Martin-Serrano, 2008). 
 
The ESCRT-II complex contains two Vps25 protein subunits of approximately 
21 KDa (Figure 3.1B). Vps25 contains two repeats of the PPXY sequence at its 
N-terminus which interact with the other two subunits of the ESCRT-II complex, 
Vps22 and Vps36 (Hurley and Emr, 2006). At the C-terminus of Vps25, two 
tandem repeats of a winged helix (WH) domain are found. This is a common 
type of protein-protein and protein-DNA interaction domain and provides a 
direct link to the ESCRT-III subunit, CHMP6 (Williams and Urbe, 2007). 
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Figure 3.1 Domain structures of Tsg101 and Vps25. (A) Tsg101 is a 390 amino acid protein 
containing a ubiquitin E2 variant (UEV) domain, a proline rich (PRD) domain, a coiled-coil (CC) 
domain and a steadiness box (SB) domain. (B) Vps25 is a 176 amino acid protein containing 
two repeats of the PPXY sequence at the N-terminus and two tandem repeats of a winged helix 
(WH) domain at the C-terminus (adapted from Pornillos et al., 2002; Hurley and Emr, 2006). 
 
 
3.1.5. Aims 
 
The primary aim of this study is to evaluate whether depletion of Tsg101 and 
Vps25 results in an alteration in mammalian epithelial cell polarity. Tsg101 and 
Vps25 will be depleted in Caco-2 cells using siRNA knockdown and the 
resulting endocytic phenotype will be analysed. The effect of ESCRT depletion 
on Caco-2 cell morphology will then be investigated. Lastly, characterisation of 
epithelial organisation and polarity will be conducted upon ESCRT knockdown 
in both 2D and 3D cell culture systems. 
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3.2. Results 
 
3.2.1. Depletion of ESCRTs via siRNA knockdown 
 
In order to assess whether ESCRT proteins are important for the establishment 
and maintenance of epithelial cell polarity, siRNA was used to knockdown 
Tsg101, a component of ESCRT-I, and Vps25, a component of ESCRT-II, in 
Caco-2 cells, a human epithelial colorectal adenocarcinoma cell line. These 
proteins were chosen as the first studies conducted in Drosophila reported that 
mutations in either Tsg101 or Vps25 resulted in a loss of cell polarity (Moberg et 
al., 2005, Thompson et al., 2005, Vaccari and Bilder, 2005).  
 
Tsg101 siRNA knockdown was optimised initially using a SMARTpool of four 
oligonucleotide sequences. After 3 days, Tsg101 protein was reduced by 
approximately 75% (Figure 3.2A). These siRNA sequences were then tested 
individually and the oligonucleotide which resulted in the most efficient 
knockdown (I1) was chosen for all further experiments throughout this thesis 
(Figure 3.2B + C). Vps25 siRNA knockdown was optimised using a SMARTpool 
only and after 3 days, protein level was reduced by approximately 50% (Figure 
3.2D). To achieve this level of Vps25 knockdown, an increased volume of 
transfection reagent was required compared with Tsg101 siRNA. Optimal 
knockdown of approximately 80% depletion in the amount of Tsg101 or Vps25 
protein was obtained 7 days after transfection, with the knockdown persisting 
for at least 10 days (Figure 3.3). Therefore, for the majority of further 
experiments a 7 day knockdown was used. 
 
3.2.2. Depletion of ESCRTs affects endosomal morphology  
 
The ESCRT machinery has a well established role within the process of 
endosomal cargo sorting and MVB formation (Raiborg and Stenmark, 2009). 
Disruption of the ESCRT machinery in mammalian cells has been shown to 
affect endocytic compartments, resulting in accumulation and enlargement of 
both early and late endosomes (Doyotte et al., 2005; Razi and Futter, 2006; 
Stuffers et al., 2009b). Therefore, the effects of Tsg101 and Vps25 depletion on  
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Figure 3.2 Optimisation of Tsg101 and Vps25 knockdown in Caco-2 cells. (A) Caco-2 cells 
were either untreated (U), mock transfected (M), transfected with Non-Targeting Control siRNA 
(C) or Tsg101 SMARTpool siRNA (P) and incubated for 3 d. Lysates were immunoblotted for 
Tsg101 and β-tubulin as a loading control.  (B) Tsg101 SMARTpool siRNA was split into four 
individual Tsg101 siRNA oligonucleotides (I1-I4). Cells were transfected with Non-Targeting 
Control siRNA (C), Tsg101 SMARTpool siRNA (P) or individual Tsg101 siRNA  oligonucleotides 
(I1-I4) and incubated for 3 d. Lysates were immunoblotted for Tsg101 and β-tubulin as a loading 
control. (C) Quantification of Tsg101 protein levels, normalised to β-tubulin and expressed as a 
percentage of the Non-Targeting Control. Data shown are the means ± standard error from 
three independent experiments.  (D) Caco-2 cells were either untreated (U), mock transfected 
(M), transfected with Non-Targeting Control siRNA (C) or Vps25 SMARTpool siRNA (V) and 
incubated for 3 d. Lysates were immunoblotted for Vps25 and β-tubulin, used as a loading 
control. Transfection was carried out with an increased volume of transfection reagent 
compared to Tsg101 siRNA.  
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Figure 3.3 Tsg101 and Vps25 knockdown in Caco-2 cells persists over time. (A) Caco-2 
cells were transfected with either Non-Targeting Control siRNA (C), Tsg101 siRNA (T) or Vps25 
siRNA (V) and incubated for 3, 7 or 10 d. Lysates were immunoblotted for Tsg101, Vps25 and 
β-tubulin as a loading control. (B) Protein levels were quantified, normalised to β-tubulin levels, 
and expressed as a percentage of the Non-Targeting Control for each timepoint. Data shown is 
the mean ± standard error from three independent experiments. Results were analysed using a 
one-way ANOVA and Dunnett’s post test, **p<0.01, ***p<0.001. 
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Caco-2 cell endosomal morphology were investigated in order to confirm that 
the siRNA knockdown was having the expected effect. Knockdown of Tsg101 or 
Vps25 resulted in enlargement and accumulation of both early and late 
endosomes after incubation with EGF, indicated by EEA1 and CD63 staining 
respectively (Figure 3.4). Despite this enlargement, the two endosomal 
compartments seemed to remain morphologically distinct, indicated by the lack 
of colocalisation of EEA1 and CD63. In the absence of EGF the endosomal 
effects were less pronounced (data not shown).  
 
Trafficking of EGF was also investigated after Tsg101 and Vps25 knockdown 
(Figure 3.5). Binding of EGF to the EGF receptor (EGFR) at the plasma 
membrane induces internalisation and delivery of the EGF-EGFR complex to 
early endosomes. The EGF-EGFR complex is then usually targeted for 
degradation via internalisation into MVBs and trafficking to the lysosome (Wiley 
and Burke, 2001). EGFR degradation is often reduced in ESCRT depleted cells 
(Bishop et al., 2002; Lu et al., 2003; Bache et al., 2006; Malerod et al., 2007; 
Raiborg et al., 2008) and consequently, EGF-induced signalling may be 
sustained (Bache et al., 2006; Malerod et al., 2007). However, in Tsg101 or 
Vsp25 depleted Caco-2 cells, EGF trafficking did not appear to be significantly 
altered, although a slightly increased amount of EGF remained in some Tsg101 
knockdown cells after a 4 hour incubation compared with control (Figure 3.5A). 
In line with this observation, sustained phosphorylation of ERK1/2, a 
downstream component of the EGF signalling pathway, was not observed in 
either Tsg101 or Vps25 knockdown cells (Figure 3.5B). Levels of 
phosphorylated ERK1/2 varied between experiments and no significant 
increase could be concluded after Tsg101 and Vps25 knockdown. Therefore, 
despite the effects on early endosomal morphology, these results suggest that 
EGF trafficking is not significantly altered upon Tsg101 or Vps25 depletion. 
 
3.2.3. Caco-2 cell morphology is altered upon ESCRT knockdown, with 
Tsg101 knockdown cells forming multilayered epithelial sheets  
 
To begin to characterise the effects of Tsg101 and Vps25 knockdown, Caco-2 
cell morphology was monitored over time (Figure 3.6). After 3 days culture, 
knockdown cells appeared similar to control. However, after 7 day Tsg101 
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Figure 3.4 Depletion of Tsg101 and Vps25 causes enlargement of both early and late 
endosomes in EGF treated Caco-2 cells. Caco-2 cells were transfected with either Non-
Targeting Control siRNA, Tsg101 siRNA, or Vps25 siRNA and incubated for 7 d. Cells were 
allowed to internalise EGF for 4 h, fixed and examined by confocal fluorescence microscopy for 
CD63 (green) and EEA1 (red). Nuclei were stained with DAPI (blue), shown in merged images. 
Bar, 10μm. 
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Figure 3.5 Tsg101 or Vps25 knockdown in Caco-2 cells does not impair degradation of 
EGF and MAPK phosphorylation is not sustained. Caco-2 cells were transfected with Non-
Targeting Control siRNA, Tsg101 siRNA, or Vps25 siRNA and incubated for 7 d. Cells were 
serum starved overnight prior to EGF treatment. (A) Caco-2 cells were allowed to internalise 
Alexa Fluor® 555-conjugated EGF for 4 h, fixed and examined by confocal fluorescence 
microscopy for EEA1 (green) and EGF (red). Nuclei were stained with DAPI (blue), shown in 
merged images. Note that although EEA1 staining is increased in Tsg101 and Vps25 
knockdown cells, residual EGF levels are similar to control. Bar, 10μm. (B) Caco-2 cells were 
pulse-labelled with EGF for 10 min, followed by a chase in SFM for indicated times. Lysates 
were immunoblotted for phosphorylated Erk1/2 (p-Erk1/2) and total Erk1/2. Immunoblotting for 
Tsg101 and Vps25 was carried out to confirm knockdown levels. Levels of p-Erk1/2 increase 
directly after EGF treatment and decrease over time at a similar rate in both control and 
knockdown cells. 
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knockdown, large areas of the epithelial sheet appeared disrupted and cells 
seemed to be growing in clumps (Figure 3.6, arrows). This aberrant morphology 
was also observed on day 10, although to a slightly lesser extent. In other 
areas, the organisation of the epithelial sheet appeared to be retained (Figure 
3.6, arrowheads) however, morphology of these cells did not resemble the 
typical cobblestone effect observed in control cells at day 10 (Figure 3.6, 
asterisk). Instead cells appeared flatter and less differentiated (Figure 3.6, 
hash). Vps25 knockdown did not disrupt the organisation of the epithelial sheet 
although, after 10 days culture, there was a reduction in the areas of cells 
showing the typical cobblestone morphology (Figure 3.6, asterisk) with cells 
appearing less differentiated than control (Figure 3.6, hash).  
 
Further analysis of the disrupted areas of the epithelial sheet formed upon 
Tsg101 knockdown indicated that the cells were stacking on top of one another 
to form multilayers (Figure 3.7). In addition, nuclear morphology of Tsg101 
knockdown cells was more irregular and nuclei often appeared flatter compared 
to control. In order to confirm that this phenotype was due to depletion of 
Tsg101 and not off-target effects, siRNA knockdown was performed using two 
alternative oligonucleotides. Tsg101 protein levels were significantly reduced to 
approximately 20-30% compared with control after 3 days (Figure 3.8A). 
However, persistence of the knockdown was not as efficient and after 7 days 
Tsg101 protein was approximately 30-50% of control levels. In addition, Tsg101 
siRNA 2 resulted in a higher level of knockdown compared with siRNA 1 at both 
timepoints. Morphology of the Tsg101 knockdown cells was similar to that seen 
previously. Organisation of the epithelial sheet was disrupted (Figure 3.8B) and 
cells formed multilayered regions (Figure 3.9). Interestingly, the level of 
knockdown appeared to correspond to the severity of the phenotype. The 
original Tsg101 siRNA resulted in the most pronounced effect whereas siRNA 
1, which gave the least efficient knockdown approach, resulted in a lesser 
effect. However, overall the multilayered phenotype was observed with all three 
Tsg101 siRNA oligonucleotides, confirming that the observed effects were 
caused by Tsg101 depletion. Therefore, Tsg101 is required in order to retain 
correct organisation of the Caco-2 epithelial monolayer. 
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Figure 3.6 Caco-2 cell morphology is altered after Tsg101 and Vps25 depletion, with 
Tsg101 knockdown disrupting organisation of the whole epithelial sheet. Caco-2 cells 
were transfected with either Non-Targeting Control siRNA, Tsg101 siRNA or Vps25 siRNA and 
analysed via phase-contrast microscopy after 3, 7 and 10 d. Tsg101 knockdown cells form 
monolayers in some areas (arrowheads) but many regions are observed where organisation of 
the epithelial sheet appears disrupted (arrows). Epithelial organisation is not disrupted after 
Vps25 knockdown. In addition, after 10 d culture there is a decrease in areas showing the 
characteristic cobblestone morphology (*) in monolayered regions of Tsg101 knockdown cells 
and Vps25 knockdown cells. Instead cell morphology appears similar to that observed at 7 d 
(#).  
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Figure 3.7 Caco-2 cells form multilayers upon Tsg101 knockdown. Caco-2 cells were 
transfected with either Non-Targeting Control siRNA or Tsg101 siRNA and incubated for 7 d. 
Nuclei were stained with DAPI and cells were examined via confocal fluorescence microscopy. 
Tsg101 knockdown disrupts nuclear morphology and regions of cells show a multilayered 
organisation. Confocal projections and corresponding z-sections (indicated by dotted line) are 
displayed. Bar, 10µm. 
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Figure 3.8 Knockdown of Tsg101 using alternative siRNA oligonucleotides results in a 
similar disruption to Caco-2 epithelial organisation. Caco-2 cells were transfected with 
either Non-Targeting Control siRNA (C) or Tsg101 siRNA (T). Tsg101 knockdown was also 
achieved using a different single siRNA oligonucleotide (1) or a combination of two different 
siRNA oligonucleotides (2). (A) Cells were incubated for 3 d and 7 d and lysates were 
immunoblotted for Tsg101 and β-tubulin as a loading control (i). Protein levels were quantified, 
normalised to β-tubulin and expressed as a percentage of the Non-Targeting Control for each 
timepoint (ii). Data shown is the mean ± standard error from three independent experiments. 
Results were analysed using a one-way ANOVA and Dunnett’s post test, *p<0.05, **p<0.01, 
***p<0.001. (B) Cells were analysed via phase-contrast microscopy after 7 d knockdown. A 
similar disruption to the epithelial sheet is observed after knockdown of Tsg101 using alternative 
siRNA oligonucleotides (1 and 2) (arrows).  
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Figure 3.9 A similar multilayered phenotype is observed upon knockdown of Tsg101 
using different siRNA oligonucleotides. Caco-2 cells were transfected with either Non-
Targeting Control siRNA (C), or two alternative Tsg101 siRNA combinations (1 and 2) and 
incubated for 7 d. Nuclei were stained with DAPI and cells were examined via confocal 
fluorescence microscopy. Tsg101 knockdown cells display a similar phenotype as observed 
previously (compare with Figure 3.6). Nuclear morphology is disrupted and multilayered regions 
of cells are formed. Confocal projections and corresponding z-sections (indicated by dotted line) 
are displayed. Bar, 10µm. 
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3.2.4. ESCRT depletion prevents differentiation of Caco-2 cells 
 
Caco-2 cells are a well characterised polarised human epithelial cell line. In 
culture they form cell-cell junctions with neighbouring cells and will polarise to 
establish distinct apical and basolateral membrane domains (Sambuy et al., 
2005). Upon reaching confluency, cells will begin to spontaneously differentiate 
to resemble mature enterocytes. During this process cell-cell junctions mature, 
lateral height increases and cells develop a brush border of microvilli at the 
apical membrane (Chantret et al., 1988; Sambuy et al., 2005; Volpe, 2008). 
This can be observed by comparing Caco-2 cell morphology over time (Figures 
3.10 and 3.11). Cell-cell junctions, including tight junctions indicated by occludin 
localisation (Figure 3.11, arrowheads) and adherens junctions indicated by E-
cadherin localisation (Figure 3.10), form between adjacent cells and mature 
over time. When confluent, Caco-2 cells establish apicobasal polarity 
demonstrated by localisation of aPKC and E-cadherin to apical and basolateral 
membranes, respectively (Figure 3.10). Four days after reaching confluency, 
cells display a more differentiated phenotype whereby intensity of apical 
staining and lateral height has increased. Localisation of the brush border 
protein, Dipeptidyl peptidase-IV (DppIV) to the apical membrane increases as 
cells reach confluency and begin to differentiate (Figure 3.11). The classic 
‘cauliflower’ pattern is displayed four days post-confluence, indicative of a 
mature brush border (Baricault et al., 1995).  
 
Upon depletion of Tsg101, some areas of the Caco-2 epithelial sheet retained a 
normal monolayered organisation whereas other areas displayed a more 
striking multilayered phenotype. Therefore, the morphology of these two 
different populations of Tsg101 knockdown cells were characterised 
independently. Firstly, the phenotype of the monolayered regions will be 
discussed (below) followed by the multilayered regions (Section 3.2.5). 
 
In the monolayered regions of Tsg101 knockdown cells, apicobasal polarity was 
retained demonstrated by correct localisation of aPKC and E-cadherin to the 
apical and basolateral membrane domains, respectively (Figure 3.12A). This 
was also observed after Vps25 knockdown. However, lateral height of the 
knockdown cells was reduced to approximately 7µm compared to 10µm for  
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Figure 3.10 Caco-2 cells polarise and differentiate over time. As Caco-2 cells proliferate 
cell-cell junctions are formed and apical and basolateral membrane domains are defined. After 
reaching confluency, lateral height increases and junctions mature as cells differentiate. Caco-2 
cells were fixed either prior to reaching confluency, when confluent, or 4 d post-confluency. 
Cells were then examined by confocal fluorescence microscopy for E-cadherin (green) and 
aPKC (red) to indicate basolateral and apical membranes, respectively. Nuclei were stained 
with DAPI (blue), shown in merged images. Apical confocal slices and corresponding z-sections 
(indicated by dotted line) are displayed. Bar, 10µm. 
104 
 
105 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11 Caco-2 cells form a brush border at the apical membrane. Upon reaching 
confluency, Caco-2 cells begin to develop a brush border at the apical membrane. Caco-2 cells 
were fixed either prior to reaching confluency, when confluent, or 4 d post-confluency and non-
permeabilised cells were immunostained for DppIV (brush border marker; green). Cells were 
then permeabilised and immunostained for occludin (tight junctions; red). Nuclei were stained 
with DAPI (blue) and cells were examined by confocal fluorescence microscopy. Confocal slices 
and corresponding z-sections (indicated by dotted line) are displayed. Arrowheads indicate tight 
junctions. Bar, 10µm. 
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control cells (Figure 3.12B). In addition, a reduction in DppIV localisation to the 
apical membrane was observed suggesting that brush border development is 
impaired upon Tsg101 and Vps25 knockdown (Figure 3.13). Therefore, 
although ESCRT proteins are not required for the initial establishment of distinct 
apical and basolateral membrane domains, Tsg101 and Vps25 knockdown 
appears to impede differentiation of Caco-2 cells.  
 
3.2.5. Tsg101 depletion disrupts epithelial cell organisation and polarity 
 
Upon Tsg101 knockdown, regions of the Caco-2 epithelial sheet were disrupted 
and cells displayed a multilayered phenotype. In these areas apicobasal polarity 
was compromised (Figure 3.14). Some cells appeared to lack a defined apical 
membrane indicated by absence of aPKC staining (Figure 3.14, asterisk) 
whereas, in other cells expansion of apical membrane is observed (Figure 3.14, 
hash). It is also important to note that some cells appeared to retain distinct 
apical and basolateral membrane domains, indicated by aPKC and E-cadherin 
staining, respectively however, due to these cells being stacked on top of each 
other apical staining appeared along what should be the basal surface of the 
epithelial sheet (Figure 3.14, arrowheads). This suggests that these cells are 
incorrectly orientated within the multilayered epithelial sheet.  
 
Multilayered regions of Tsg101 knockdown cells also displayed brush border 
defects (Figure 3.15, asterisks). Often multilayered areas lacked DppIV staining 
(Figure 3.15, arrowheads) however, in some cases cells displayed DppIV 
staining localised to the apical membrane (Figure 3.15, arrows). This suggests 
that the ability of Tg101 knockdown cells to form a brush border is compromised 
but not lost entirely. This effect also appears different to that seen in Tsg101 
knockdown cells which retained their monolayered organisation (Figure 3.13). 
Instead of a general reduction in DppIV localisation to the apical membrane 
observed in Tsg101 monolayered regions, multilayered cells seem to either 
display strong DppIV staining or very little/no staining at all, although this effect 
is difficult to quantify.  
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Figure 3.12 Tsg101 and Vps25 depleted Caco-2 cells establish distinct apical and 
basolateral membrane domains but lateral height is reduced. (A) Caco-2 cells were 
transfected with either Non-Targeting Control siRNA, Tsg101 siRNA or Vps25 siRNA, incubated 
for 7 d and stained for E-cadherin (green) and aPKC (red) to visualise basolateral and apical 
surfaces, respectively. Nuclei were stained with DAPI (blue). Apical confocal slices and 
corresponding z-sections (indicated by dotted line) are displayed.  Bar 10µm. (B) Lateral height 
was quantified using ImageJ. For each condition, lateral height was quantified for at least two 
images per experiment. Ten z-sections were analysed per image, taking three measurements 
per z-section, and average lateral height was calculated. Data shown are means ± standard 
error from three independent experiments. Results were analysed using a One-Way ANOVA 
and Dunnett’s post-test, *p<0.05. Note that for Tsg101 knockdown cells, analysis was carried 
out on areas where monolayered organisation was maintained, a more striking polarity 
phenotype is seen in the multilayered regions (Figure 3.14). 
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Figure 3.13 Knockdown of Tsg101 and Vps25 impairs brush border formation. (A) 
Localisation of the brush border protein DppIV to the apical membrane is reduced in Tsg101 
and Vps25 depleted cells. Caco-2 cells were transfected with either Non-Targeting Control 
siRNA, Tsg101 siRNA or Vps25 siRNA and incubated for 7 d.  Non-permeabilised cells were 
immunostained for DppIV (green), followed by permeabilisation and staining for the tight 
junction protein, occludin (red). Nuclei were stained with DAPI (blue). Confocal projections and 
corresponding z-sections (indicated by dotted line) are displayed.  Bar 10µm. (B) Quantification 
of DppIV fluorescence was carried out using ImageJ. For each condition, DppIV fluorescence 
was quantified for at least three images per experiment. Random projections were obtained and 
average fluorescence intensity in the green channel was quantified for each field of view and 
expressed as a ratio over corresponding cell number. Data shown are means ± standard error 
from four independent experiments. Results were analysed using a One-Way ANOVA and 
Dunnett’s post-test, *p<0.05. Note that for Tsg101 knockdown cells, analysis was carried out on 
areas where monolayered organisation was maintained. 
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Figure 3.14 Tsg101 is required to maintain a polarised epithelial monolayer in Caco-2 
cells. Tsg101 knockdown cells form multilayered regions with compromised apicobasal polarity. 
Caco-2 cells were transfected with either Non-Targeting Control siRNA or Tsg101 siRNA, 
incubated for 7 d and stained for E-cadherin (green) and aPKC (red) to visualise basolateral 
and apical surfaces, respectively. Nuclei were stained with DAPI (blue). Note that some Tsg101 
knockdown cells lack aPKC staining (*), whereas other cells show an expanded apical 
membrane (#). In addition, some cells retain distinct aPKC and E-cadherin staining, however, 
aPKC staining appears along the basal surface of the epithelial sheet (arrowheads). Apical 
confocal slices and corresponding z-sections (indicated by dotted line) are displayed.  Bar 
10µm.  
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Figure 3.15 Brush border formation is compromised in multilayered regions of Tsg101 
depleted Caco-2 cells. Caco-2 cells were transfected with either Non-Targeting Control siRNA 
or Tsg101 siRNA, incubated for 7 d and stained for the brush border protein, DppIV (green). 
Nuclei were stained with DAPI (blue). Multilayered regions are indicated by an asterisk. Note 
that some multilayered Tsg101 knockdown cells show an absence of DppIV staining (i, 
arrowheads) whereas, for other cells, DppIV staining is apparent (ii, arrows). Confocal 
projections and corresponding z-sections (indicated by dotted line) are displayed.  Bar 10µm. 
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3.2.6. Formation of Caco-2 cysts is compromised upon ESCRT 
knockdown 
 
Finally, in order to further investigate the role of ESCRT proteins in regulation of 
epithelial cell polarity, a three-dimensional (3D) epithelial cyst formation assay 
was performed. When cultured in a matrigel suspension, Caco-2 cells form 3D 
cysts whereby a single layer of cells surrounds a central lumen. These cells 
polarise so that their apical membranes are orientated to the luminal side and 
the basal membranes are in contact with the matrigel. Therefore, these 3D 
cultures are an additional method of  investigating cell polarity in vitro and are 
considered more physiologically relevant (Martin-Belmonte and Mostov, 2008). 
When transfected with non-targeting control siRNA, 64% of Caco-2 cysts 
displayed a single central lumen (Figure 3.16). The remainder of cysts either 
failed to form an extended lumen or displayed multiple small cavities. 
Knockdown of Tsg101 or Vps25 resulted in a significant reduction in the number 
of cysts formed with a central lumen, instead the proportion of multi-lumen cysts 
approximately doubled from 20% in control to 40% upon ESCRT knockdown. 
This observation is indicative of a defect in epithelial cell polarity and therefore 
suggests that Tsg101 is required for establishment and/or maintenance of 
Caco-2 cell polarity in both 2D and 3D cultures. Although Vps25 knockdown did 
not appear to affect cell polarity in 2D cultures, this 3D cyst formation assay 
suggests that Vps25 is required for correct polarisation of Caco-2 cells. 
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Figure 3.16 Tsg101 and Vps25 knockdown impairs formation of Caco-2 3D cysts. (A) 
Caco-2 cells were transfected with either Non-Targeting Control siRNA, Tsg101 siRNA or 
Vps25 siRNA, incubated for 3 d and then replated into a Matrigel suspension. Following 
incubation for 7 d, cysts were stained for aPKC (red) and E-cadherin (green) to mark the apical 
and basolateral membranes respectively. Nuclei were stained with DAPI (blue). Cysts displayed 
either a single lumen, multiple lumen or no lumen. Representative images are shown for each 
phenotype. Z-sections are displayed for each cyst along with a confocal plane through the 
centre.  Bar, 10µm. (B) The number of cysts showing either single, multiple or no lumen was 
quantified. Data shown are the means ± standard error from three independent experiments, 
>100 cysts were analysed per condition for each experiment. Results were analysed using a 
One-Way ANOVA and Dunnett’s post-test, ** p=< 0.01 * p=< 0.05. 
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3.3. Discussion 
 
This study sought to establish whether ESCRT proteins are required for 
maintenance of mammalian epithelial cell polarity. Although studies in 
Drosophila have demonstrated an important link between ESCRT proteins and 
epithelial cell polarity (Moberg et al., 2005; Thompson et al., 2005; Vaccari and 
Bilder, 2005; Rodahl et al., 2009b; Vaccari and Bilder, 2009), no similar 
definitive link has been identified in mammalian cells. My results demonstrate 
that depletion of Tsg101 and Vps25 can be achieved in the polarised human 
epithelial Caco-2 cell line via siRNA knockdown, and that this induces an 
enlarged endosomal phenotype characteristic of ESCRT disruption. 
Differentiation of Caco-2 cells is impaired upon knockdown of both Tsg101 and 
Vps25. In addition, Tsg101 depletion compromises organisation and polarity of 
the Caco-2 epithelial sheet. Finally ESCRT-I and -II are required for the 
formation of 3D Caco-2 polarised cysts. Therefore, these results begin to 
elucidate a role for ESCRT proteins within the maintenance of mammalian 
epithelial cell organisation and polarity. 
 
3.3.1. ESCRT depletion in Caco-2 cells via siRNA knockdown 
 
Disruption of ESCRT-I or -II was achieved in the human epithelial Caco-2 cell 
line via efficient siRNA knockdown of Tsg101 or Vps25, respectively. Tsg101 
depletion was achieved using an individual siRNA duplex. This was identified as 
providing the most efficient knockdown from a SMARTpool of four siRNA 
oligonucleotides designed to target Tsg101 mRNA. However, Vps25 
knockdown was performed using a siRNA SMARTpool only. Due to the lack of 
an effective commercial Vps25 antibody, the Vps25 siRNA oligonucleotides 
contained within the SMARTpool were not tested individually and therefore, 
further studies may require additional optimisation and verification of the Vps25 
knockdown phenotype. 
 
3.3.2. Endosomal effects upon ESCRT depletion 
 
Depletion of ESCRT-I and -II resulted in an accumulation and enlargement of 
both early and late endosomes after EGF internalisation. However, despite the 
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similar effects on morphology, these compartments remained clearly 
differentiated.  Previous studies have shown a similar endocytic phenotype 
upon ESCRT depletion in a variety of cell lines (Bishop et al., 2002; Doyotte et 
al., 2005; Razi and Futter, 2006; Stuffers et al., 2009b), therefore, 
demonstrating that ESCRT knockdown in Caco-2 cells results in the 
characteristic changes to endosomal morphology. In the absence of EGF, 
however, endosomal morphology was not significantly altered. This has been 
observed previously (Razi and Futter, 2006) and indeed, most studies into 
alterations in endosomal morphology after ESCRT disruption are carried out 
after EGF stimulation (Doyotte et al., 2005; Stuffers et al., 2009b). It is possible 
that the burst of endocytosis induced by EGF stimulation results in the 
endosomal effects induced by ESCRT disruption becoming more pronounced.  
 
Previous studies have also demonstrated a requirement for the ESCRT 
machinery in the degradation of both EGF and EGFR (Bishop et al., 2002; Lu et 
al., 2003; Bache et al., 2006; Malerod et al., 2007; Raiborg et al., 2008). In 
addition, depletion of ESCRTs has been reported to affect EGF signalling. 
Sustained phosphorylation and activation of extracellular-signal-regulated 
kinase 1/2 (ERK1/2) which, upon EGF stimulation, becomes phosphorylated, 
translocates to the nucleus and is involved in regulation of various transcription 
factors (Murphy and Blenis, 2006), has been observed upon disruption of 
ESCRT-0 and -I, but not ESCRT-II and -III (Bache et al., 2006; Malerod et al., 
2007).  This suggests that the early ESCRT complexes are required for 
silencing of EGF signalling whereas ESCRT-II and -III are not. However, no 
significant accumulation of EGF or sustained phosphorylation of ERK1/2 was 
observed in Caco-2 cells after Tsg101 or Vps25 knockdown, despite the 
characteristic endosomal enlargement. This suggests that EGF degradation is 
not perturbed in ESCRT depleted Caco-2 cells.  
 
It could be speculated that alternative ESCRT-independent mechanisms of EGF 
trafficking and degradation exist and that, upon ESCRT depletion, these 
pathways may be upregulated or preferentially selected. A recent study which 
depleted subunits of all four ESCRT complexes demonstrated that, upon 
disruption of the entire ESCRT machinery, MVBs can still form, although the 
resulting compartment was considerably enlarged (Stuffers et al., 2009b).  This 
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suggests that ESCRT-independent mechanisms of MVB formation exist and is 
supported by additional studies which demonstrate ESCRT-independent cargo 
sorting into intraluminel vesicles of MVBs (Theos et al., 2006; Trajkovic et al., 
2008).  
 
The relevance of these possible alternative mechanisms may also be 
dependent on cell type. This could explain the discrepancies between my 
results and those published by other groups as the effect of ESCRT disruption 
has not previously been studied in polarised epithelial cells, with the majority of 
studies undertaken in the HeLa cell line (Bishop et al., 2002; Lu et al., 2003; 
Doyotte et al., 2005; Bache et al., 2006; Raiborg et al., 2008). Polarised 
epithelial cells have a more complex endosomal system with a number of 
additional endocytic compartments (Hoekstra et al., 2004; Mellman and Nelson, 
2008; Folsch et al., 2009; Weisz and Rodriguez-Boulan, 2009) therefore, it is 
likely that additional and/or different trafficking routes exist compared with 
unpolarised cells. The kinetics of EGF-EGFR trafficking upon ESCRT disruption 
could be studied in more detail, for example using radiolabelled 125I-EGF to 
study its’ degradation and recycling. 
 
3.3.3. ESCRT depletion alters Caco-2 cell morphology  
 
Caco-2 cells are a well characterised polarised human epithelial cell line. In 
culture they form a functional polarised monolayer with established cell-cell 
junctions and distinct apical and basolateral membrane domains. Upon 
reaching confluency, cells spontaneously differentiate during which cell-cell 
junctions mature, lateral height increases and a brush border of microvilli forms 
at the apical membrane (Grasset et al., 1984; Chantret et al., 1988; Sambuy et 
al., 2005; Volpe, 2008). At this stage, Caco-2 cells exhibit the characteristic 
cobblestone morphology via phase contrast microscopy, which is typical of a 
differentiated epithelial monolayer. However, upon knockdown of Tsg101 and 
Vps25, Caco-2 cell differentiation was inhibited. Although ESCRT depleted cells 
were still able to establish apicobasal polarity if monolayered epithelial 
organisation was retained, lateral height and brush border formation were 
reduced. This suggests that establishment of distinct apical and basolateral 
membrane domains does not require a functional ESCRT machinery, however, 
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differentiation to a fully polarised epithelial monolayer is directly or indirectly 
ESCRT-dependent.  
 
In support of this observation, ESCRT mutant cells also fail to differentiate in 
Drosophila (Vaccari and Bilder, 2005; Herz et al., 2006). In mammalian 
epithelial cells, several studies have demonstrated a requirement for 
phosphatidylinositol 3-kinase (PI3K) signalling for differentiation (Laprise et al., 
2002; Gassama-Diagne et al., 2006; Jeanes et al., 2009). Inhibition of PI3K 
impaired differentiation of epithelial cells, shown by a reduction in cell height 
and brush border formation. This was accompanied by a reduction in 
phosphatidylinositol-3,4,5-triphosphate (PIP3), a key regulator of basolateral 
membrane formation in epithelial cells (Gassama-Diagne et al., 2006). 
Interestingly, although PI3K has been shown to be important for adherens 
junction assembly (Laprise et al., 2002), surface expression of E-cadherin and 
apicobasal polarity of established epithelial monolayers was not affected by 
PI3K inhibition (Laprise et al., 2002; Jeanes et al., 2009). Therefore, this 
phenotype is similar to that observed upon ESCRT depletion in Caco-2 cells. 
The ESCRT machinery is important for regulation of various receptor signalling 
pathways (Wegner et al., 2011) although a role within the PI3K pathway has not 
been documented. As PI3K activity is important for epithelial cell differentiation, 
it would be of interest to establish whether the effects seen on Caco-2 cell 
height and brush border formation are accompanied by alterations in PI3K 
signalling.  
 
3.3.4. ESCRT-I is required for maintenance of a polarised Caco-2 
epithelial monolayer 
 
In addition to defects in differentiation of Caco-2 cells upon Tsg101 knockdown, 
large areas of the epithelial sheet lost the normal monolayered organisation and 
multilayered stacks of cells were formed. These multilayers displayed 
compromised apicobasal polarity and brush border formation. This phenotype 
was confirmed using two different Tsg101 siRNA oligonucleotides and therefore 
is specific for Tsg101 depletion. The loss of epithelial polarity and organisation 
is similar to that observed in Drosophila upon mutation of Tsg101 (Moberg et 
al., 2005) and suggests that the requirement for a functional ESCRT machinery 
123 
 
is conserved in mammalian cells. Studies in Drosophila also demonstrated a 
similar disruption in epithelial cell polarity upon Vps25 mutation as well as other 
components of the ESCRT machinery (Thompson et al., 2005; Vaccari and 
Bilder, 2005; Herz et al., 2006; Rodahl et al., 2009b; Vaccari et al., 2009). This 
is in contrast to my data in which Vps25 knockdown does not cause a disruption 
in apicobasal polarity or organisation of the epithelial sheet. The role of ESCRT-
II in mammalian cells is unclear as it has been demonstrated that Vps25 is 
dispensable for MVB protein sorting (Bowers et al., 2006). It is possible that the 
requirement for ESCRT-II varies from Drosophila to mammals and therefore, 
this may explain why Vps25 knockdown does not affect apicobasal polarity in 
Caco-2 cells.  
 
Alternatively, this difference in phenotype between Tsg101 and Vps25 depletion 
may be due to the level of knockdown achieved over time. After 3 days 
approximately 80% Tsg101 knockdown was achieved whereas only 60% of 
Vps25 protein was depleted. After 7 days, Vps25 knockdown reached a similar 
level to Tsg101, however, by this timepoint cells will have been subjected to an 
extended period of Tsg101 depletion compared with Vps25. Therefore, this may 
result in a stronger phenotype for Tsg101 knockdown cells. It would be of 
interest to optimise Vps25 knockdown to the same level as Tsg101 knockdown 
in order to investigate whether a defect in epithelial cell polarity and 
organisation is observed. One approach to accomplish this would be to split the 
Vps25 siRNA SMARTpool into the four individual oligonucleotides and 
determine whether a more efficient knockdown could be achieved at an earlier 
timepoint. In addition, other ESCRT-II components could be depleted, either 
individually or in combination. 
 
The disruption in apicobasal polarity and formation of multilayers after Tsg101 
knockdown in Caco-2 cells could be due to a number of possible mechanisms. 
Firstly, disruption of ESCRT-I may affect the trafficking of various proteins 
important for the maintenance of epithelial cell polarity. For example, in 
Drosophila ESCRT mutants, loss of cell polarity was attributed to mislocalisation 
of Crumbs from the apical membrane to a subapical compartment (Moberg et 
al., 2005). It is clear that localisation of polarity complexes to specific membrane 
domains is also crucial for establishment and maintenance of mammalian 
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epithelial cell polarity. The PAR and CRB complexes are important for apical 
membrane identity and the SCRIB complex for basolateral membrane identity 
(Roh et al., 2003; Kallay et al., 2006; Suzuki and Ohno, 2006; Yamanaka et al., 
2006; Horikoshi et al., 2009). In addition, maintenance of cell-cell junctions is 
also important to retain a polarised phenotype. Tight junctions provide a fence 
function to prevent diffusion of lipids between the apical and basolateral 
membrane domains (Matter and Balda, 2003; Shin et al., 2006) and loss of E-
cadherin from the adherens junctions is often associated with epithelial to 
mesenchymal transition (Perl et al., 1998; Yang and Weinberg, 2008). In fact, it 
is becoming increasingly apparent that cell-cell junctions function as a platform 
for many regulatory and signalling proteins important for establishing the 
epithelial phenotype (Ivanov et al., 2005). Cell-cell junctions are dynamic 
structures that are constantly being remodelled (Shen et al., 2008; Steed et al., 
2010) and there is growing evidence of links between endocytosis, regulation of 
epithelial junctions (Ivanov et al., 2005) and cell polarity (Shivas et al., 2010). 
Thus, it is likely that protein trafficking plays a crucial role in maintaining 
epithelial cell polarity. ESCRT-I depletion has been shown to disrupt the 
endocytic pathway (Bishop et al., 2002; Doyotte et al., 2005; Razi and Futter, 
2006; Stuffers et al., 2009b) and therefore, compromised Caco-2 cell polarity 
observed upon Tsg101 knockdown may be due to perturbed trafficking of 
proteins important for maintenance of apicobasal polarity and cell-cell junctions. 
As a result of this defect in polarity cells may be unable to retain the correct 
organisation within the epithelial sheet and begin to form multilayers. The 
effects of ESCRT depletion on cell-cell junctions will be analysed in more detail 
in Chapter Four. 
 
Conversely, Tsg101 knockdown cells may lose correct epithelial organisation, 
form multilayers and, as a consequence, apicobasal polarity of the epithelial 
sheet cannot be retained. Some cells within the multilayered regions do seem to 
retain distinct apical and basolateral membrane domains suggesting that 
individually apicobasal polarity may be maintained however, due to loss of the 
monolayered organisation, cells are incorrectly orientated within the 
multilayered epithelial sheet. Multilayering of cells may be due to an increased 
rate of proliferation whereby cells divide too rapidly to maintain epithelial 
organisation. Alternatively, Tsg101 knockdown may result in a defect in contact 
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inhibition. Upon reaching confluency, Caco-2 cells will reduce rate of cell 
division as a result of contact inhibition (Nelson and Daniel, 2002) and begin to 
differentiate (Volpe, 2008). If Tsg101 knockdown somehow interferes with this 
process, cells may continue to proliferate and as a result begin to pile on top of 
one another, disrupting the normal epithelial monolayer. Studies in Drosophila 
support this hypothesis as the overgrowth observed in epithelial tissues 
composed almost entirely of ESCRT mutant cells was attributed to a failure of 
cells to exit the cell cycle rather than an increased rate of proliferation (Moberg 
et al., 2005; Vaccari and Bilder, 2005). Chapter Five will begin to investigate the 
effects of ESCRT knockdown on Caco-2 cell proliferation. 
 
Finally, Tsg101 knockdown may destabilise cellular contacts with the ECM 
resulting in a loss of basal adhesion. Cells may then detach and migrate out of 
the epithelial monolayer, leading to the formation of multilayers. The main 
components of cellular adhesions to the ECM are the cell surface integrin 
receptors (Bosman et al., 1993; Matlin et al., 2003; Lobert et al., 2010). 
Integrins are heterodimeric type I transmembrane glycoproteins comprised of α 
and β chains which, upon binding to ECM ligands such as fibronectin, laminin or 
collagen, regulate many aspects of cell behaviour (Matlin et al., 2003; Lobert et 
al., 2010). In epithelial cells, integrins are important for the maintenance of 
apicobasal polarity (Eaton and Simons, 1995; Matlin et al., 2003). Orientation of 
the apicobasal axis in MDCK cells is dependent on β1 integrin (Ojakian and 
Schwimmer, 1994) and loss of apical polarity and formation of multilayers in 
MDCK cells transformed with viral K-ras (Schoenenberger et al., 1991) has 
been attributed to a reduction in β1 integrin (Schoenenberger et al., 1994). A 
role for ESCRT proteins in the regulation of integrins has been suggested by a 
recent study which demonstrated that in fibroblasts, ESCRT-I binds to α5β1 
integrin after fibronectin-induced activation and subsequent ubiquitination. 
Furthermore, ESCRT-I was required for degradation of α5β1 integrin via sorting 
into MVBs and this in turn, was required for efficient cell migration (Lobert et al., 
2010). Therefore, it is possible that ESCRT proteins may function to regulate 
integrin levels in epithelial cells. It would be interesting to investigate whether 
the multilayering of Caco-2 cells induced by Tsg101 knockdown was 
accompanied by alterations in integrin protein levels and localisation.  
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3.3.5. ESCRTs are required for epithelial cell polarity in 3D cultures  
 
ESCRT depletion resulted in an increase in the proportion of Caco-2 cysts 
displaying multiple small lumen. This phenotype is indicative of a defect in 
epithelial cell polarity (Schluter and Margolis, 2009) and provides additional 
evidence for a role of ESCRT proteins in the establishment and maintenance of 
cell polarity. Interestingly, whilst Vps25 knockdown did not appear to disrupt 
formation of a polarised Caco-2 cell monolayer in 2D cultures, formation of 3D 
cysts was perturbed by Vps25 depletion. 3D cell cultures may provide a more 
sensitive assay for detecting defects in epithelial cell polarity, providing a 
possible explanation for this disparity. This has been observed in previous 
studies whereby defects in epithelial cell polarity were only apparent upon 
growth of cells in 3D cultures (Roh et al., 2003; Martin-Belmonte et al., 2007; 
Torkko et al., 2008). It has been suggested that polarisation and formation of 
the apical membrane is extremely robust and can be executed despite defects 
in epithelial architecture and therefore, polarity defects are not observed upon 
formation of a simple 2D epithelial monolayer (Torkko et al., 2008). Epithelial 
cyst formation is also considered to be a more physiologically relevant method 
of investigating epithelial cell polarity in vitro (Martin-Belmonte and Mostov, 
2008). This, therefore, highlights the necessity to utilise a variety of methods to 
fully characterise a knockdown phenotype in polarised epithelial cells.   
 
Formation of 3D polarised epithelial cysts requires individual cells to generate 
apical, lateral and basal membrane surfaces in a coordinated manner in order 
to establish a polarised multicellular structure (O’Brien et al., 2002). Formation 
of a central lumen is thought to occur via two mechanisms: hollowing and 
cavitation (Martin-Belmonte and Mostov, 2008). During hollowing, separation of 
opposing membranes results in the formation of an intercellular lumen, whereas 
cavitation involves apoptosis of cells in the centre of the structure to create 
luminal space (O’Brien et al., 2002; Martin-Belmonte and Mostov, 2008; 
Schluter and Margolis, 2009). Separation of membranes is thought to be 
induced by the delivery of lumen formation factors, such as anti-adhesive large 
transmembrane glycoproteins, to the nascent luminal surface. In addition, 
exocytosis of a specialised fluid-filled organelle, the vacuolar apical 
compartment (VAC) to the centre of the forming cyst aids in lumen formation 
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(O’Brien et al., 2002; Martin-Belmonte and Mostov, 2008; Schluter and 
Margolis, 2009).  
 
The mechanism of lumen formation can shift between hollowing and cavitation 
and this has been shown to be dependent on efficiency of apicobasal 
polarisation (Martin-Belmonte et al., 2008). In the absence of apicobasal 
polarity, lumen formation does not occur (Martin-Belmonte and Mostov, 2008; 
Schluter and Margolis, 2009). For example, interference with the key polarity 
proteins, such as CRB3, during cyst formation results in an abnormal lumen 
phenotype (Roh et al., 2003; Straight et al., 2004; Shin et al., 2005; Martin-
Belomonte et al., 2007; Schluter et al., 2009). In addition, formation of tight 
junctions and correct localisation of apical and basolateral proteins is also 
important for formation of polarised epithelial cysts (Schluter and Margolis, 
2009). Depletion of JAM-A, a tight junction component, (Rehder et al., 2006) 
and abnormal segregation of membrane phosphoinositides (Martin-Belmonte et 
al., 2007) resulted in defective cyst formation.  
 
It has been proposed that defective trafficking of proteins involved in epithelial 
cyst formation could result in abnormal lumen phenotypes (Schluter and 
Margolis, 2009). In support of this, depletion of various proteins implicated in 
apical transport perturbed polarised epithelial cyst formation (Torkko et al., 
2008). Therefore, the increase in Caco-2 cysts displaying multiple lumen after 
ESCRT depletion may reflect a defect in trafficking of proteins important for 
maintenance of apicobasal polarity and/or cell-cell junctions. Interestingly, 
abnormal lumen formation is also observed in epithelial glandular cancers such 
as breast cancer, and thus proteins important for epithelial cyst formation may 
be implicated in the process of tumourigenesis (Debnath and Brugge, 2005). 
Therefore, this provides further evidence for a potential role of the ESCRT 
proteins as tumour suppressors in vertebrates.  
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3.4. Conclusion 
 
This study demonstrates for the first time that ESCRT proteins have an 
important role within the maintenance of mammalian epithelial cell polarity. 
Depletion of Tsg101 in the human Caco-2 cell line results in loss of epithelial 
organisation and the formation of a multilayered epithelium with compromised 
apicobasal polarity. In addition both ESCRT-I and -II are required for 
differentiation of a mature Caco-2 epithelial sheet and formation of polarised 3D 
Caco-2 cysts. These results are very similar to findings in Drosophila whereby 
disruption of the ESCRT machinery resulted in a loss of epithelial cell polarity, 
reduced differentiation and the formation of tumour-like tissue overgrowths 
(Moberg et al., 2005; Thompson et al., 2005; Vaccari and Bilder, 2005; Herz et 
al., 2006; ; Herz et al., 2009; Rodahl et al., 2009b; Vaccari et al.,, 2009). 
Therefore, these results demonstrate that ESCRT proteins are required for the 
maintenance of mammalian epithelial cell organisation and polarity, suggesting 
that the role of ESCRTs as tumour suppressors may be conserved from 
Drosophila to mammals.   
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CHAPTER FOUR 
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4. Claudin localisation to tight junctions and 
epithelial barrier formation is dependent on 
ESCRT-I 
 
4.1. Introduction 
 
4.1.1. Cell-Cell Junctions and Epithelial Cell Polarity 
 
Establishment and maintenance of epithelial cell polarity is regulated, in part, 
through the formation of specialised cell-cell junctions. These form between the 
lateral membranes of adjacent cells and are composed of various 
transmembrane and membrane-associated proteins (Bryant and Mostov, 2008; 
Coradini et al., 2011). At the most apical part of the lateral membrane, tight 
junctions define the boundary between the apical and basolateral membrane 
domains where they provide a fence function to restrict intramembrane diffusion 
of lipids (Matter and Balda, 2003). Tight junctions also form a barrier to control 
paracellular diffusion across the epithelial sheet (Matter and Balda, 2003; Shin 
et al., 2006). Localised below tight junctions are adherens junctions, 
desmosomes and gap junctions, important for cell-cell adhesion, anchoring the 
cytoskeleton to the plasma membrane and intercellular signalling (Yin and 
Green, 2004; Niessen and Gottardi, 2008; Nakagawa et al., 2010).  
 
Disruption of cell-cell junctions can often perturb epithelial cell polarity (Brennan 
et al., 2010; Coradini et al., 2011; Turksen and Troy, 2011). For example, loss 
of E-cadherin from adherens junctions is associated with epithelial to 
mesenchymal transition (Perl et al., 1998; Yang and Weinberg, 2008) and 
alterations in tight junction structure and function are often associated with 
enhanced invasiveness of human carcinomas (Miyoshi and Takai, 2005; 
Oliveira and Morgado-Diaz, 2007). In addition, cell-cell junctions are thought to 
function as a platform for many regulatory and signalling proteins important for 
establishing the epithelial phenotype (Ivanov et al., 2005). 
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4.1.2. ESCRT Proteins and Cell-Cell Junctions 
 
Once formed, cell-cell junctions are dynamic structures that are continuously 
being remodelled (Shen et al., 2008; Steed et al., 2010). Previous studies have 
demonstrated that the tight junction proteins, claudin and occludin, and 
adherens junction protein, E-cadherin, are endocytosed in epithelial cells (Le et 
al., 1999; Marzesco et al., 2002; Matsuda et al., 2004; Morimoto et al., 2005). 
Internalisation of different junctional components appears to be highly specific 
and may be mediated by ubiquitylation by specific E3 ubiquitin ligases (Fujita et 
al., 2002; Traweger et al., 2002; Yu and Turner, 2008; Takahashi et al., 2009).  
 
Due to growing evidence of links between endocytosis, regulation of epithelial 
junctions (Ivanov et al., 2005) and cell polarity (Shivas et al., 2010), it is likely 
that protein trafficking plays a crucial role in maintaining a polarised epithelium. 
Previously I have demonstrated that ESCRT-I depletion compromises epithelial 
organisation and polarity of Caco-2 cells in both 2D and 3D cultures. As 
ESCRT-I depletion has been shown to disrupt the endocytic pathway (Bishop et 
al., 2002; Doyotte et al., 2005; Razi and Futter, 2006; Stuffers et al., 2009b), it is 
possible that the compromised Caco-2 cell polarity observed upon Tsg101 
knockdown is due to perturbed trafficking of junctional proteins. As a result, cell-
cell junctions may be destabilised and this could in turn disrupt epithelial cell 
polarity. 
 
4.1.3. Aims 
 
The work described in this chapter aims to establish whether depletion of 
Tsg101 or Vps25 affects cell-cell junctions in Caco-2 epithelial cells. 
Localisation of various junctional proteins will be investigated followed by 
analysis of the functional consequences of knockdown on epithelial barrier 
formation and migratory ability. In addition, the dynamics of cell-cell junction 
proteins in Caco-2 cells will be characterised.  
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4.2. Results 
 
4.2.1. Tsg101 depletion affects localisation of claudin-1 and -4 to tight 
junctions 
 
In order to investigate whether ESCRT depletion affected cell-cell junctions, the 
localisation of various junction proteins was analysed following Tsg101 and 
Vps25 knockdown in Caco-2 cells. Note that characterisation of Tsg101 
knockdown cells was carried out in areas where the epithelial monolayered 
organisation was retained. Multilayered areas of Tsg101 knockdown cells 
display compromised epithelial cell polarity which may have indirect effects on 
cell-cell junctions. In addition, these multilayered regions were difficult to image 
in detail using confocal fluorescence microscopy. Upon knockdown of Tsg101 
or Vps25, the tight junction proteins, occludin and ZO-1, desmosomal protein, 
desmoglein-2, and adherens junction protein, E-cadherin, all localised to cell-
cell junctions as in control cells (Figure 4.1A+B). However, localisation of 
claudin-1 and claudin-4 was disrupted in Tsg101 knockdown cells compared 
with control (Figure 4.2A). Claudin-1 and -4 appeared to accumulate within the 
same intracellular compartment (Figure 4.2A, arrowheads). In addition, 
localisation of these proteins to tight junctions was reduced but not completely 
lost. This intracellular claudin accumulation was not accompanied by significant 
changes in total claudin levels (Figure 4.2B). In contrast, Vps25 knockdown did 
not appear to significantly affect claudin-1 or -4 localisation or protein levels and 
these cells appeared similar to control (Figure 4.2A+B).  
 
The effect of Tsg101 knockdown on claudin-1 localisation was confirmed using 
two alternative siRNA oligonucleotides which were optimised previously 
(Chapter 3, section 3.2.3). Intracellular accumulation of claudin-1 was observed 
after Tsg101 knockdown using these alternative siRNA oligonucleotides 
indicating that the effect is specific to Tsg101 depletion rather than any off-
target effects (Figure 4.3). Therefore, this demonstrates that ESCRT-I is 
required for the correct localisation of claudin-1 and -4 to tight junctions in Caco-
2 cells. Interestingly, other cell-cell junction proteins analysed were not affected. 
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Figure 4.1 Depletion of Tsg101 and Vps25 does not alter the localisation of a number of 
cell-cell junction proteins in Caco-2 cells. Caco-2 cells were transfected with either Non-
Targeting Control siRNA, Tsg101 siRNA or Vps25 siRNA and incubated for 7 d. Cells were fixed 
and examined by confocal fluorescence microscopy for (A) occludin (red) and desmoglein-2 
(green) or (B) ZO-1 (red) and E-cadherin (green). Nuclei were stained with DAPI (blue). Bar, 
10μm. 
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Figure 4.2 Tsg101 knockdown results in intracellular accumulation of claudins in Caco-2 
cells. (A) Caco-2 cells were transfected with either Non-Targeting Control siRNA, Tsg101 
siRNA or Vps25 siRNA and incubated for 7 d. Cells were fixed and examined by confocal 
fluorescence microscopy for claudin-1 (green) and claudin-4 (red). Nuclei were stained with 
DAPI (blue) shown in merged images. Claudin-1 and -4 accumulate in a similar intracellular 
compartment after Tsg101 knockdown (arrowheads) whereas Vps25 knockdown cells appear 
similar to control. Bar, 10μm. (B) Caco-2 cells were transfected with either Non-Targeting 
Control siRNA (C), Tsg101 siRNA (T) or Vps25 siRNA (V) and incubated for 7 d. Lysates were 
immunoblotted for claudin-1 and claudin-4. β-tubulin is shown as a loading control. Total 
claudin-1 and claudin-4 protein levels do not appear to be altered in Tsg101 or Vps25 
knockdown cells compared to control. 
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Figure 4.3 Knockdown of Tsg101 using alternative siRNA oligonucleotides results in a 
similar intracellular accumulation of claudin-1 in Caco-2 cells. Caco-2 cells were 
transfected with either Non-Targeting Control siRNA or Tsg101 siRNA. Tsg101 knockdown was 
also achieved using a different single siRNA oligonucleotide (1) or a combination of two different 
siRNA oligonucleotides (2). After 7 d incubation, cells were fixed and examined by confocal 
fluorescence microscopy for claudin-1 (green). Nuclei were stained with DAPI (blue) shown in 
merged images. A similar intracellular accumulation of claudin-1 is observed after knockdown of 
Tsg101 using alternative siRNA oligonucleotides (1 and 2). Bar, 10µm. 
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4.2.2. Tsg101 depleted Caco-2 cells accumulate ubiquitylated cargo  
 
In addition to intracellular accumulation of claudin-1, Tsg101 knockdown cells 
show a dramatic increase in ubiquitin staining, compared to low levels in control 
cells (Figure 4.4A). This demonstrates that ubiquitylated proteins are 
accumulating in Tsg101 depleted cells. This has been reported in other studies 
analysing the effects of ESCRT disruption (Bishop et al., 2002; Dukes et al., 
2008; Stuffers et al., 2009b) and suggests that Tsg101 knockdown alters the 
flux of ubiquitylated proteins along the endocytic pathway. The internal pool of 
claudin-1 observed upon Tsg101 knockdown partially colocalises with this 
ubiquitin, indicating that at least some of the mislocalised claudin-1 is 
accumulating within a similar intracellular compartment (Figure 4.4A, 
arrowheads). In contrast, Vps25 knockdown had no effect on ubiquitin staining 
(data not shown). 
 
Ubiquitylation of claudin-1 by the ubiquitin ligase, LNXp180, has previously 
been shown to induce internalisation (Takahashi et al., 2009). To analyse 
whether ubiquitylation of claudin-1 was increased in Tsg101 knockdown cells, 
claudin-1 was immunoprecipitated following Tsg101 knockdown and in control 
cells. Analysis was carried out for any associated ubiquitin using an antibody 
which recognises mono- and poly-ubiquitylated proteins but not free ubiquitin 
(Figure 4.4B). Although ubiquitin was observed in the whole cell lysate, shown 
by the characteristic smear after immunoblotting (Figure 4.4B, Total Lysate), 
ubiquitin was not detected in claudin-1 pull downs (Figure 4.4B, IP: CL-1; IB: 
Ub). Bands showing on the blot are likely to be antibody heavy chain as these 
are absent from the no IgG control sample (Figure 4.4B, arrowhead). Results 
demonstrate that claudin-1 immunoprecipitation was successful and specific as 
claudin-1 was detected in all samples except those which did not include a 
claudin-1 antibody (Figure 4.4B, no IgG and Rb IgG). Therefore, this 
demonstrates that claudin-1 ubiquitylation is not observably increased after 
Tsg101 or Vps25 knockdown. Although the internal pool of claudin-1 often 
colocalised with ubiquitin in Tsg101 depleted cells, these results suggest that 
claudin-1 accumulates in a similar compartment to ubiquitylated cargo rather 
than being directly modified with ubiquitin.   
140 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 Ubiquitin accumulates in Caco-2 cells upon Tsg101 knockdown in a similar 
intracellular compartment to claudin-1. (A) Caco-2 cells were transfected with either Non-
Targeting Control siRNA or Tsg101 siRNA and incubated for 7 d. Cells were fixed and 
examined by confocal fluorescence microscopy for claudin-1 (green) and ubiquitin (red). Nuclei 
were stained with DAPI (blue) shown in merged images. Right panels are zoomed images of 
areas indicated by dotted lines. Ubiquitin also accumulates in Tsg101 knockdown cells and 
often localises to a similar intracellular compartment as claudin-1 (arrowhead). However, some 
claudin-1 and ubiquitin localise to separate compartments (arrows). Bar, 10µm. (B) Caco-2 cells 
were transfected with either Non-Targeting Control siRNA (C), Tsg101 siRNA (T) or Vps25 
siRNA (V) and incubated for 3, 7 or 10 d. Claudin-1 was immunoprecipitated from cell lysates at 
each timepoint and samples were immunoblotted for ubiquitin, arrowhead indicates non-specific 
(ns) bands. Claudin-1 is shown to confirm efficiency of immunoprecipitation. Controls were 
performed on untransfected cells and show specific pull down of claudin-1 (compare No IgG/Rb 
IgG with CL-1 IgG). Total lysates are shown as loading controls. Claudin-1 ubiquitylation does 
not appear to increase after Tsg101 or Vps25 knockdown.  
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4.2.3. Characterisation of the internal claudin-1 positive compartment in 
Tsg101 depleted Caco-2 cells 
 
To further characterise the claudin-1 positive internal compartment observed in 
Tsg101 knockdown cells, co-staining with various endosomal markers was 
performed (Figure 4.5 and 4.6). Claudin-1 does not colocalise completely with 
any of the markers analysed (Figure 4.5 and 4.6, arrows), however, partial 
colocalisation was demonstrated with the early endosome marker, EEA1, and 
with transferrin receptor (TfR) as a marker of recycling endosomes (Figure 4.5, 
arrowheads). Partial colocalisation was also observed with the late endosome 
markers, mannose-6-phosphate receptor (M6PR) and CD63, and with the 
lysosome marker, Lamp-1, although this was to a slightly lesser extent (Figure 
4.6, arrowheads). These results show that the intracellular pool of claudin-1 
observed upon Tsg101 knockdown localises to multiple endosomal 
compartments, suggesting that claudin-1 trafficking through the endocytic 
system is perturbed.  
 
4.2.4. ESCRT-I depletion impairs Caco-2 epithelial barrier formation 
 
Claudins are important for producing a tight junction permeability barrier (Van 
Itallie and Anderson, 2006) and therefore, reduced localisation of claudin-1 and 
-4 to tight junctions may affect their barrier function. To establish whether 
ESCRT depletion had an impact on epithelial barrier formation, transepithelial 
resistance (TER) was monitored after Tsg101 and Vps25 knockdown. TER is a 
measure of resistance to an electrical current passed from the apical to the 
basal surface of an epithelial sheet and can be used to indicate the integrity of 
cell-cell junctions. As junctions mature TER will increase and, conversely, 
disruption of junctions is often accompanied with a reduction in TER (Cereijido 
et al., 1978). Establishment of TER was monitored over 4 days after plating 
siRNA transfected Caco-2 cells onto Transwell filters. Tsg101 knockdown 
significantly reduced TER compared to control at all timepoints measured 
whereas Vps25 knockdown had no effect (Figure 4.7A).  
 
In addition, TER recovery after calcium switch was measured (Figure 4.7B). 
Removal of calcium from the cell culture growth media induces internalisation of  
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Figure 4.5 The internal pool of claudin-1 in Tsg101 knockdown localises to both early and 
recycling endosomes. Caco-2 cells were transfected with either Non-Targeting Control siRNA 
or Tsg101 siRNA and incubated for 7 d. Cells were fixed and examined by confocal 
fluorescence microscopy for claudin-1 (green) and either EEA1 or TfR (red). Nuclei were 
stained with DAPI (blue) shown in merged images. Right panels are zoomed images of areas 
indicated by dotted lines. Intracellular claudin-1 partially colocalises with the early endosome 
marker, EEA1 (top panels) and the recycling endosome marker, TfR (bottom panels). 
Colocalisation is shown as yellow in zoomed images (arrowheads). Note that for each marker, 
some claudin-1 localises to an unlabelled compartment (arrows). Bar, 10µm. 
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Figure 4.6 Intracellular claudin-1 partially colocalises with late endosomal markers in 
Tsg101 depleted Caco-2 cells. Caco-2 cells were transfected with either Non-Targeting 
Control siRNA or Tsg101 siRNA and incubated for 7 d. Cells were fixed and examined by 
confocal fluorescence microscopy for claudin-1 (green) and either M6PR, CD63 or Lamp-1 
(red). Nuclei were stained with DAPI (blue) shown in merged images. Right panels are zoomed 
images of areas indicated by dotted lines. The internal pool of claudin-1 partially colocalises 
with late endosomal markers, M6PR (top panels) and CD63 (middle panels) and less so with 
the lysosome marker, Lamp-1 (bottom panels). Colocalisation is shown as yellow in zoomed 
images (arrowheads). Note that for each marker, some claudin-1 localises to an unlabelled 
compartment (arrows). Bar, 10µm. 
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Figure 4.7 Transepithelial resistance (TER) is reduced following Tsg101 siRNA 
knockdown  in  Caco-2 cells. Caco-2 cells were transfected with either Non-Targeting Control 
siRNA, Tsg101 siRNA or Vps25 siRNA, replated on day 3 to transwell filters and incubated for a 
further 4 days (A) TER was measured between day 4 and day 7. Tsg101 depletion reduces 
TER at all time points compared to control whereas Vps25 knockdown has no effect. (B) On 
day 7 cells were incubated in calcium-free media for 2 h to destabilise cell-cell junctions. 
Incubation in calcium-containing media then allowed junctions to reform and TER was 
measured at the indicated timepoints. TER recovers after calcium switch in ESCRT depleted 
cells however Tsg101 knockdown cells consistently display a reduced TER compared to 
control. Data shown are the means ± standard error of three independent experiments. Results 
were analysed using a two-way ANOVA and Bonferroni post test, *** p<0.001 * p<0.05. 
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cell-cell junction proteins and as a result TER dropped to almost zero (Figure 
4.7B, 0 h timepoint). Calcium was then added back into the media, allowing cell-
cell junctions to reform. In control cells, a gradual increase of TER was 
observed over a 5 hour period. A similar increase was seen after Vps25 
knockdown, however TER was consistently lower in Tsg101 depleted cells 
(Figure 4.7B). Therefore, establishment of TER as well as recovery after a 
calcium switch requires Tsg101 indicating that depletion of ESCRT-I results in 
impaired barrier formation of the Caco-2 epithelial sheet. In contrast, Vps25 
knockdown does not appear to have a significant effect on TER.  
 
4.2.5. Tsg101 knockdown enhances Caco-2 cell migratory ability 
 
Loss of apicobasal polarity and cell-cell adhesion can promote migration of 
epithelial cells and is often observed during metastasis of cancer cells 
(Hanahan and Weinberg, 2011). As tight junctions play an important role in 
maintenance of the polarised epithelial phenotype, alterations in tight junction 
structure and function are often associated with enhanced invasiveness of 
human carcinomas (Miyoshi and Takai, 2005; Oliveira and Morgado-Diaz, 
2007). In addition, changes in expression of claudins are frequently observed in 
various human tumours (reviewed in Morin, 2005; Oliveira and Morgado-Diaz, 
2007; Turksen and Troy, 2011). For example claudin-1 has been found to be 
reduced in breast (Kramer et al., 2000; Tokes et al., 2005), lung (Chao et al., 
2008) and colon (Resnick et al., 2005) cancer. Conversely, upregulation of 
claudins has also been associated with carcinogenesis (Oliveira et al., 2005). 
As Tsg101 depletion compromised apicobasal polarity and altered claudin-1 
and -4 localisation, the effect of knockdown on the migratory ability of Caco-2 
cells was investigated.  
 
After siRNA knockdown, a scratch assay was performed on confluent Caco-2 
cells and migration of cells into the wound area was monitored over time (Figure 
4.8). After 24 h, approximately 35% of the original scratch area was covered by 
Tsg101 knockdown cells compared to 12% in control (Figure 4.8B). Therefore, 
ESCRT-I depletion significantly enhances migration of Caco-2 cells. 
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Figure 4.8 Tsg101 depleted Caco-2 cells display enhanced migratory ability. Caco-2 cells 
were transfected with Non-Targeting Control siRNA or Tsg101 siRNA and replated on day 3 to 
cell culture inserts used to assess cell migration. Migration was initiated on day 6 by removal of 
the cell culture insert to reveal a cell-free area of approximately 500µm. Images were obtained 
using phase contrast microscopy 0, 12 and 24 h after initiation of migration. (A) Representative 
images for 0 and 24 h migration are shown. The migratory front of the epithelial sheet was 
detected using ImageJ at each timepoint and can be overlaid to show cell migration after 24 h 
(overlay, black lines) compared to 0 h (overlay, red lines). (B) Scratch area was quantified using 
ImageJ and expressed as an inverse percentage of 0 h. After 24 h, migration of Tsg101 
depleted cells is increased compared to control. Data shown are the means ± standard error of 
three independent experiments. Results were analysed using a two-way ANOVA and Bonferroni 
post test, * p<0.05.  
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4.2.6. Caco-2 cell tight junctions are dynamic structures 
 
Tsg101 depletion results in intracellular accumulation of claudin-1 which 
localises to multiple endosomal compartments, suggesting that claudin-1 
trafficking is perturbed. A functional ESCRT machinery is required for the 
degradation of various membrane proteins (Raiborg and Stenmark, 2009) and 
so disruption of claudin-1 trafficking to lysosomes for degradation may explain 
its intracellular accumulation. However, ESCRT proteins have also been shown 
to be important for protein recycling (Yoshimori et al., 2000; Fujita et al., 2003; 
Doyotte et al., 2005; Baldys and Raymond, 2009). Therefore, the internal pool 
of claudin-1 could also arise due to inhibition of endocytic recycling. Although 
previous studies have begun to analyse the dynamic behaviour of cell-cell 
junction proteins (Le et al., 1999; Marzesco et al., 2002; Matsuda et al., 2004; 
Morimoto et al., 2005), trafficking of tight junction components has not been 
studied in Caco-2 cells. 
 
In order to investigate whether tight junction proteins constitutively traffic 
through the endosomal system in Caco-2 cells, a surface biotinylation assay 
was used. This assay employs a membrane-impermeant biotin molecule to 
label cell surface proteins. Trafficking of biotinylated proteins can then be 
followed over time, using various incubation and stripping procedures, followed 
by neutravidin pull down and immunoblotting for the protein of interest (for 
schematic, see Chapter 2: Materials and Methods, Figure 2.1). Surface claudin-
1 and occludin could be labelled with biotin and were successfully detected after 
neutravidin pull down (Figure 4.9A, ‘Surface Biotinylated’). No detection was 
observed in mock treated cells, indicating that the pull down was specific to 
biotinylated proteins (Figure 4.9A, ‘Non Specific’).  In addition, the biotin could 
be efficiently removed from labelled proteins by a surface stripping procedure 
(Figure 4.9A, ‘Strip Control’). Endocytosis of claudin-1 and occludin was then 
analysed over time (Figure 4.9B). After labelling surface proteins with biotin at 
4°C, Caco-2 cells were incubated at 37°C for the indicated timepoints to allow 
trafficking. Following this, biotin was stripped from surface proteins and analysis 
of the remaining biotinylated claudin-1 and occludin was performed. This 
therefore indicated the amount of biotinylated claudin-1 and occludin 
endocytosed within each time period. Following a 60 min incubation, 
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Figure 4.9 Claudin-1 and occludin are endocytosed in Caco-2 cells. Surface biotinylation 
and endocytosis assays were performed on Caco-2 cells. (A) Caco-2 cells were incubated at 
4°C with non-membrane permeable biotin to label surface proteins. Biotinylated proteins were 
isolated using neutravidin pull down and samples were immunoblotted for claudin-1 and 
occludin. Surface claudin-1 and occludin was successfully labelled with biotin (‘Surface 
Biotinylated’). No signal was observed after mock treatment (‘Non-specific’) or after stripping 
with MESNA (‘Strip Control). Total cell lysate is shown as a loading control. (B) After surface 
biotinylation, Caco-2 cells were incubated at 37°C for indicated timepoints to allow endocytosis. 
Remaining biotin at the cell surface was stripped with MESNA and biotinylated proteins were 
isolated using neutravidin pull down. Samples were immunoblotted for claudin-1 and occludin to 
indicate the amount of protein endocytosed within each time period. Total cell lysate 
immunoblotted for claudin-1 is shown as a representative loading control. (C) Protein levels 
were quantified, normalised to total protein and expressed as a percentage of the 
corresponding amount of surface biotinylated protein. Claudin-1 and occludin are endocytosed 
in Caco-2 cells. This endocytosis is rapid and a steady state is reached after approximately 30 
min. Data shown are the means ± standard error of three independent experiments. 
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approximately 50% of biotinylated occludin and 20% of biotinylated claudin-1 
was endocytosed (Figure 4.9B + C). The amount of internal biotinylated claudin-
1 and occludin only increased slightly between 30 min and 2 h suggesting that 
the level of endocytosis reaches an approximate plateau after 30 min.   
 
The fate of the endocytosed claudin-1 and occludin was then investigated. 
Caco-2 cells were labelled with biotin and incubated at 37°C for 1 h to allow 
endocytosis (Figure 4.10A+B, ‘Endocytosis 60 min’). Surface biotin was 
stripped and cells were incubated for a further 20 min at 37°C. Following this, 
cells were surface stripped for a second time or mock treated. This second 
stripping procedure removes biotin from endocytosed proteins which have 
returned to the cell surface and therefore allows the fate of the endocytosed 
proteins to be studied. A reduction in the amount of biotinylated protein detected 
after mock treatment compared to the endocytosis condition indicates that some 
of the endocytosed protein has been targeted for degradation (Figure 4.10A+B, 
‘Degradation Control’). Levels of recycled proteins are indicated by a reduction 
in the amount of biotinylated protein pulled down after a second surface strip 
compared with the degradation control (Figure 4.10A+B, ‘Recycling 20 min). 
This procedure revealed that approximately 40% of endocytosed claudin-1 is 
recycled with very little being targeted for degradation (Figure 4.10A+B). In 
contrast, the fate of endocytosed occludin was split between degradation and 
recycling with approximately 40% degraded and 30% of the remaining internal 
occludin recycled (Figure 4.10A+B). Therefore, in Caco-2 cells claudin-1 is 
constitutively endocytosed and recycled and occludin is endocytosed then 
either degraded or recycled.  
 
4.2.7. Turnover of tight junction proteins occurs over time 
 
The biotinylation assay studied the degradation and recycling of endocytosed 
claudin-1 and occludin over a short time period of 20 min. Analysis of claudin-1 
and occludin turnover over a longer time period was performed by monitoring 
protein levels after varying lengths of cycloheximide treatment (Figure 4.11). 
Effective inhibition of protein synthesis via cycloheximide treatment was 
demonstrated after 6 h by a reduction in the levels of connexin-43, a gap 
junction protein known to undergo rapid turnover (Fallon and Goodenough, 
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Figure 4.10 Claudin-1 and occludin are constitutively endocytosed and recycled in Caco-
2 cells. The surface biotinylation, endocytosis and recycling assay was performed on Caco-2 
cells. (A) After surface biotinylation, Caco-2 cells were incubated at 37°C for 60 min to allow 
endocytosis. Remaining biotin at the cell surface was stripped with MESNA and cells were 
incubated at 4°C for 20 min to allow recycling. Cells were surface stripped to indicate recycling 
or mock treated to control for degradation. After each step cells were lysed, biotinylated proteins 
were isolated using neutravidin pull down and samples were immunoblotted for claudin-1 and 
occludin. Total cell lysate is shown as a loading control. Lanes marked ‘Surface biotinylated’ 
represent the initial biotinylated protein at the cell surface and ‘Endocytosis 60 min’ is the 
internal biotinylated protein that is resistant to surface stripping. Degradation is shown by a 
reduction of signal in the ‘Degradation control’ lane in comparison to the ‘Endocytosis 60 min’ 
lane. Recycling is the reduction of signal in the ‘Recycling 20 min’ lane relative to the 
‘Degradation control’ lane. (B) Protein levels were quantified, normalised to total protein and 
expressed as a percentage of the corresponding amount of surface biotinylated protein. 
Claudin-1 is endocytosed and recycled in Caco-2 cells whereas occludin is endocytosed and 
then either recycled or degraded. Data shown are the means ± standard error of three 
independent experiments. 
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1981). Importantly, up to 24 h treatment with cycloheximide had no effect on 
Caco-2 cell viability (data not shown). After 6 h cycloheximide treatment, total 
occludin and claudin-1 levels remained stable. However, 16 h and 24 h 
treatment reduced total protein levels (Figure 4.11), suggesting that over time 
tight junction proteins are turned over in Caco-2 cells. 
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Figure 4.11 Claudin-1 and occludin are turned over in Caco-2 cells. Caco-2 cells were 
incubated at 37°C with 2µg/ml cycloheximide (CHX) for the indicated time periods and lysates 
were immunoblotted for occludin and claudin-1. Connexin-43 is shown as a positive control for 
CHX treatment and β-tubulin is shown as a loading control. Turnover of claudin-1 and occludin 
is demonstrated after 24 h CHX treatment.  
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4.3. Discussion 
 
This work aimed to investigate whether ESCRT proteins are required for the 
formation and/or maintenance of epithelial cell-cell junctions in Caco-2 cells. 
Functional cell-cell junctions are important to maintain a polarised epithelium 
and therefore defective epithelial junctions could provide a mechanism for the 
compromised Caco-2 cell polarity and organisation observed upon ESCRT-I 
depletion (discussed in Chapter 3). My results demonstrate that Tsg101 
knockdown causes an internal accumulation of claudins whereas the 
localisation of various other cell-cell junction proteins is unaffected. In addition, 
Tsg101 depletion impairs Caco-2 epithelial barrier formation and enhances 
migratory ability, providing further support for a tumour suppressor role of 
ESCRT-I in mammalian epithelial cells. I have shown that claudin-1 and 
occludin are continuously trafficked through the endosomal system in Caco-2 
epithelial cells. Therefore, the intracellular accumulation of claudin-1 in ESCRT 
deficient cells is likely to be due to defective claudin-1 endosomal trafficking.  
 
4.3.1. Claudin localisation to tight junctions and Caco-2 epithelial barrier 
formation is dependent on ESCRT-I 
 
Depletion of Tsg101 in Caco-2 cells caused an intracellular accumulation of 
claudin-1 and -4 whereas localisation of various other cell-cell junction proteins 
was unaffected. Knockdown of Vps25 however had no significant effect on 
localisation of claudin-1 and -4 or any of the other junctional proteins studied. 
Additional data from our laboratory has demonstrated a similar internal 
accumulation of claudin-1 in MDCK cells, a canine kidney cell line, after 
disruption of ESCRT-III and inactivation of the AAA-ATPase Vps4 using 
dominant negative constructs (Dukes et al., 2011). This suggests that ESCRT 
function is required for junctional localisation of claudin-1 in at least two different 
epithelial cell types. Analysis of other cell lines would indicate whether this 
requirement is a common feature of vertebrate epithelial cells. 
 
Ubiquitylated proteins also accumulated within Tsg101 depleted Caco-2 cells, a 
phenotype which has been observed in other cell lines after ESCRT disruption 
and is indicative of a defect in trafficking through the endocytic pathway (Bishop 
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et al., 2002; Dukes et al., 2008; Stuffers et al., 2009b). Claudin-1 often localised 
to the same internal compartment as these ubiquitylated proteins although 
modification of claudin-1 with ubiquitin was not observed. Further 
characterisation of the claudin-1 positive compartment revealed that the internal 
pool of claudin-1 partially colocalised with markers for both early and recycling 
endosomes, and to a lesser extent with markers for late endosomes and 
lysosomes. This suggests that endosomal trafficking of claudin-1 is perturbed in 
ESCRT-I depleted Caco-2 cells and, as a result, claudin-1 accumulates within 
numerous endocytic compartments. In addition, identity of individual endosomal 
domains may be disrupted upon ESCRT depletion (Woodman, 2009). 
Therefore, claudin-1 may accumulate within a hybrid compartment which is 
positive for multiple endosomal markers. Previous results demonstrated that 
although early and late endosomes are enlarged in EGF treated Caco-2 Tsg101 
knockdown cells, these two compartments remained morphologically distinct 
(Chapter 3, section 3.2.2). However, co-staining with multiple endosomal 
markers has not been carried out and therefore, this could be investigated 
further by studying the localisation of various markers for recycling, early and 
late endosomes after Tsg101 knockdown.  
 
ESCRT-I depletion also resulted in a reduction in Caco-2 transepithelial 
resistance (TER) whereas ESCRT-II depletion had no effect. This is consistent 
with results demonstrating that Tsg101 knockdown, but not Vps25 knockdown, 
causes an intracellular accumulation of claudin-1 and -4. Despite this internal 
accumulation, claudin-1 and -4 are not completely lost from tight junctions in 
Tsg101 knockdown cells. However, as claudins are crucial for producing a tight 
junction permeability barrier (Van Itallie and Anderson, 2006), reduced 
localisation of claudin-1 and -4 to tight junctions may affect their barrier function. 
The sensitivity of tight junction structure and function to claudin composition has 
been demonstrated previously (reviewed in Krause et al., 2007; Lal-Nag and 
Morin, 2009). Therefore, this suggests that mislocalisation of claudin-1 and -4 
disrupts tight junction integrity and has a functional impact on Caco-2 epithelial 
barrier formation. The claudin family consists of least 27 different proteins 
(Mineta et al., 2011) and therefore, it is possible that ESCRT depletion affects 
the localisation of other claudins. This may contribute to the defective barrier 
formation and it would be interesting to analyse the localisation of other claudin 
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proteins after Tsg101 depletion. In addition, it would be of interest to investigate 
the impact of ESCRT depletion on tight junction structure further, for example 
using electron microscopy to analyse the integrity of the tight junction strands in 
detail.  
 
Alternatively, the reduction in TER following Tsg101 knockdown could be due to 
loss of a polarised Caco-2 epithelial monolayer. Previous results demonstrated 
that ESCRT-I depleted cells formed multilayered regions lacking normal 
epithelial organisation and apicobasal polarity (discussed in Chapter 3). Barrier 
function may also be perturbed in these areas and therefore this could account 
for the reduction in TER rather than mislocalisation of claudins. This could be 
investigated in more detail using dominant negative ESCRT-III constructs which 
cause a similar internal accumulation of claudins but do not disrupt epithelial 
cell polarity (Dukes et al., 2011). 
 
Therefore, these results demonstrate that ESCRT-I is required to maintain 
localisation of claudin-1 and -4 to tight junctions in Caco-2 cells. In addition, 
epithelial barrier formation is also dependent on ESCRT-I function. This could 
be a consequence of claudin-1 and -4 mislocalisation but there may also be 
additional effects of ESCRT-I depletion on other junctional proteins which were 
not analysed in this study. It can be speculated that mislocalisation of claudins, 
and possibly other junction proteins, destabilises Caco-2 tight junctions and, as 
a result, epithelial cell polarity is disrupted. Cells may then lose correct epithelial 
organisation and this may lead to the multilayered sheets observed upon 
Tsg101 knockdown.  
 
4.3.2. ESCRT-I depletion enhances Caco-2 migratory ability 
 
ESCRT-I depletion was also shown to increase Caco-2 cell migration. This 
could be due to the mislocalisation of claudin-1 and -4 from tight junctions as 
alterations in tight junction structure and function are often associated with 
enhanced invasiveness of human carcinomas (Miyoshi and Takai, 2005; 
Oliveira and Morgado-Diaz, 2007; Turksen and Troy, 2011). Furthermore, 
changes in expression of claudins are frequently observed in various human 
tumours (reviewed in Morin, 2005; Oliveira and Morgado-Diaz, 2007). Claudin-1 
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has been found to be reduced in breast (Kramer et al., 2000; Tokes et al., 
2005); lung (Chao et al., 2008); and colon (Resnick et al., 2005) cancer, and 
upregulation of claudins has also been associated with carcinogenesis (Oliveira 
et al., 2005). In addition, tight junctions play an important role in maintenance of 
the polarised epithelial phenotype (Miyoshi and Takai, 2005) and loss of 
apicobasal polarity is often observed during metastasis of cancer cells 
(Hanahan and Weinberg, 2011). Therefore, the disruption of claudin localisation 
to tight junctions caused by ESCRT-I depletion may perturb apicobasal polarity 
which, in turn, promotes migration of epithelial cells.  
 
Deregulated matrix metalloproteinases (MMP) activity may provide one 
potential mechanism for the enhanced migratory ability of Caco-2 cells upon 
Tsg101 knockdown. MMPs are a family of zinc-dependent endopeptidases 
which function in various different physiological processes such as tissue 
remodelling, development and inflammation (Kessenbrock et al., 2010). They 
are also important in pathological processes such as cancer and MMPs are 
upregulated in almost every type of human cancer (Egeblad and Werb, 2002; 
Kessenbrock et al., 2010). The role of MMPs in cancer cell invasion and 
metastasis has been well documented and is due to their ability to degrade a 
diverse group of substrates. These include structural components of the 
extracellular matrix (ECM), growth factor receptors and cell adhesion molecules 
which results in an alteration in cellular adhesion and signalling, therefore 
promoting cell migration and invasion (Egeblad and Werb, 2002).  
 
Several studies have identified a role for claudins in the regulation of MMP 
activity (Miyamori et al., 2001). Claudin-4 overexpression increases activity of 
MMP-2 and -9 which is accompanied by an increase in migration of Caco-2 
cells (Takehara et al., 2009). Overexpression of claudin-1 has also been shown 
to increase MMP activity and metastasis (Dhawan et al., 2005). In addition, 
decreased expression of claudins has been shown to promote cell migration 
and invasion via an increase in MMP activity (Osanai et al., 2007; Ikari et al., 
2011). Interestingly, in Drosophila ESCRT mutants, increased expression of 
MMP-1 was observed (Rodahl et al., 2009b; Vaccari et al., 2009; Lobert and 
Stenmark, 2011). Therefore, ESCRT depletion may increase MMP activity, 
possibly via disruption of claudin localisation, and this could then enhance the 
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migratory ability of Caco-2 cells. To investigate this further, it would be 
interesting to analyse MMP expression and activity in Caco-2 cells after ESCRT 
knockdown. 
 
It is also important to note that the increased rate of scratch closure observed 
for Tsg101 knockdown Caco-2 cells may be due to increased proliferation 
rather than enhanced migration. The assay was carried out in serum-free media 
in order to reduce cell proliferation, however, the migration assay could also be 
carried out in the presence of mitomycin c. This inhibits cell proliferation (Lee 
and Kay, 2006) and therefore, would confirm whether ESCRT-I depletion is 
enhancing migratory ability of Caco-2 cells independently of cell proliferation. 
 
4.3.3. Constitutive trafficking of tight junction proteins is a feature of 
Caco-2 cells 
 
The structure and function of tight junctions may contribute to the maintenance 
of a polarised epithelium (Brennan et al., 2010; Coradini et al., 2011). 
Therefore, it is crucial to understand the processes that regulate the 
maintenance of tight junctions in epithelial cells.  Cell-cell junctions are thought 
to be dynamic structures that are constantly being remodelled (Shen et al., 
2008; Steed et al., 2010). My data demonstrates that claudin-1 and occludin are 
constitutively endocytosed in unstimulated Caco-2 epithelial monolayers. 
Internalised claudin-1 is rapidly recycled back to the plasma membrane 
whereas the fate of occludin is split between recycling and degradation. This 
was also observed in 16-HBE cells, a human lung epithelial cell line (data 
shown in Dukes et al., 2011).  
 
Endocytosis of claudins and occludin has been demonstrated previously in 
vertebrate epithelial cells (Marzesco et al., 2002; Matsuda et al., 2004; 
Morimoto et al., 2005; Takahashi et al., 2009). Trafficking of tight junction 
proteins appears to be highly specific for each individual junctional component. 
For example, claudin-3 is selectively segregated and internalised independently 
from other tight junction proteins (Matsuda et al., 2004). Ubiquitylation of 
claudin-1 and occludin has been shown to be promoted by the specific E3 
ubiquitin ligases, LNX1p80 (Takahashi et al., 2009) and Itch (Traweger et al., 
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2002), respectively and, therefore, this may provide a mechanism for selective 
internalisation. In addition, the dynamics of tight junctions appear dependent on 
cell type. Inhibition of recycling altered the localisation of occludin in MTD-1A 
epithelial cells (Morimoto et al., 2005) whereas in MDCK cells, claudin-1 
localisation was affected (Marzesco et al., 2002).  
 
Therefore, my data provides further insight into our understanding of tight 
junction biology, supporting a model whereby stability of cell-cell junctions in 
epithelial monolayers is maintained by a balance between assembly and 
disassembly of junctions (Shen and Turner, 2008). This analysis could be 
widened to include other tight junction transmembrane proteins, such as 
different claudin family members, JAMs and marvelD3, as well as proteins 
present in adherens junctions and desmosomes. Regulation of cell-cell junction 
assembly and disassembly could also be studied in detail. EGF stimulation has 
been shown to regulate expression and localisation of specific junction proteins 
(Singh and Harris, 2004; Ikari et al., 2010) and ERK1/2 signalling has been 
shown to influence tight junction integrity and assembly (Aggarwal et al., 2011). 
In addition, phosphorylation of junctional proteins such as occludin appears to 
be important for tight junction assembly (Sakakibara et al., 1997). Therefore, it 
would be interesting to establish the mechanisms that regulate trafficking of 
junctional proteins and the importance of these pathways for assembly and 
disassembly of cell-cell junctions in vertebrate epithelial cells.  
 
4.3.4. ESCRT-I is required for continuous claudin-1 trafficking in Caco-2 
cells 
 
This study has identified a role for ESCRT-I in maintaining localisation of 
claudins to tight junctions in Caco-2 epithelial cells. However, the question still 
remains as to why this internal pool of claudin-1 and -4 accumulates in Tsg101 
depleted cells. It can be hypothesised that ESCRT-I is required for constitutive 
claudin-1 trafficking in Caco-2 cells. Depletion of ESCRT-I may specifically 
perturb claudin-1 trafficking to tight junctions and as a result an internal pool of 
claudin-1 accumulates. This intracellular accumulation could be due to an 
inhibition of claudin-1 recycling and/or degradation. Although ESCRT proteins 
have been classically characterised for their involvement in degradation of 
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membrane proteins (Hurley and Emr, 2006; Raiborg and Stenmark, 2009), it is 
also reported that ESCRT function is important for recycling (Yoshimori et al., 
2000; Fujita et al., 2003; Doyotte et al., 2005; Baldys and Raymond, 2009). 
Therefore, disruption of either of these pathways could explain the accumulation 
of claudin-1 observed upon Tsg101 knockdown. 
 
The majority of endocytosed claudin-1 was shown to be continuously recycled 
in Caco-2 epithelial monolayers, therefore, it is possible that depletion of 
ESCRT-I inhibits claudin-1 recycling. Endocytosis continues and so internalised 
claudin-1 accumulates over time. This has been demonstrated by additional 
data from our laboratory whereby disruption of ESCRT-III was shown to inhibit 
claudin-1 recycling in MDCK cells (Dukes et al., 2011). A similar inhibition of 
claudin-1 recycling in Caco-2 cells upon ESCRT-I depletion is difficult to show 
directly due to the experimental approach employed. ESCRT-III disruption in 
MDCK cells was achieved using adenoviral expression of a dominant negative 
ESCRT-III protein, CHMP31-179. This system resulted in expression in virtually 
all cells and caused disruption to the ESCRT machinery within a short time 
period of approximately 16 hours. In contrast, ESCRT-I depletion via siRNA 
knockdown of Tsg101 was achieved after 7 days. Claudin-1 accumulation 
presumably occurs steadily during this time and, therefore, a reduction in 
recycling over a 20 min period will be difficult to detect using the biotinylation 
assay. In addition, cells may adapt their trafficking pathways to compensate for 
the effects of ESCRT-I depletion. Therefore, an alternative approach to disrupt 
ESCRT-I in Caco-2 cells would be required in order to demonstrate a direct 
involvement of ESCRT-I in claudin-1 recycling.  
 
Conversely, the internal pool of claudin-1 observed upon ESCRT-I depletion in 
Caco-2 cells may be due to a block in lysosomal degradation. Using the 
biotinylation assay, significant degradation of endocytosed biotinylated claudin-
1 was not detected within 20 minutes. However, over a longer time period of 16 
- 24 hours, claudin-1 turnover was demonstrated. This has also been shown 
previously (Takahashi et al., 2009) and therefore it is possible that, while the 
majority of endocytosed claudin-1 is recycled, a small percentage is directed for 
degradation resulting in a gradual turnover of claudin-1 in Caco-2 cells. 
Perturbation of the degradative pathway via ESCRT disruption is well 
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documented (Doyotte et al., 2005; Razi and Futter, 2006; Raiborg and 
Stenmark, 2009; Stuffers et al., 2009b; Woodman, 2009), thus it is possible that 
Tsg101 knockdown inhibits degradation of claudin-1 and leads to intracellular 
accumulation over time. However, my results suggest that a block in claudin 
degradation is not the major cause of intracellular accumulation as total claudin-
1 levels were not increased following Tsg101 knockdown. Furthermore, claudin-
1 ubiquitylation, which targets proteins for degradation, was not observed. 
Therefore, this suggests that a block in claudin-1 degradation is not responsible 
for the majority of intracellular claudin-1 accumulation. 
 
To analyse this further, treatment with a lysosomal inhibitor, such as 
chloroquine, could be carried out to establish whether a similar effect on 
claudin-1 localisation is observed when lysosomal degradation is blocked. This 
may provide further insight into whether claudin-1 accumulation is likely to arise 
due to a block in its degradation. However, the time frame may not be 
comparable with that used to efficiently knockdown Tsg101 as prolonged 
lysosomal inhibition is likely to be cytotoxic. In addition, cycloheximide treatment 
could be carried out on ESCRT-I depleted cells to block protein synthesis. 
Comparison of claudin-1 levels between control and Tsg101 knockdown cells 
would then indicate whether claudin-1 turnover can occur after ESCRT-I 
depletion.   
 
In summary, it is likely that the intracellular accumulation of claudin-1 observed 
upon ESCRT-I depletion is due to inhibition of both claudin-1 recycling and 
degradation. In support of this, the intracellular pool of claudin-1 in Tsg101 
knockdown cells localises to a compartment/s positive for markers of recycling, 
early and late endosomes as well as lysosomes. My results, along with 
additional data generated in our laboratory, strongly suggest that ESCRT-I 
function is required for the constitutive recycling of claudin-1 in Caco-2 cells. 
Therefore, it is hypothesised that the majority of claudin-1 accumulation in 
ESCRT-I depleted cells is due to a block in claudin-1 recycling. However, long 
term turnover of claudin-1 may also be dependent on a functional ESCRT 
machinery.   
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4.3.5. Variation between claudin-1 and occludin trafficking in Caco-2 
cells 
 
The intracellular accumulation of claudin-1 caused by ESCRT-I depletion can 
be explained by an inhibition of claudin-1 trafficking through the endocytic 
system. However, occludin is also continuously endocytosed in Caco-2 cells but 
does not accumulate after Tsg101 knockdown. This may indicate that occludin 
and claudin-1 are following independent endocytic trafficking routes. In support 
of this, the dynamics of claudin-1 and occludin trafficking in Caco-2 cells are 
different. The majority of endocytosed claudin-1 is recycled, whereas the fate of 
endocytosed occludin is split between recycling and degradation, suggesting 
that these two proteins are following distinct endosomal pathways. Trafficking of 
claudin-1 requires ESCRT function whereas occludin may follow an ESCRT-
independent trafficking pathway. There are a number of independent recycling 
pathways (Grant and Donaldson, 2009; Golachowska et al., 2010) and 
polarised epithelial cells contain a number of distinct recycling compartments 
(Hoekstra et al., 2004; Weisz and Rodriguez-Boulan, 2009). Therefore, it is 
possible that claudin-1 is returned to the plasma membrane by a pathway 
requiring ESCRT function and this is distinct from that used to recycle occludin.  
 
It is interesting that occludin accumulation is not observed upon ESCRT-I 
depletion despite the fact that some of the endocytosed occludin is directed for 
degradation. ESCRT proteins have an established role within the endosomal 
degradative pathway (Doyotte et al., 2005; Razi and Futter, 2006; Raiborg and 
Stenmark, 2009; Stuffers et al., 2009b; Woodman, 2009), however, the majority 
of studies into ESCRT function are conducted in non-polarised cells. Polarised 
epithelial cells contain additional endosomal compartments and endocytic 
trafficking is thought to be more complex (Hoekstra et al., 2004; Mellman and 
Nelson, 2008; Farr et al., 2009; Folsch et al., 2009; Weisz and Rodriguez-
Boulan, 2009). Therefore, there may be additional degradative routes in Caco-2 
cells which are independent of ESCRT function. This is supported by my 
previous results demonstrating that EGF degradation is not significantly 
inhibited in ESCRT depleted Caco-2 cells (Chapter 3, section 3.2.2), suggesting 
that trafficking to lysosomes can occur independently of ESCRTs.   
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4.4. Conclusion 
 
Altered epithelial junctions are associated with a wide range of pathological 
conditions, such as cancer and inflammatory bowel diseases (Yang and 
Weinberg, 2008; Yu and Turner, 2008; Capaldo and Nusrat, 2009; Brennan et 
al., 2010). Therefore, a thorough understanding of cell-cell junction formation, 
maintenance and remodelling is crucial. My data begins to elucidate some of 
the mechanisms important for regulation of epithelial junctions and suggests a 
role for ESCRT-I in this process. The tight junction proteins, claudin-1 and 
occludin, are constitutively endocytosed and recycled in Caco-2 epithelial 
monolayers. Depletion of ESCRT-I in Caco-2 cells results in mislocalisation of 
claudins from tight junctions to an intracellular endocytic compartment/s. 
Therefore, I propose that claudin-1 recycling is dependent on ESCRT-I function 
and that this provides a mechanism for the intracellular accumulation of claudin-
1 observed upon ESCRT-I depletion in Caco-2 cells.  
 
In addition, ESCRT-I is required for Caco-2 epithelial barrier formation. This 
may be an effect of claudin mislocalisation and suggests that tight junction 
integrity is impaired. Tight junctions are thought to be important for maintenance 
of a polarised epithelium (Brennan et al., 2010; Coradini et al., 2011) and 
therefore destabilisation may contribute to the loss of Caco-2 cell organisation 
and polarity observed upon ESCRT-I depletion. Finally, ESCRT-I depletion 
enhances Caco-2 cell migratory ability. This data, together with previous results 
demonstrating a requirement of ESCRTs in maintenance of epithelial cell 
polarity, provides further support for a role of ESCRT proteins as tumour 
suppressors in vertebrates.  
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5. Multilayered Tsg101 depleted Caco-2 cells are 
eliminated by apoptosis 
 
5.1. Introduction 
 
5.1.1. ESCRTs and Epithelial Cell Proliferation 
 
Cell proliferation is a tightly regulated process (King and Cidlowski, 1998). 
Disruption to any number of important regulatory pathways can trigger 
uncontrolled cell growth, a hallmark of tumourigenesis (Hanahan and Weinberg, 
2011). A role for ESCRT proteins in epithelial cell proliferation has been 
demonstrated previously in Drosophila. Mutation of various components of the 
ESCRT machinery in epithelial tissues results in increased proliferation (Moberg 
et al., 2005; Thompson et al., 2005; Vaccari and Bilder, 2005; Herz et al., 2006; 
Herz et al., 2009; Rodahl et al., 2009b; Vaccari and Bilder, 2009; Vaccari et al., 
2009). When epithelial tissues are predominantly mutant for ESCRT 
components, mutant cells lose polarity and overgrow to form large masses 
lacking normal epithelial morphology. The resulting mutant larvae are enlarged 
and eventually die. This neoplastic growth is thought to be due to an extended 
period of proliferation rather than an increased growth rate and suggests that 
ESCRT mutant cells are unable to respond to signals which usually sense and 
restrict organ size (Moberg et al., 2005; Vaccari and Bilder, 2005; Herz et al., 
2009; Vaccari et al., 2009).  
 
However, in mosaic epithelial tissues where mutant cells are surrounded by wild 
type cells, the situation is somewhat different. ESCRT mutant cells still lose 
epithelial polarity and organisation but do not overproliferate. Instead increased 
proliferation of surrounding wild type cells is observed, despite these cells 
displaying a normal epithelial morphology (Moberg et al., 2005; Thompson et 
al., 2005; Vaccari and Bilder, 2005; Herz et al., 2006; Herz et al., 2009; Rodahl 
et al., 2009b; Vaccari and Bilder, 2009; Vaccari et al., 2009). This hyperplastic 
growth is attributed to a block in Notch trafficking within ESCRT mutant cells. 
Consequently Notch accumulates within large aberrant endosomes, is activated 
and results in ectopic production of the secreted growth factor, Unpaired (Upd). 
173 
 
This then induces proliferation of surrounding wild type cells via activation of the 
Jak-STAT signalling pathway (Thompson et al., 2005; Vaccari and Bilder, 2005; 
Herz et al., 2006; Herz et al., 2009; Gilbert et al., 2009; Vaccari et al., 2009).  
 
Another mechanism by which ESCRT disruption could influence cell growth is 
through aberrant receptor tyrosine kinase (RTK) signalling. For example, 
ESCRTs have been identified as important regulators of epidermal growth 
factor receptor (EGFR) signalling (Vaccari and Bilder, 2009; Woodman, 2009). 
In both Drosophila and vertebrates, ESCRT proteins are required for the 
degradation of EGFR and attenuation of EGF-induced signalling (Jekely and 
Rorth, 2003; Bache et al., 2006; Lloyd et al., 2006; Malerod et al., 2007; 
Raiborg et al., 2008; Vaccari et al., 2009). Increased RTK signalling can induce 
overproliferation and is often linked to tumourigenesis (Kim and Choi, 2010) and 
therefore this may contribute to the overgrowth associated with ESCRT 
disruption in Drosophila. 
 
In contrast to the studies conducted in Drosophila, mouse models have 
demonstrated a reduction in proliferation upon ESCRT disruption (Ruland et al., 
2001; Wagner et al., 2003). However, the role of ESCRT proteins in growth of 
vertebrate epithelial tissues has not been analysed in detail. Therefore, it is of 
interest to determine if ESCRTs are important for the regulation of epithelial cell 
proliferation in mammalian cells and whether this could contribute to their role 
as tumour suppressors. 
 
5.1.2. ESCRTs and Cell Death 
 
In addition to the role of ESCRTs proteins in cell proliferation, ESCRTs have 
also been implicated in the process of apoptosis. Apoptosis is a highly regulated 
mechanism of programmed cell death, important for many physiological 
processes and often deregulated in cancer (Pettigrew and Cotter, 2009; Ola et 
al., 2011).  In Drosophila, Vps25 mutation has been shown to increase levels of 
Diap1, an inhibitor of apoptosis, in wild type cells surrounding ESCRT mutant 
clones (Herz et al., 2006). Therefore, loss of ESCRT function may confer 
apoptotic resistance and enhance the survival of surrounding wild type tissue.  
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However, a more commonly reported consequence of ESCRT mutation is the 
proapoptotic response. Loss of ESCRT-I function has been shown to induce cell 
death of mouse mammary epithelial cells, both in vivo and in vitro (Wagner et 
al., 2003). Consistent with this, in Drosophila, if ESCRT mutant cells are 
surrounded by wild type cells, the mutant cells are eventually eliminated from 
the epithelium via an increase in apoptosis (Thompson et al., 2005; Herz et al., 
2006; Rodahl et al., 2009b). This means that the resulting enlarged tissue is 
mainly comprised of wild type cells. Studies have demonstrated that this 
apoptosis is induced by at least two pathways, one mediated by JNK signalling 
and another mediated by Hid/Diap1/Dronc/Ark (Herz et al., 2006; Rodahl et al., 
2009b; Vaccari and Bilder, 2009). In addition, Hippo signalling has been 
suggested to function as an upstream regulator of the overall proapoptotic 
response observed in ESCRT mutant cells (Herz et al., 2006). Interestingly, if 
apoptosis of ESCRT mutant cells is inhibited a dramatic overproliferation of 
mutant tissue is observed resulting in the formation of neoplastic tumours 
capable of metastasis (Thompson et al., 2005; Herz et al., 2006; Rodahl et al., 
2009b). 
 
5.1.3. A Role for ESCRT Proteins as Tumour Suppressors 
 
Previous studies suggest that the ESCRT machinery is required for trafficking of 
important regulators of epithelial cell polarity and proliferation in Drosophila 
(Vaccari and Bilder, 2009). In this model system, disruption of the ESCRT 
machinery can lead to loss of cell polarity and self-sufficiency in growth 
signalling, two important hallmarks of cancer (Hanahan and Weinberg, 2011). 
Therefore, ESCRT proteins have been classified as potential tumour 
suppressors. Consistent with these studies, I have shown that ESCRT-I is 
required for maintenance of mammalian epithelial cell polarity and organisation. 
I have demonstrated that this phenotype may be due to disruption in trafficking 
of cell-cell junction proteins which may be important for maintaining a polarised 
epithelium. Therefore, the tumour suppressor role of ESCRTs may be 
conserved from Drosophila to vertebrates. However, it is likely that further 
alterations in cell physiology, such as evasion of apoptosis, are required in 
order to exert the full tumourigenic potential of the ESCRT machinery. 
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5.1.4. Aims 
 
In addition to the defects in epithelial cell-cell junctions, it is also possible that 
alterations in proliferation and/or cell death contribute to the aberrant epithelial 
morphology observed upon ESCRT-I depletion. Therefore, the aims of this 
chapter are to determine whether Tsg101 and Vps25 siRNA knockdown affects 
Caco-2 cell proliferation and apoptosis. In addition, the effect of inhibiting 
apoptosis in Tsg101 depleted Caco-2 cells will be investigated. 
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5.2. Results 
 
5.2.1. ESCRT-I depletion results in overproliferation of Caco-2 cells 
 
The effect of ESCRT depletion on Caco-2 cell number was assessed using a 
MTT assay. This assay measures the metabolic conversion of MTT to 
formazan. Absorbance of the resulting formazan solution has a linear 
relationship to cell number and therefore can be used to indicate changes in cell 
number over time (data not shown). Results demonstrated that absorbance 
increased over time in control and ESCRT knockdown cell cultures, suggesting 
that Caco-2 cell number increased over time in culture. However, the 
absorbance measurements for Tsg101 knockdown cells appeared to increase 
at a faster rate and, after 7 days, absorbance was significantly increased 
compared to control (Figure 5.1A).  This suggests that Tsg101 depletion results 
in an increase in Caco-2 cell number. Caco-2 cell number was also analysed by 
counting cells using confocal fluorescence microscopy (Figure 5.1B). This 
demonstrated that increased cell number was only found in multilayered regions 
of Tsg101 knockdown cells. In monolayered regions of Tsg101 depleted cells, 
there seemed to be a slight decrease in cell number although this difference 
was not statistically significant. This may correspond to the reduced 
differentiation of Tsg101 knockdown cells shown previously (Chapter 3, section 
3.2.4) as cells may not be as tightly packed as in control. In contrast, Vps25 
knockdown had no effect on cell number, demonstrated by both the MTT assay 
and fluorescence microscopy cell counting (Figure 5.1A+B).   
 
Despite this significant increase in cell number after Tsg101 knockdown, there 
was no significant increase in the proportion of phosphorylated Histone H3-
positive Tsg101 knockdown cells (Figure 5.2A). Histone H3 is phosphorylated 
during mitosis and therefore this suggests that after 7 days culture, proliferation 
of Tsg101 knockdown cells was similar to control. This was also demonstrated 
by quantifying BrdU (Bromodeoxyuridine) incorporation in Tsg101 depleted cells 
(Figure 5.2B). BrdU is a synthetic analogue of thymidine which can be 
incorporated into newly synthesised DNA during S phase of the cell cycle. It is 
therefore used to indicate the proportion of cells which have divided during a set 
time period. Results indicated that after Tsg101 knockdown, BrdU incorporation 
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Figure 5.1 Caco-2 cell number increases upon Tsg101 knockdown. (A) Caco-2 cells were 
transfected with either Non-Targeting Control siRNA, Tsg101 siRNA, or Vps25 siRNA and 
incubated for 1, 3, 7 and 10 d. At each timepoint the MTT assay was carried out, used as a 
measure of cell number. Cells were incubated with MTT and metabolic conversion of MTT to 
formazan was measured by reading absorbance at 570nm. After 7 d Tsg101 knockdown Caco-
2 absorbance is significantly increased compared with control. Vps25 knockdown has no effect. 
(B) Caco-2 cells were transfected with either Non-Targeting Control siRNA, Tsg101 siRNA, or 
Vps25 siRNA and incubated for 7 d. Cells were fixed and nuclei were stained using DAPI. Cells 
were examined by confocal fluorescence microscopy and z-stack images were taken at 
random. Cell number was quantified by counting individual nuclei in each image using ImageJ. 
Six images were taken per condition and, for Tsg101 knockdown cells regions were 
distinguished as either monolayerd or multilayered. Tsg101 knockdown increases Caco-2 cell 
number due to regions of multilayered cells. Vps25 knockdown has no effect. Data shown are 
the means ± standard error of at least three independent experiments. Results were analysed 
using a one-way ANOVA and Dunnett’s post test, *** p<0.001. 
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Figure 5.2 Rate of Caco-2 cell proliferation is not increased after 7 day Tsg101 
knockdown. (A) Caco-2 cells were transfected with Non-Targeting Control siRNA or Tsg101 
siRNA and incubated for 7 d. Cells were fixed and examined by confocal fluorescence 
microscopy for phosphorylated Histone H3 (red). Nuclei were stained using DAPI. Number of p-
Histone H3-positive cells was quantified using ImageJ and represented as a percentage of total 
cell number. The proportion of dividing Caco-2 cells is not affected by Tsg101 knockdown. (B)  
Caco-2 cells were transfected with Non-Targeting Control siRNA or Tsg101 siRNA and 
incubated for 7 d. BrdU was added to the media on day 6 for 24 h. Cells were fixed and 
examined by confocal fluorescence microscopy for BrdU (green). Nuclei were stained using 
DAPI. Number of BrdU-positive cells was quantified using ImageJ and represented as a 
percentage of total cell number. BrdU incorporation is not significantly altered in monolayered 
regions of Tsg101 knockdown cells whereas multilayered regions show a reduction in BrdU 
labelling. For each experiment, six images were taken at random per condition and, for Tsg101 
knockdown cells regions were distinguished as either monolayerd or multilayered. An example 
image is shown with the graphical representation of the data. Bar, 10µm. Data shown are the 
means ± standard error of at least three independent experiments. Results were analysed using 
a one-way ANOVA and Dunnett’s post test, * p<0.05. 
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was not significantly increased between 6 and 7 days cell culture (Figure 5.2B). 
However, the proportion of BrdU-positive cells did show a slight increase in 
monolayered regions of Tsg101 knockdown cells suggesting that a slightly 
higher proportion of these cells divided over 24 h compared with control.  
  
In contrast, multilayered regions of Tsg101 knockdown cells displayed a 
significant reduction in BrdU incorporation (Figure 5.2B). In addition, Histone H3 
phosphorylation appeared slightly reduced, although this was not statistically 
significant (Figure 5.2A). This demonstrates that after 7 days culture, 
proliferation is reduced in multilayered areas of Tsg101 depleted cells. It is also 
important to note that between 7 and 10 days of Tsg101 knockdown cell culture, 
there was a reduction in cell number (Figure 5.1A). As a result, after 10 days 
the number of Tsg101 knockdown cells was similar to control. This may be due 
to an increase in cell death and will be analysed later.  
 
5.2.2. ERK1/2 signalling is not increased after ESCRT-I depletion 
 
Cell proliferation can be regulated by various mitogenic signalling pathways, 
such as the extracellular signal-regulated kinase (ERK) pathway. The ERK 
signal transduction pathway is a mitogen-activated protein kinase (MAPK) 
pathway which functions in proliferation, differentiation and survival and is often 
deregulated during tumourigenesis (Kim and Choi, 2010). ERK signalling can 
be mediated by EGFR activation and ESCRTs have been identified as 
important regulators of this signalling pathway (Jekely and Rorth, 2003; Bache 
et al., 2006; Lloyd et al., 2006; Malerod et al., 2007; Raiborg et al., 2008; 
Vaccari et al., 2009). Therefore, it is possible that the increased numbers of 
Tsg101 knockdown cells is due to altered ERK signalling. The ERK pathway 
can be stimulated by EGF which results in the phosphorylation of ERK1/2. This 
was detected via immunofluorescence confocal microscopy using an antibody 
specific to the phosphorylated form of ERK1/2 (p-ERK1/2) (Figure 5.3A). 
However, levels of p-ERK1/2 were similar in control and Tsg101 knockdown 
Caco-2 cells (Figure 5.3B). This suggests that the ERK pathway was not 
perturbed in Tsg101 knockdown cells after 7 days culture and argues that the 
overproliferation is not due to altered ERK signalling.   
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Figure 5.3 Tsg101 knockdown does not appear to alter ERK1/2 activation in Caco-2 cells. 
(A) To test the efficiency of the phosphorylated Erk1/2 (p-Erk1/2) antibody, Caco-2 cells were 
incubated with 500ng/ml EGF for 10 min or mock treated. Cells were fixed and examined by 
confocal fluorescence microscopy for p-Erk1/2 (green). Nuclei were stained using DAPI. p-
Erk1/2 levels increase after EGF treatment. (B) Caco-2 cells were transfected with Non-
Targeting Control siRNA or Tsg101 siRNA and incubated for 7 d. Cells were fixed and 
examined by confocal fluorescence microscopy for p-Erk1/2 (green). Nuclei were stained using 
DAPI. Tsg101 knockdown has no discernible effect on activation of Erk1/2. Bar, 10µm. 
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5.2.3. Tsg101 depleted Caco-2 cells are eliminated by apoptosis  
 
As cell number appeared to decrease when Tsg101 depleted cells were 
cultured for longer than 7 days (Figure 5.1A), the level of cell death after 
ESCRT knockdown was investigated. Active caspase-3 was used as a marker 
of apoptotic cells and cells were analysed via immunofluorescence confocal 
microscopy. The proportion of apoptotic cells was significantly increased in 
multilayered regions of Tsg101 knockdown Caco-2 cells (Figure 5.4A). Tsg101 
knockdown cells which retained their monolayered organisation and Vps25 
knockdown cells displayed a similar level of active caspase-3 staining to control. 
Further analysis of Tsg101 knockdown cells demonstrated that the apoptotic 
cells were mostly located at the apical side of the multilayered epithelial sheet 
(Figure 5.4B).  
 
An increase in cell death was also observed in Drosophila ESCRT mutants and 
this was attributed to an increase in JNK signalling (Herz et al., 2006; Rodahl et 
al., 2009b). However, JNK activation was not observed 3, 7 or 10 days after 
Tsg101 knockdown in Caco-2 cells (Figure 5.4C).  
 
5.2.4. Inhibition of apoptosis may enhance the multilayered phenotype of 
Tsg101 depleted Caco-2 cells 
 
In Drosophila ESCRT mutants, inhibition of apoptosis resulted in a dramatic 
overproliferation of ESCRT mutant cells to form neoplastic tumours (Thompson 
et al., 2005; Herz et al., 2006; Rodahl et al., 2009b). As a similar increase in 
apoptosis was observed in Caco-2 cells after Tsg101 depletion, the effect of 
inhibiting cell death was investigated. A general caspase inhibitor was used 
which effectively reduced the number of caspase-3 positive cells after 7 and 10 
days culture (Figure 5.5A). Initial results demonstrated that caspase inhibition 
had no effect on the number of Tsg101 knockdown cells after 7 days culture 
(Figure 5.5B, ‘7d Knockdown’). However, after 10 days culture the number of 
Tsg101 knockdown cells dramatically increased after caspase inhibition (Figure 
5.5B, ‘10d Knockdown’). In addition, caspase inhibition appeared to enhance 
the degree of multilayering observed upon Tsg101 knockdown after 10 days 
culture (Figure 5.5C).  
185 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Cell death is increased in multilayered regions of Tsg101 knockdown Caco-2 
cells. (A) Caco-2 cells were transfected with either Non-Targeting Control siRNA, Tsg101 
siRNA or Vps25 siRNA and incubated for 7 d. Cells were fixed and examined by confocal 
fluorescence microscopy for active caspase-3. Nuclei were stained using DAPI. Number of 
caspase-3 positive cells was quantified using ImageJ and represented as a percentage of total 
cell number. Six images were taken at random per condition and, for Tsg101 knockdown cells 
regions were distinguished as either monolayerd or multilayered. Cell death is increased in 
multilayered regions of Tsg101 knockdown cells whereas in monolayered regions and Vps25 
knockdown cells, the level of cell death is similar to control. Data shown are the means ± 
standard error of at least three independent experiments. Results were analysed using a one-
way ANOVA and Dunnett’s post test, * p<0.05. (B) A representative image of active caspase-3 
(green) staining in a multilayered region of Tsg101 knockdown Caco-2 cells. Nuclei were 
stained with DAPI (blue). A confocal projection is displayed in the xy plane (top) and z plane 
(bottom). Active caspase-3 positive cells are found apically in the multilayered Caco-2 epithelial 
sheet. Bar, 10µm. (C) Caco-2 cells were transfected with either Non-Targeting Control siRNA 
(C), Tsg101 siRNA (T), or Vps25 siRNA (V) and incubated for 3, 7 or 10 d. Lysates were 
immunoblotted for phosphorylated JNK (p-JNK) and total JNK as a loading control. A lysate 
from UV treated Caco-2 cells was used as a positive control for JNK activation. Tsg101 and 
Vps25 knockdown does not result in an increase in p-JNK in Caco-2 cells.  
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In the absence of caspase inhibition, after 10 days Tsg101 knockdown total cell 
number was similar to control (Figure 5.5B, ‘10d Knockdown’) and the extent of 
multilayering was reduced (Figure 5.5C, top panels) compared with the 
phenotype observed after 7 days (see previous results, Chapter 3, Figure 3.7). 
This indicates that after extended culture, cells in multilayered regions are 
eliminated via apoptosis and may explain results from the MTT assay shown 
previously (Figure 5.1A). If apoptosis is inhibited it seems that Caco-2 cells 
continue to proliferate and multilayering is enhanced. It is important to note that 
these results were generated from one initial experiment and therefore, will 
need to be confirmed with further work. 
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Figure 5.5 Caspase inhibition enhances the multilayering of Tsg101 knockdown Caco-2 
cells. Caco-2 cells were transfected with Non-Targeting Control siRNA or Tsg101 siRNA and 
incubated for total of 7 or 10 d. The pan-caspase inhibitor (Q-VD-OPh) was added to cells on 
day 4 and day 7. DMSO controls were carried out alongside. Cells were fixed and examined by 
confocal fluorescence microscopy for active caspase-3. Nuclei were stained using DAPI. (A) 
The number of caspase-3 positive cells was quantified using ImageJ and represented as a 
percentage of total cell number. Caspase-3 activation is reduced upon addition of the general 
caspase inhibitor. (B) Total cell number was quantified using ImageJ. Caspase inhibition 
dramatically increases the number of Tsg101 knockdown Caco-2 cells after 10 d culture. For 
quantification, six images were taken at random per condition. Note that separation of Tsg101 
knockdown cells into monolayered and multilayered regions was not carried out. Data shown 
are the means from one preliminary experiment. (C) Representative images of Caco-2 cells with 
and without caspase inhibition 10 d after knockdown with Non-Targeting Control or Tsg101 
siRNA. The multilayered phenotype of Tsg101 knockdown Caco-2 cells is enhanced upon 
caspase inhibition. Confocal projections and corresponding z-sections (indicated by dotted line) 
are displayed. Bar, 10µm. 
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5.3. Discussion 
 
This study sought to investigate the effect of ESCRT depletion on Caco-2 cell 
growth. I have previously demonstrated that ESCRT-I depleted Caco-2 cells 
form multilayered epithelial sheets (discussed in Chapter 3). Disruption of 
ESCRT function has been shown to cause overproliferation in Drosophila 
(Moberg et al., 2005; Thompson et al., 2005; Vaccari and Bilder, 2005; Herz et 
al., 2006; Herz et al., 2009; Rodahl et al., 2009b; Vaccari et al., 2009). 
Therefore, it is possible that formation of Caco-2 cell multilayers is due to an 
increase in proliferation. In addition, studies in Drosophila found that in mosaic 
epithelial tissues, ESCRT mutant cells were eventually eliminated via apoptosis 
and if this was inhibited neoplastic tumours formed (Thompson et al., 2005; 
Herz et al., 2006; Rodahl et al., 2009b). Thus, the effect of ESCRT depletion on 
apoptosis was also analysed in Caco-2 cells. My results demonstrate that Caco-
2 cell number increases after Tsg101 depletion. There is also an increase in 
apoptosis of Tsg10 depleted Caco-2 cells, however this is observed within 
multilayered regions only. Finally, inhibition of apoptosis appears to enhance 
the multilayered phenotype of Tsg101 depleted Caco-2 cells suggesting that 
inhibition of cell death is required in order to demonstrate the full tumourigenic 
potential of ESCRT-I depletion. 
 
5.3.1. Caco-2 cells overproliferate upon ESCRT-I depletion 
 
ESCRT-I depletion appeared to result in overproliferation of Caco-2 cells. After 
7 days culture of Tsg101 knockdown cells, there was a significant increase in 
the metabolic conversion of MTT suggesting that cell number was increased. 
Counting cells manually using immunofluorescence confocal microscopy 
indicated that an increase cell number was observed in the multilayered regions 
of Tsg101 knockdown cells only. In contrast, a reduction in BrdU incorporation 
was observed in these multilayered regions of Tsg101 knockdown cells 
suggesting that cell division in these areas is reduced. However, at this 
timepoint apoptosis of multilayered cells is increased and therefore, this may 
inhibit any further proliferation. Therefore, analysis of Tsg101 knockdown cells 
at earlier timepoints is required in order to investigate whether proliferation is 
enhanced in certain areas of the epithelial sheet. This may then suggest that 
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increased proliferation of ESCRT-I depleted cells results in the formation of 
multilayered regions of the Caco-2 epithelial sheet.  
 
Interestingly, in Tsg101 knockdown cells which retained their monolayered 
organisation there was also no significant increase in the proportion of dividing 
cells 7 days after knockdown. However, the largest increase in cell number 
appears to occur between 3 and 7 days after Tsg101 knockdown and therefore, 
it is possible that the most substantial increase in cell division occurs at an 
earlier timepoint. It is also possible that the MTT assay is misleading as the 
metabolic activity of Caco-2 cells may be affected by the differentiation status of 
the cell culture. I have previously shown that Tsg101 knockdown results in 
reduced Caco-2 cell differentiation. Undifferentiated cells may have higher 
metabolic activity and therefore, the large increase in metabolic conversion of 
MTT may not accurately represent a proportional increase in cell number. 
Therefore, a thorough analysis of Caco-2 cell division is required in order to 
establish whether Tsg101 knockdown causes a significant increase in Caco-2 
cell proliferation. Fluorescence-activated cell sorting (FACS) analysis could be 
conducted at various timepoints after Tsg101 knockdown in order to quantify 
the proportion of cells undergoing cell division.  
 
Studies in Drosophila have demonstrated that ESCRT mutation results in 
overproliferation of epithelial cells. However, the mechanism behind this 
overproliferation varies depending on the tissue context surrounding the ESCRT 
mutant cells. When epithelial tissues are predominantly mutant for ESCRT 
components, mutant cells lose polarity and overgrow to form large masses 
lacking normal epithelial morphology. This neoplastic growth is thought to be 
due to an extended period of proliferation rather than an increased growth rate 
(Moberg et al., 2005; Vaccari and Bilder, 2005; Herz et al., 2009; Vaccari et al., 
2009). Caco-2 cells are known to undergo contact inhibition whereby when cells 
reach confluency they reduce proliferation rate and begin to differentiate 
(Nelson and Daniel, 2002; Volpe, 2008). It is possible that ESCRT-I depletion 
inhibits contact inhibition and, as a result, cells continue proliferating for an 
extended period of time. In support of this, I have previously demonstrated that 
differentiation of Caco-2 cells is reduced upon Tsg101 knockdown. This may 
suggest that cells cannot sense their environment correctly and continue to 
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divide instead of initiating the differentiation process. One mechanism which is 
important for the regulation of cell contact inhibition and organ size control is the 
Hippo signalling pathway (Zeng and Hong, 2008). Hippo signalling is 
deregulated in Drosophila Vps25 mutants (Herz et al., 2006) suggesting that 
ESCRTs are important for regulation of this pathway. The core components of 
the Hippo pathway are conserved in mammals (Dong et al., 2007; Zeng and 
Hong, 2008), and therefore aberrant Hippo signalling may provide a mechanism 
for the overproliferation of Tsg101 depleted Caco-2 cells and warrants further 
investigation. 
 
On the other hand, if Drosophila ESCRT mutant cells are surrounded by wild 
type cells, mutant cells still lose epithelial polarity and organisation but do not 
overproliferate. Instead increased proliferation of surrounding wild type cells is 
observed which has been attributed to an increase in Notch induced signalling 
(Thompson et al., 2005; Vaccari and Bilder, 2005; Herz et al., 2006; Herz et al., 
2009; Gilbert et al., 2009; Vaccari et al., 2009). Using a siRNA knockdown 
approach, Tsg101 depletion should be induced in almost all Caco-2 cells. 
However, it is impossible to know whether the extent of knockdown is uniform 
across all transfected cells or whether some cells show a higher level of 
knockdown compared to others. Therefore, overproliferation of ESCRT-I 
depleted Caco-2 cells may be induced via multiple mechanisms and the effect 
on the regulation of cell proliferation may depend on the extent of Tsg101 
knockdown. Further work could be carried out to establish whether the Notch 
signalling pathway is affected by ESCRT-I depletion. Notch protein levels and 
localisation could be analysed using immunoblotting and immunofluorescence 
microscopy, respectively. Notch activity could be investigated by analysing 
downstream effectors of the Notch signalling pathway, such as activation of 
Jak-STAT signalling. In addition, a Notch inhibitor could be applied to ESCRT 
depleted cells in order to investigate whether this prevents the formation of 
multilayered regions.  
 
Finally, aberrant receptor tyrosine kinase (RTK) signalling could result in 
overproliferation of Tsg101 depleted Caco-2 cells. ESCRTs have been 
identified as important regulators of epidermal growth factor receptor (EGFR) 
signalling in both Drosophila and vertebrates (Jekely and Rorth, 2003; Bache et 
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al., 2006; Lloyd et al., 2006; Malerod et al., 2007; Raiborg et al., 2008; Vaccari 
et al., 2009).  Activation of EGFR can induce signalling via various MAPK 
pathways, including the ERK signalling pathway. No increase in ERK1/2 
activation was detected 7 days after Tsg101 knockdown suggesting that the 
ERK1/2 signalling pathway is not upregulated in ESCRT-I depleted cells. This 
could be confirmed by immunoblotting, using additional timepoints. Analysis of 
other signalling pathways important for cell proliferation could also be 
conducted using additional timepoints after Tsg101 knockdown in order to 
establish the mechanism of overproliferation. 
 
5.3.2. ESCRT-I depleted Caco-2 cells are eventually eliminated via 
apoptosis 
 
Apoptosis of ESCRT-I depleted Caco-2 cells is increased 7 days after siRNA 
knockdown. This supports previous studies in both Drosophila and mice models 
which demonstrate an increase in cell death upon disruption of the ESCRT 
machinery (Wagner et al., 2003; Thompson et al., 2005; Herz et al., 2006; 
Rodahl et al., 2009b). In Drosophila, this was attributed in part to an increase in 
JNK signalling (Herz et al., 2006; Rodahl et al., 2009b), however in this study 
apoptosis of Tsg101 depleted Caco-2 cells appears to be JNK-independent. 
This could be confirmed by analysing active JNK levels via immunofluorescence 
as a small increase in activity in multilayered cells may not be detected using 
immunoblotting. It is possible that in Caco-2 cells ESCRT-I depletion triggers 
apoptosis via another mechanism. Activation of the Hid/Diap1/Dronc/Ark 
proapoptotic pathway has also been demonstrated in Drosophila ESCRT 
mutants (Herz et al., 2006). This pathway is similar to the intrinsic (or 
mitochondrial) pathway of apoptosis in vertebrates and Diap1, Dronc and Ark 
are homologues of vertebrate inhibitor of apoptosis proteins (IAPs), initiator 
caspase-9 and APAF-1, respectively (Oberst et al., 2008; Steller, 2008). The 
intrinsic pathway is extremely important for regulation of cell death in 
mammalian cells (Kroemer et al., 2007; Martinou and Youle, 2001) and 
therefore it would be of interest to determine whether this pathway plays a role 
in the apoptosis of ESCRT-I depleted Caco-2 cells. Mitochondrial outer 
membrane permeabilisation (MOMP) could be investigated as this is often 
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considered to be the point-of-no-return for the intrinsic pathway of apoptosis as 
well as other models of programmed cell death (Galluzzi et al., 2007).  
 
In addition, Hippo signalling has been suggested to control the overall apoptotic 
response in Drosophila ESCRT mutants (Herz et al., 2006; Vaccari and Bilder, 
2009). Therefore, this pathway may also be activated in ESCRT depleted Caco-
2 cells and it would be interesting to investigate this further in future studies. In 
addition to cell death, Hippo signalling is important for a wide range of cellular 
processes including cell proliferation and polarity (Genevet and Tapon, 2011; 
Halder and Johnson, 2011). Therefore, this represents a potential mechanism 
to link the apoptotic, proliferative and polarity defects observed upon disruption 
of the ESCRT machinery in epithelial cells (Vaccari and Bilder, 2009). 
 
Alternatively, apoptosis of Caco-2 cells may be induced by loss of cellular 
contacts. Caspase-3 activation was only detected in multilayered areas of 
Tsg101 knockdown cells where cell-cell adhesion and cellular contact with the 
extracellular matrix (ECM) may be perturbed. Loss of or inappropriate cell 
adhesion can induce a specific type of apoptosis termed anoikis (Gilmore, 2005; 
Chiarugi and Giannoni, 2008). ECM receptors of the integrin family play an 
important role in the process of anoikis. Not only do they provide a physical 
attachment to the ECM but they also activate several pro-survival signalling 
pathways (Gilmore, 2005; Chiarugi and Giannoni, 2008). In addition, growth 
factor receptors and cadherin-mediated cell-cell contacts also promote cell 
survival (Chiarugi and Giannoni, 2008). Lack of ECM or cell-cell contacts 
removes pro-survival signalling activation thereby inducing anoikis. Anoikis can 
be triggered by both the intrinsic apoptotic pathway and the extrinsic apoptotic 
pathway, involving activation of cell surface death receptors, such as the Fas 
receptor. Both pathways eventually converge with the activation of caspase-3, 
initiating a proteolytic cascade key to the apoptotic process (Gilmore, 2005; 
Chiarugi and Giannoni, 2008). Inhibition of anoikis is often observed in 
malignant cancers. Epithelial cells which acquire resistance to anoikis are able 
to survive after detachment from their primary site and metastasise to a 
secondary location (Simpson et al., 2008; Coates et al., 2010). 
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Therefore, it would be interesting to investigate whether cell death observed 
after ESCRT-I depletion in Caco-2 cells represents activation of the anoikis 
pathway. ESCRT proteins have been implicated in the regulation of integrins 
(Lobert et al., 2010) and therefore Tsg101 depletion may affect integrin levels in 
Caco-2 cells resulting in destabilisation of cell-ECM contacts. Initially, this may 
allow cells to detach from the ECM and migrate out of the epithelial monolayer, 
resulting in the formation of a multilayered epithelial sheet. However, 
detachment of cells may also induce cell death via anoikis which may account 
for the increase in caspase-3 activation observed in multilayered regions of 
Tsg101 knockdown cells. Alternatively, ESCRT depletion may cause 
multilayering of Caco-2 cells via a separate mechanism and in turn, these 
multilayered cells could then activate anoikis. Therefore, it is also possible that 
cell death is an indirect effect of ESCRT-I depletion.  
 
5.3.3. Inhibition of apoptosis may enhance the tumourigenic potential of 
ESCRT-I 
 
After extended culture of Tsg101 depleted Caco-2 cells, an increase in 
apoptosis results in cell number returning to a similar level as control. In 
addition, multilayering is reduced as the majority of cell death occurs in the 
multilayered areas of the epithelial sheet. However, initial results demonstrate 
that inhibition of caspases increases the number of ESCRT-I depleted Caco-2 
cells after 10 days culture. Furthermore, organisation of the epithelial sheet was 
extensively disrupted and multilayering of cells was enhanced. This supports 
previous work in Drosophila which demonstrates that inhibition of apoptosis 
causes dramatic overgrowth of ESCRT mutant cells to form tumourous growths 
capable of metastasis (Thompson et al., 2005; Herz et al., 2006; Rodahl et al., 
2009b). Although these experiments must be repeated to ensure the results are 
reproducible, it can be speculated that inhibition of apoptosis enhances the 
tumourigenic potential of ESCRT-I depletion in mammalian epithelial cells. 
Activation of caspases is a critical step in the apoptotic pathway, however, there 
are upstream events which may still occur, such as MOMP, and could result in 
caspase-independent apoptosis or other types of cell death such as necrosis 
(Dussmann et al., 2003). Therefore, it is possible that ESCRT depleted cells will 
eventually still die by another mechanism. This could be analysed further using 
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a general marker of cell viability such as propidium iodide. It would also be 
interesting to investigate whether Tsg101 knockdown increases the 
invasiveness of Caco-2 cells and if caspase inhibition enhanced this behaviour. 
This would provide further support for a tumour suppressor role of ESCRT-I. 
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5.4. Conclusion 
 
This study demonstrates that ESCRT-I depletion results in overproliferation of 
Caco-2 epithelial cells. Together with my previous data this highlights a role for 
ESCRT-I in regulation of epithelial cell proliferation and polarity, supporting 
previous observations in Drosophila (Vaccari and Bilder, 2009). Loss of cell 
polarity and self-sufficiency in growth signalling are two important hallmarks of 
cancer (Hanahan and Weinberg, 2011) and, therefore, ESCRT-I may function 
as a tumour suppressor in mammalian epithelial tissues. However, ESCRT-I 
depleted Caco-2 cells are eventually eliminated via apoptosis, although it is 
currently unclear whether this is a direct effect of Tsg101 knockdown. This 
suggests that the full tumourigenic potential of ESCRT proteins may not be 
exerted unless further alterations occur to allow epithelial cells to evade 
apoptosis. Considering the multi-step process of tumourigenesis this is a 
substantial possibility, especially as apoptosis is often inhibited in many human 
cancers (Lowe et al., 2004; Cotter, 2009; Hanahan and Weinberg, 2011). 
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6. FINAL DISCUSSION 
 
6.1. ESCRTs and Maintenance of Epithelial Cell Polarity 
 
6.1.1. ESCRT-I is required for epithelial organisation and polarity 
 
Since ESCRT proteins were classified as tumour suppressors in Drosophila, 
much effort has been made to elucidate the crucial role of the ESCRT 
machinery within the maintenance of epithelial tissue architecture in this 
species.  Disruption of the ESCRT machinery in Drosophila results in loss of 
epithelial cell polarity and overproliferation, two hallmarks of cancer (Vaccari 
and Bilder, 2009; Hanahan and Weinberg, 2011). This phenotype is attributed 
to a disruption in the trafficking of various proteins important for the regulation of 
polarity and growth in epithelial tissues.  
 
In vertebrates, ESCRTs are well characterised for their role within the endocytic 
pathway (Raiborg and Stenmark, 2009). Their importance within the regulation 
of receptor signalling pathways has been demonstrated and alterations in the 
expression of various ESCRT components have been observed in human 
cancers (Stuffers et al., 2009a; Wegner et al., 2011). However, a definitive link 
between the ESCRT proteins, mammalian epithelial cell polarity and 
tumourigenesis has not been investigated.  
 
This thesis demonstrates for the first time that the ESCRT-I component, Tsg101 
is required for the maintenance of mammalian epithelial cell polarity and 
organisation (Figure 6.1). Depletion of Tsg101 results in an aberrant epithelial 
phenotype with cells displaying impaired cell-cell junctions, reduced 
differentiation and enhanced migratory ability. In addition, in some regions of 
the epithelial sheet organisation and polarity are lost and cell proliferation is 
increased. Overall, these results suggest that the function of ESCRT-I as a 
tumour suppressor is conserved from Drosophila to vertebrates.  
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Figure 6.1 Tsg101 is required for maintenance of mammalian epithelial cell polarity and 
organisation. Caco-2 cells form a polarised epithelial monolayer with cell-cell junctions (blue) 
and distinct apical (red) and basolateral (green) membrane domains. When cells reach 
confluency differentiation occurs whereby junctions mature, lateral height increases and a brush 
border forms at the apical membrane. When Tsg101 is depleted via siRNA knockdown, Caco-2 
cells initially maintain apicobasal polarity however cell-cell junctions are disrupted and migratory 
ability is enhanced. In addition, Tsg101 depletion inhibits differentiation so lateral height and 
brush border formation are reduced. In some areas, Tsg101 depleted cells overproliferate and 
lose epithelial polarity and organisation forming a multilayered epithelial sheet with 
compromised apicobasal polarity.  
 
 
Loss of epithelial cell polarity and organisation following Tsg101 depletion 
demonstrated in chapter three of this thesis can be attributed to at least three 
possible mechanisms, discussed in detail below (Figure 6.2). Tsg101 depletion 
may perturb trafficking of proteins important for the maintenance of cell polarity, 
resulting in loss of polarised epithelial morphology and organisation. 
Alternatively, cellular overproliferation or destabilisation of cell-ECM contacts 
could disrupt organisation of the epithelial sheet and consequently polarised 
morphology is lost. It is currently unclear whether loss of epithelial cell polarity 
precedes loss of epithelial organisation or vice versa. It is also possible that 
these events occur simultaneously and therefore, a combination of the 
mechanisms detailed below may account for the effects of ESCRT depletion on 
epithelial morphology. 
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Figure 6.2 Three possible mechanisms for loss for epithelial cell polarity and 
organisation following ESCRT-I depletion in Caco-2 cells. (A) Maintenance of a polarised 
epithelium is a tightly regulated process. Localisation of various polarity complexes and 
formation of cell-cell junctions is crucial for establishment and maintenance of epithelial cell 
polarity. Protein trafficking appears to play an important role in this process and at least two 
tight junction components, claudin-1 and occludin, are constitutively endocytosed and recycled 
back to the plasma membrane in Caco-2 cells. In addition, lysosomal degradation may be 
important for maintenance of polarity. Epithelial cell proliferation is controlled through regulation 
of mitogenic signalling and contact inhibition. Lastly, cellular contacts with the ECM are required 
to retain a polarised epithelial monolayer. (B) ESCRT-I depletion results in the loss of epithelial 
polarity and organisation in Caco-2 cells. This may be attributed to at least three mechanisms. 
(i) Disrupted trafficking of proteins important for maintenance of polarity. ESCRT-I is required for 
localisation of claudin-1 and -4 to tight junctions. Trafficking of other junctional components and 
polarity complexes may also be affected by ESCRT-I depletion. (ii) Increased cell proliferation. 
ESCRT depletion may increase mitogenic signalling and inhibit contact inhibition. (iii) Loss of 
cell-ECM adhesion. ESCRT depletion may destabilise cellular contacts with the ECM. One or a 
combination of all three of these mechanisms could disrupt cell-cell adhesion, apicobasal 
polarity and signalling resulting in the aberrant epithelial phenotype associated with ESCRT-I 
depletion. 
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(i) ESCRT-I depletion affects trafficking of proteins important for 
maintenance of epithelial cell polarity  
Cell-cell junctions are important to retain a polarised epithelium, functioning to 
maintain apicobasal polarity and cell-cell adhesion (Shin et al., 2006; Bryant 
and Mostov, 2008; Coradini et al., 2011). In addition, it is becoming increasingly 
apparent that cell-cell junctions function as a platform for many regulatory and 
signalling proteins important for establishing the epithelial phenotype (Ivanov et 
al., 2005). Chapter four of this thesis demonstrates that the localisation of 
claudin-1 and -4 to tight junctions is dependent on ESCRT-I. Depletion of 
Tsg101 results in an intracellular accumulation of claudin-1 and -4 and is 
thought to be due to a block in the recycling of these junctional components 
back to the plasma membrane.  
 
Mislocalisation of claudin-1 and -4 alone is unlikely to explain the loss of polarity 
phenotype as claudin-1 knockout mice have an epidermal defect but do not 
appear to display a large scale loss of epithelial polarity (Furuse et al., 2002). 
However, epithelial cells contain many junctional proteins and it is possible that 
ESCRT function is required for their recycling. In addition, as ESCRTs are 
known to be important for endo-lysosomal trafficking, perturbations in the 
degradation of junction proteins may also affect cell-cell junction integrity. 
Destabilisation of cell-cell junctions could affect apicobasal polarity, cell-cell 
adhesion and signalling, all of which may contribute to the loss of epithelial cell 
polarity following Tsg101 depletion. Therefore, thorough analysis of the 
endosomal trafficking of additional junctional components should be conducted 
in the future using the biotinylation endocytosis and recycling assay. The effect 
of Tsg101 knockdown on these cell-cell junction proteins could then also be 
investigated.  
 
Localisation of various polarity complexes is also crucial for establishment and 
maintenance of epithelial cell polarity (Gibson and Perrimon, 2003; Suzuki and 
Ohno, 2006; Bryant and Mostov, 2008). In Drosophila, ESCRT function is 
required for the correct localisation of Crb, which is important for apical 
membrane identity (Moberg et al., 2005; Gilbert et al., 2009). Therefore, 
ESCRTs may also be required for the trafficking of polarity complexes in 
mammalian epithelial cells and disruption in these trafficking pathways may 
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contribute to the loss of polarity phenotype in Tsg101 depleted cells. It would be 
of interest to investigate the effect of Tsg101 knockdown on the localisation of 
CRB3, the mammalian homologue of Crb, in Caco-2 cells. This could be 
analysed in the first instance using confocal fluorescence microscopy. However, 
in Drosophila ESCRT mutant cells, Crb is mislocalised from the apical 
membrane to a sub-apical compartment (Moberg et al., 2005; Gilbert et al., 
2009). This may be difficult to determine using fluorescence microscopy, 
especially within multilayered regions of Tsg101 depleted cells, and therefore 
immuno-electron microscopy could also be used to identify any small changes 
in CRB3 localisation.  
 
(ii) ESCRT-I depletion causes overproliferation of epithelial cells 
Overproliferation may cause cells to stack up on top of one another, disrupting 
organisation of the epithelial monolayer and consequently perturbing apicobasal 
polarity. Chapter five of this thesis begins to investigate this, demonstrating that 
Tsg101 depleted cells overproliferate to form multilayered regions of the 
epithelial sheet which display compromised apicobasal polarity.  
 
There are at least two possible mechanisms to explain this overproliferation. 
Firstly, it may be due to an increase in mitogenic signalling. The ESCRT 
machinery has been identified as important for attenuation of receptor-mediated 
signalling and so ESCRT depletion may result in sustained mitogenic signalling 
and consequently cell proliferation may increase (Wegner et al., 2011). One 
signalling pathway which is enhanced in Drosophila ESCRT mutants is the 
EGFR pathway (Jekely and Rorth, 2003; Lloyd et al., 2006; Vaccari et al., 
2009). Reduced EGFR degradation and sustained signalling in response to 
EGF has also been demonstrated in cultured mammalian cells deficient in 
ESCRT function (Bache et al., 2006; Malerod et al., 2007; Raiborg et al., 2008). 
However, my results indicate that Tsg101 is not required for EGF degradation 
or attenuation of ERK signalling upon EGF treatment in polarised Caco-2 cells 
(Chapter 3). In addition, no alterations in constitutive ERK1/2 activation were 
observed 7 days after Tsg101 knockdown (Chapter 5). This suggests that 
overproliferation of Tsg101 depleted Caco-2 cells may not be due to a 
significant increase in the EGFR signalling pathway. To confirm this ERK1/2 
activation should be analysed at additional timepoints, using both 
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immunofluorescence microscopy and immunoblotting. In addition, protein levels 
and localisation of EGFR could also be investigated in order to establish 
whether Tsg101 knockdown affects trafficking of this receptor in Caco-2 cells.  
 
Another mitogenic signalling pathway which is deregulated in Drosophila 
ESCRT mutants is Notch signalling. Endosomal accumulation of Notch in 
ESCRT mutant cells results in increased Notch activation (Thompson et al., 
2005; Vaccari and Bilder, 2005; Herz et al., 2006; Vaccari et al., 2008; Herz et 
al., 2009; Vaccari et al., 2009). This has been shown to induce overproliferation 
in a non-cell autonomous manner via ectopic production of the secreted growth 
factor Upd and paracrine activation of the Jak-STAT signalling pathway 
(Thompson et al., 2005; Vaccari and Bilder, 2005; Herz et al., 2006; Herz et al., 
2009; Gilbert et al., 2009; Vaccari et al., 2009). Whether Notch accumulation is 
also responsible for the cell-autonomous overproliferation observed in 
Drosophila ESCRT mutants remains to be established. Therefore, it would be of 
interest to establish whether the Notch signalling pathway is affected by Tsg101 
depletion in Caco-2 cells. Notch protein levels and localisation could be 
analysed using immunoblotting and immunofluorescence microscopy, 
respectively. Notch activity could be investigated by analysing downstream 
effectors of the Notch signalling pathway, such as activation of Jak-STAT 
signalling. In addition, a Notch inhibitor could be applied to ESCRT depleted 
cells in order to investigate whether this stops the formation of multilayered 
regions. 
 
Alternatively, overproliferation of ESCRT-I depleted Caco-2 cells may be due to 
a loss of contact inhibition. Usually upon reaching confluency, Caco-2 cell 
proliferation will reduce as a result of contact inhibition and cells will begin to 
differentiate (Nelson and Daniel, 2002; Volpe, 2008). It is possible that ESCRT-I 
depletion inhibits contact inhibition and, as a result, cells continue proliferating 
for an extended period of time. This is supported by studies in Drosophila 
demonstrating that when epithelial tissues are predominantly mutant for ESCRT 
components, cells lose polarity, fail to differentiate and overgrow to form large 
masses lacking normal epithelial morphology. Interestingly, this overgrowth is 
thought to be due to an extended period of proliferation rather than an 
increased growth rate although the mechanism responsible for this is currently 
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unknown (Moberg et al., 2005; Vaccari and Bilder, 2005; Herz et al., 2009; 
Vaccari et al., 2009). 
 
In line with this, my results demonstrate that differentiation of Caco-2 cells is 
reduced upon Tsg101 depletion (Chapter 3). Therefore, this may suggest that 
Tsg101 depleted cells cannot sense their environment correctly and continue to 
divide instead of initiating the differentiation process. It is possible that ESCRT-I 
may be required for trafficking of proteins important for regulation of the contact 
inhibition process, such as components of the Hippo signalling pathway (Zeng 
and Hong, 2008). Indeed, Hippo signalling is deregulated in Drosophila Vps25 
mutants (Herz et al., 2006) suggesting that ESCRTs are important for regulation 
of this pathway.  Therefore if, and how, ESCRT proteins regulate contact 
inhibition are questions worth considering for the future.  
 
(iii) ESCRT-I depletion destabilises cellular contacts with the ECM 
Destabilisation of cellular contacts with the ECM can result in loss of basal 
adhesion. Consequently, cells may detach and lose epithelial organisation and 
polarity. The main components of cellular adhesions to the ECM are the cell 
surface transmembrane integrin receptors (Bosman et al., 1993; Matlin et al., 
2003; Lobert et al., 2010). Integrins regulate many aspects of cell behaviour 
and, in epithelial cells, are important for the maintenance of apicobasal polarity 
(Eaton and Simons, 1995; Matlin et al., 2003). A role for ESCRT proteins in the 
regulation of integrins has been recently suggested in fibroblasts (Lobert et al., 
2010). It is possible that ESCRT proteins function to regulate integrins in 
epithelial cells and therefore, the effect of Tsg101 depletion on integrin 
expression and localisation warrants further investigation.   
 
6.1.2. Importance of other ESCRT proteins 
 
This thesis reveals a requirement for Tsg101, an ESCRT-I component, within 
the maintenance of mammalian epithelial organisation and polarity. This study 
also investigated the role of the ESCRT-II component, Vps25, and results 
demonstrate that epithelial organisation and polarity are not perturbed in 2D 
cultures. However, depletion of Vps25 significantly reduced formation of 
polarised 3D epithelial cysts suggesting that Vps25 may also be important for 
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epithelial polarisation. Incidences whereby defects in epithelial cell polarity were 
only apparent upon growth of cells in 3D cultures have also been observed in 
other studies (Roh et al., 2003; Martin-Belmonte et al., 2007; Torkko et al., 
2008), suggesting that 3D cell cultures may provide a more sensitive assay for 
detecting defects in epithelial cell polarity. Epithelial cyst formation is often 
considered to be a more physiologically relevant method of investigating 
epithelial cell polarity in vitro (Martin-Belmonte and Mostov, 2008) and therefore 
this highlights the necessity to utilise a variety of methods to fully characterise a 
knockdown phenotype in polarised epithelial cells. The level of Vps25 
knockdown may also affect the severity of the phenotype observed in 2D cell 
cultures. Therefore, it would be of interest to try and increase efficiency of 
Vps25 knockdown and determine whether this results in a stronger loss of 
polarity phenotype. 
 
In the future it would also be important to extend this investigation in order to 
analyse the role of other components of the ESCRT machinery. The effect of 
siRNA knockdown of ESCRT-0, -I, -II and -III proteins on mammalian epithelial 
cell polarity could be investigated, using both 2D and 3D cell culture systems. 
Reduced expression of the ESCRT-I component, Vps37A, and ESCRT-III 
component, CHMP1A, have been associated with human tumours (Xu et al., 
2003; Bache et al., 2004; Li et al., 2008). Therefore, it would be interesting to 
begin by investigating how siRNA knockdown of these proteins affects Caco-2 
epithelial cell polarity. In addition, the ESCRT-I protein, Vps28, ESCRT-II 
proteins, Vps22 and Vps36, and ESCRT-III proteins, Vps20 (CHMP6), Vps32 
(CHMP4), Vps2 (CHMP2), have been identified as important for regulation of 
epithelial cell polarity in Drosophila (Herz et al., 2009; Vaccari et al., 2009). 
Therefore, thorough analysis of other ESCRT components would expand our 
knowledge on the importance of the ESCRT machinery within the maintenance 
of mammalian epithelial cell polarity.  
 
6.2. ESCRTs: Tumour Suppressors in Vertebrates? 
 
Results presented in this thesis demonstrate that ESCRT-I is required for the 
maintenance of epithelial cell polarity and organisation in both 2D and 3D 
mammalian cell culture models. In addition, regulation of epithelial cell 
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proliferation is dependent on ESCRT-I function. This phenotype is extremely 
similar to that observed in Drosophila (reviewed in Vaccari and Bilder, 2009) 
and suggests that ESCRT-I acts as a tumour suppressor in mammalian 
epithelial tissues. Loss of epithelial polarity and self-sufficiency in growth 
signalling are two important hallmarks of human cancers. In addition to this, my 
results also demonstrate that loss of ESCRT-I function results in reduced 
cellular differentiation and enhanced migratory ability, characteristics often 
attributed to tumourigenic cells (Hanahan and Weinberg, 2011).   
 
Links between ESCRT proteins and human cancers have been documented 
previously with aberrant Tsg101 transcripts observed in various tumours 
including breast (Lee and Feinberg, 1997), cervical (O’Boyle et al., 1999) and 
small cell lung cancer (Oh et al., 1998). In addition, reduced expression of 
Tsg101 (Bennett et al., 2001), Vps37A (Xu et al., 2003; Bache et al., 2004) and 
CHMP1A (Li et al., 2008) has been associated with various human tumours. In 
the future it would be interesting to investigate expression levels of ESCRT 
proteins in different human tumour samples. This would provide more clinical 
relevance for the involvement of ESCRTs in carcinogenesis. It is also important 
to note that overexpression of ESCRTs has been associated with various 
human cancers (Liu et al., 2002; Oh et al., 2007; Toyoshima et al., 2007; Young 
et al., 2007). This implies that ESCRT proteins can also exhibit oncogenic 
properties, although it has also been suggested that overexpressed protein may 
be acting as a dominant negative (Vaccari et al., 2009). The effect of ESCRT 
protein overexpression on epithelial cell organisation and polarity may therefore 
be worth considering in the future. 
 
Importantly, this study also demonstrates that ESCRT depleted cells are more 
susceptible to cell death via apoptosis. Inhibition of this apoptotic response 
enhances the aberrant epithelial phenotype, as demonstrated by my preliminary 
results (Chapter 5) and those conducted in Drosophila (Thompson et al., 2005; 
Herz et al., 2006; Rodahl et al., 2009b). Therefore, it seems that the ability to 
evade apoptosis is an important factor in determining the tumourigenic potential 
of ESCRT protein depletion. It is possible that disruption of the ESCRT 
machinery will only result in tumour formation when cell death is inhibited. 
Tumourigenesis is a multi-step process and there is mounting evidence that 
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apoptosis is blocked in most human cancers (Hanahan and Weinberg, 2000; 
Lowe et al., 2004; Cotter, 2009; Hanahan and Weinberg, 2011). Therefore, the 
possibility of epithelial cells acquiring the ability to evade cell death in addition to 
loss of ESCRT function is feasible.  
 
In conclusion, this thesis along with previous data generated in the field, 
suggests that ESCRT proteins are important tumour suppressors, a role which 
is conserved from Drosophila to vertebrates. 
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